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Preface 
This thesis is the collection of our search for environmently friendlier atom transfer 
radical polymerization (ATRP) and protein nanoreactors, that was conducted in the 
group of Nico Bruns and Wolfgang Meier at the University of Basel from October 
2009 until November 2013. The thesis is divided into ten chapters where each 
corresponds to different research projects inspired and influenced by each other. The 
corresponding current state of the research is also enclosed in each chapter along with a 
brief introduction in this particular domain. Original publications were rearanged and 
reformatted so as not to impede the reading flow of the thesis. The experimental 
data, a full list of publications, as well as a curriculum vitae can be found in the 
appendices at the end of this thesis.  
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1 General Introduction1 
 
  
 
 
The advent of controlled radical polymerizations has made polymer science a key 
discipline for the preparation of nano-, biomedical-, and high tech-materials. Atom 
transfer radical polymerization (ATRP) is one of the most widely applied controlled 
radical polymerization. However, an ongoing quest is to develop ATRP reaction 
conditions that allow reducing the amount of catalyst needed, e.g by confining the 
reaction into a nanoreactor, or to replace the currently used transition metal complex 
catalysts with less toxic ones, e.g. enzymes. 
 
 
 
 
 
 
 
 
 
 
                                           
1  Parts of this chapter were published in: a) K. Renggli, M. Spulber, J. Pollard, M. Rother, N. 
Bruns, ACS Symp. Ser. 2013, 1144, 163–171 b) T. B. Silva, M. Spulber, M. K. Kocik, F. Seidi, H. 
Charan, M. Rother, S. J. Sigg, K. Renggli, G. Kali, N. Bruns, Biomacromolecules 2013, 14, 
2703–2712 c) G. Kali, T. B. Silva, S. J. Sigg, F. Seidi, K. Renggli, N. Bruns, ACS Symp. Ser. 
2012, 1011, 171–181 d) K. Renggli, M. G. Nussbaumer, R. Urbani, T. Pfohl, N. Bruns, Angew. 
Chem. Int. Ed. 2014, 53, 1443–1447 e) K. Renggli, P. Baumann, K. Langowska, O. Onaca, N. 
Bruns, W. Meier, Adv. Funct. Mater. 2011, 21, 1241–1259. 
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1.1 Radical Polymerization 
Radical polymerizations are one of the most widely employed reactions used to 
synthesize polymers on an industrial scale or in academic labs, principally due to its 
simplicity and tolerance of functional groups. Products like polystyrene (e.g. 
Styrofoam), polymethylmethacrylate (Plexiglass), and polyvinylchloride (PVC) are all 
synthesized on a scale of millions of tons per year worldwide by free radical 
polymerization, i.e. a chain growth polymerization in which the active, propagating 
species are radicals. These radicals are highly reactive and readily undergo termination 
and side reactions that interrupt the growth of a polymer chain.2 Due to the short life-
span of the growing chains, they are active for about 1 s, chemical control of these 
reactions is poor, giving rise to ill-defined molecular weights and preventing end-
group-functionalization of polymer chains.3 Poor control represents the main drawback 
of the method, especially when well-defined molecular weights, architectures, 
sequences of monomers, and functional chain end groups are desired. An example 
where well-defined molecular weights are desired are block copolymers, e.g. as 
emulsifiers, as drug-delivery systems, as building blocks for nanostructures, and as 
materials in solar cells and batteries.4 The formation of conjugates of polymers and 
proteins, e.g. for therapeutic applications, relies on the well-defined end-group 
chemistry of polymers.5 If control of radical polymerization is achieved, some 
materials' applications, e.g. self-healing plastics, can be implemented.6 Over the last 
two decades, synthesis techniques have been developed that allow a degree of control 
of radical polymerizations, such as atom transfer radical polymerization (ATRP), 
reversible addition-fragmentation chain transfer (RAFT) polymerization, and nitroxide-
mediated radical polymerization (NMP).7 
However, radical polymerizations are not limited to man-made processes. Nature 
uses radical polymerization to produce a variety of biopolymers.8 The prime example is 
the synthesis of lignin by an enzyme-catalyzed coupling between aromatic 
compounds.9 Lignin's key function is to strengthen wood, and it is the second most 
                                           
2  W. A. Braunecker, K. Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146. 
3  a) M. Ouchi, T. Terashima, M. Sawamoto, Chem. Rev. 2009, 109, 4963–5050 b) W. A. 
Braunecker, K. Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146. 
4  a) K. Renggli, P. Baumann, K. Langowska, O. Onaca, N. Bruns, W. Meier, Adv. Funct. Mater. 
2011, 21, 1241–1259 b) S. Egli, M. G. Nussbaumer, V. Balasubramanian, M. Chami, N. Bruns, 
C. Palivan, W. Meier, J. Am. Chem. Soc. 2011, 133, 4476–4483 c) O. Onaca, R. Enea, D. W. 
Hughes, W. Meier, Macromol. Biosci. 2009, 9, 129–139 d) K. Kita-Tokarczyk, J. Grumelard, T. 
Haefele, W. Meier, Polymer 2005, 46, 3540–3563 e) P. D. Topham, A. J. Parnell, R. C. Hiorns, J. 
Polym. Sci. B Polym. Phys. 2011, 49, 1131–1156. 
5  a) H.-A. Klok, Macromolecules 2009, 42, 7990–8000 b) K. L. Heredia, H. D. Maynard, Org. 
Biomol. Chem. 2007, 5, 45–53. 
6  H. P. Wang, Y. C. Yuan, M. Z. Rong, M. Q. Zhang, Macromolecules 2010, 43, 595–598. 
7  a) K. Matyjaszewski, Macromolecules 2012, 45, 4015–4039 b) W. A. Braunecker, K. 
Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146. 
8  R. J. P. Williams, E. C. Baughan, R. L. Willson, Philos. Trans. R. Soc., B 1985, 311, 593–603. 
9  R. Hatfield, W. Vermerris, Plant Physiol. 2001, 126, 1351–1357. 
 15 
abundant polymer on earth.10 However, the manner in which Nature controls this 
polymerization is not fully understood and is a topic of ongoing scientific debate.11 
Enzymes are environmentally friendly, sustainable, and non-toxic catalysts.12 They 
are derived from natural sources, are completely biodegradable (and even edible), and 
work under mild conditions such as ambient temperature, ambient pressure and in 
aqueous solution. Moreover, they are highly selective, allowing for desired regio-, 
stereo-, or chemo-selective transformations. Not surprisingly, enzymes have been 
extensively used in vitro to the benefit of synthetic chemists, and are often considered 
as green alternatives to conventional catalysts.13 Indeed, many enzymatic reactions 
have been exploited for the synthesis of polymers, including polycondensation, ring-
opening polymerizations, free radical polymerizations of vinyl-type monomers and the 
polymerization of aromatic compounds by radical-induced oxidative coupling.14 
However, controlled/living radical polymerizations catalyzed by enzymes remained 
unknown. Recently our group15 and di Lena and coworkers16 discovered concurrently 
and independently that some metalloproteins can mediate ATRP. These findings 
represent the first reports of biocatalytic, controlled/living radical polymerization. 
Since the middle of the 1990s, controlled/living radical polymerizations such as 
ATRP have become some of the most widely used polymerization techniques in 
academic research,17 applicable to most common monomers such as styrene, and 
(meth)acrylates.18 ATRP allows for the synthesis of well-defined polymers with 
predetermined molecular weights, low molecular weight distributions, complex 
polymer architectures, as well as polymer chains terminated by functional groups. In 
ATRP, an organic halide initiator reacts with a low-oxidation-state transition metal 
catalyst, most commonly complexes of CuI, RuII, and FeII.19 This results in a high 
                                           
10  W. Boerjan, J. Ralph, M. Baucher, Annu. Rev. Plant Biol. 2003, 54, 519–546. 
11  a) R. Hatfield, W. Vermerris, Plant Physiol. 2001, 126, 1351–1357 b) W. Boerjan, J. Ralph, M. 
Baucher, Annu. Rev. Plant Biol. 2003, 54, 519–546 c) B. Pickel, M.-A. Constantin, J. Pfannstiel, 
J. Conrad, U. Beifuss, A. Schaller, Angew. Chem. Int. Ed. 2009, 49, 202–204. 
12  F. Hollmann, I. W. C. E. Arends, Polymers 2012, 4, 759–793. 
13  a) S. Kobayashi, A. Makino, Chem. Rev. 2009, 109, 5288–5353 b) F. Hollmann, I. W. C. E. 
Arends, Polymers 2012, 4, 759–793 c) P. Walde, Z. Guo, Soft Matter 2011, 7, 316–331 d) K. 
Loos, Ed., Biocatalysis in Polymer Chemistry, Wiley-VCH Verlag GmbH & Co. KGaA, 2010. 
14  a) S. Kobayashi, A. Makino, Chem. Rev. 2009, 109, 5288–5353 b) F. Hollmann, I. W. C. E. 
Arends, Polymers 2012, 4, 759–793 c) P. Walde, Z. Guo, Soft Matter 2011, 7, 316–331 d) K. 
Loos, Ed., Biocatalysis in Polymer Chemistry, Wiley-VCH Verlag GmbH & Co. KGaA, 2010. 
15  a) S. J. Sigg, F. Seidi, K. Renggli, T. B. Silva, G. Kali, N. Bruns, Macromol. Rapid Commun. 
2011, 32, 1710–1715 b) T. B. Silva, M. Spulber, M. K. Kocik, F. Seidi, H. Charan, M. Rother, S. 
J. Sigg, K. Renggli, G. Kali, N. Bruns, Biomacromolecules 2013, 14, 2703–2712 c) G. Kali, T. B. 
Silva, S. J. Sigg, F. Seidi, K. Renggli, N. Bruns, ACS Symposium Series, American Chemical 
Society, Washington, DC, 2012. 
16  a) Y.-H. Ng, F. di Lena, C. L. L. Chai, Polym. Chem. 2011, 2, 589 b) Y.-H. Ng, F. di Lena, C. L. 
L. Chai, Chem. Commun. 2011, 47, 6464–6466. 
17  a) K. Matyjaszewski, J. S. Wang, J. Am. Chem. Soc. 1995, 117, 5614–5615 b) M. Kato, M. 
Kamigaito, M. Sawamoto, T. Higashimura, Macromolecules 1995, 28, 1721–1723. 
18  a) W. A. Braunecker, K. Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146 b) N. V. Tsarevsky, 
K. Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299 c) M. Ouchi, T. Terashima, M. Sawamoto, 
Chem. Rev. 2009, 109, 4963–5050 d) F. di Lena, K. Matyjaszewski, Prog. Polym. Sci. 2010, 35, 
959–1021 e) K. Matyjaszewski, Macromolecules 2012, 45, 4015–4039. 
19  a) M. Ouchi, T. Terashima, M. Sawamoto, Chem. Rev. 2009, 109, 4963–5050 b) F. di Lena, K. 
Matyjaszewski, Prog. Polym. Sci. 2010, 35, 959–1021. 
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oxidation state metal halide complex and an organic radical, which undergoes chain 
propagation. The halogen atom transfer is an equilibrium reaction, so that the halide is 
transferred back from the catalyst to the polymer radical. This effectively interrupts 
chain growth until the dormant, halide-terminated polymer chain is reactivated. By this 
process, the radical concentration in the reaction mixture at any given time is low; as a 
result, termination reactions are suppressed. Although ATRP has considerable 
commercial potential, conventional ATRP has some drawbacks. It is carried out with 
transition metal complexes as catalysts, most often CuI complexes. These catalysts are 
difficult to remove from the polymer product. Due to the (mild) toxicity of transition 
metal ions and amine ligands, the catalysts interfere with the application of the 
resulting polymers in biomedical and food grade applications.20 Moreover, copper ion 
and amine ligand residues in polymers also represent a problem for technical 
applications in plastics, as they cause unwanted colouration.21 
Three approaches have been followed in order to make ATRP environmentally 
more favorable, i.e. greener and the resulting polymers more compatible with medical 
and food grade requirements. One approach is the substitution of copper complexes 
with non-toxic catalysts that are based e.g. on iron ions.22 However, iron-based ATRP 
catalysts often have much poorer catalytic properties compared to their copper 
counterparts. The second approach is to reduce the amount of catalyst required by 
designing catalysts with higher activity and better performance or by changing the 
experimental protocol.23 In particular, the development of techniques such as activators 
regenerated by electron transfer (ARGET) ATRP, and initiators for continuous 
activator regeneration (ICAR) ATRP has permitted a reduction in catalyst 
concentration to the ppm range. In both methods, a reagent (a reducing agent in 
ARGET, a radical source in ICAR) is added to the reaction mixture in excess, so that 
inactive, high oxidation state metal complexes that accumulate due to termination 
reactions are regenerated to their ATRP-active, lower oxidation state, allowing the 
starting concentration of catalyst to be reduced significantly.24 The third approach is to 
remove the catalyst from the polymerization solution at the end of the reaction, e.g. by 
simple filtration over aluminium oxide columns, scavenging with ion exchange resins, 
or using Cu-complexes immobilized on solid supports.25 
 
                                           
20  a) L. Mueller, K. Matyjaszewski, Macromol. React. Eng. 2010, 4, 180–185 b) N. V. Tsarevsky, 
K. Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299. 
21  L. Mueller, K. Matyjaszewski, Macromol. React. Eng. 2010, 4, 180–185. 
22  a) F. di Lena, K. Matyjaszewski, Prog. Polym. Sci. 2010, 35, 959–1021 b) M. Ouchi, T. 
Terashima, M. Sawamoto, Chem. Rev. 2009, 109, 4963–5050. 
23  a) W. A. Braunecker, K. Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146 b) N. V. Tsarevsky, 
K. Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299 c) K. Matyjaszewski, W. Jakubowski, K. 
Min, W. Tang, J. Huang, W. A. Braunecker, N. V. Tsarevsky, Proc. Natl. Acad. Sci. 2006, 103, 
15309–15314. 
24  W. A. Braunecker, K. Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146. 
25  a) N. V. Tsarevsky, K. Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299 b) L. Mueller, K. 
Matyjaszewski, Macromol. React. Eng. 2010, 4, 180–185. 
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1.2 Nanoreactors 
In the macroscopic world, a chemical reactor is a conventional reaction vessel that 
constrains a chemical reaction within a defined volume. Substrates are fed into reactors 
through valves or openings, and products are retrieved from the reactor via similar 
means. Often, a catalyst is present in the reactor to facilitate the reaction. The 
advantages of chemical reactors include the opportunity to control reaction conditions 
internally in a precise manner, e.g. by selection of solvents, by setting the temperature, 
and by speed and mode of agitation. In the micro- and nanoworlds, compartments can 
be found or generated that also enclose a solvent-filled volume and sequester it from 
the bulk medium. If a chemical reaction is confined to such a compartment, e.g. by 
encapsulation of a catalytic species, these compartments can be considered nanoscale 
reactors.26 The advantages that arise from such conditions are manifold, but they do not 
coincide with all of the reasons that macroscopic reactors are usually used. In a 
nanoreactor, the catalyzed reaction itself might be subject to greater control or 
selectivity as a result of the confined space available.27 Furthermore, substrates or 
intermediates might be enriched inside of the nanoreactor as compared to the outside 
environment, thereby increasing the catalytic rate.28 Toxic or unstable substances, e.g. 
the catalyst or intermediates, may be sequestered from bulk medium, reducing the 
toxicity of the system or enhancing the stability of the catalyst.29 Moreover, because of 
their small size, nanoreactors are ideal vessels for reactions within living tissue in the 
context of drug-delivery,30 or immobilized on surfaces as e.g. sensors.31 
Confined reaction spaces that span various length scales ranging from the 
macroscopic world down to nanosized structures are found abundantly in biological 
systems. The controlled and selective exchange of substances across the confining 
layer is a characteristic hallmark of life. Every organism is a macroscopic entity with a 
distinct inner volume in which complex chemical transformations occur. This internal 
volume is separated from the environment by a boundary layer, e.g. the skin. Likewise, 
cells can be regarded as very complex microreactors. The cell membrane encloses 
catalytically active species, i.e. enzymes, in a confined volume. It controls access and 
release of substances into and out of the cell by a variety of pores and active and 
                                           
26  a) D. M. Vriezema, M. Comellas Aragonès, J. A. A. W. Elemans, J. J. L. M. Cornelissen, A. E. 
Rowan, R. J. M. Nolte, Chem. Rev. 2005, 105, 1445–1490 b) M. Uchida, M. T. Klem, M. Allen, 
P. Suci, M. Flenniken, E. Gillitzer, Z. Varpness, L. O. Liepold, M. Young, T. Douglas, Adv. 
Mater. 2007, 19, 1025–1042 c) A. de la Escosura, R. J. M. Nolte, J. J. L. M. Cornelissen, J. 
Mater. Chem. 2009, 19, 2274 d) K. T. Kim, S. A. Meeuwissen, R. J. M. Nolte, J. C. M. van Hest, 
Nanoscale 2010, 2, 844 e) K. Renggli, P. Baumann, K. Langowska, O. Onaca, N. Bruns, W. 
Meier, Adv. Funct. Mater. 2011, 21, 1241–1259 f) M. Marguet, C. Bonduelle, S. Lecommandoux, 
Chem. Soc. Rev. 2013, 42, 512. 
27  a) B. Helms, S. J. Guillaudeu, Y. Xie, M. McMurdo, C. J. Hawker, J. M. J. Fréchet, Angew. 
Chem. 2005, 117, 6542–6545 b) P. Cotanda, N. Petzetakis, R. K. O'Reilly, MRS Commun. 2012, 
2, 119–126 c) P. B. Zetterlund, Macromol. Theory Simul. 2011, 20, 660–666 d) P. B. Zetterlund, 
Polym. Chem. 2011, 2, 534–549. 
28  M. Kimura, M. Kato, T. Muto, K. Hanabusa, Macromolecules 2000, 33, 1117–1119. 
29  E. M. Sampson, T. A. Bobik, J. Bacteriol. 2008, 190, 2966–2971. 
30  P. Tanner, V. Balasubramanian, C. G. Palivan, Nano Lett. 2013, 13, 2875–2883. 
31  a) M. Grzelakowski, O. Onaca, P. Rigler, M. Kumar, W. Meier, Small 2009, 5, 2545–2548 b) A. 
Napoli, M. J. Boerakker, N. Tirelli, R. J. M. Nolte, N. A. J. M. Sommerdijk, J. A. Hubbell, 
Langmuir 2004, 20, 3487–3491. 
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passive mechanisms. Moreover, organelles within cells provide another, smaller level 
of compartmentalization. Organelles are also equipped with various means to 
selectively exchange materials with the cytosol. Nature manages to stabilize and 
protect catalytically active species by separating the reaction space within cells and 
organelles from the surrounding environment. The reaction conditions, e.g. pH or 
concentration of certain substrates in the compartments, are controlled in order to 
influence the course of reactions. Another important feature of Nature’s micro- and 
nanocompartments is spatial control of individual reaction steps in various complex 
reaction cascades.   
When chemical reactions are carried out under man-made conditions, e.g. in 
organic synthesis, they are often conducted in homogeneous solution. However, 
Nature’s strategy of compartmentalization shows that confining reactions to 
microscopic or nanoscopic volumes can yield tremendous advantages. Reaction 
compartments permit the study of the influence of spatial confinement on chemical 
reactions and provide an opportunity to perform organic synthetic transformations in 
‘exotic’ environments, e.g. biocatalysis in organic solvents32 or in living cells.33 
Therefore, reaction compartments have attracted much attention recently.34 Given that 
their size is most often below 500 nm in diameter, they are referred to as nanoreactors. 
However, reference to size range is vague and the term is also used for larger structures 
– some authors speak of microreactors instead.  
 
 
 
Figure 1.1 Concept of selective and responsive nanoreactors. a) Selective nanoreactors allow 
only specific molecules to enter the inner cavity while others are blocked from entering. Selection 
criteria can be size, charge or hydrophobicity of the diffusing molecules, amongst others. b) 
Responsive or gated nanoreactors possess pores in the membrane that open or close upon a particular 
trigger. This trigger can be an external stimulus such a change in pH, the presence of certain reagents, 
or a change in the local environment of the pores, such as the potential across the shell of the 
nanoreactor. 
 
                                           
32  N. Bruns, J. C. Tiller, Nano Lett. 2005, 5, 45–48. 
33  P. Tanner, V. Balasubramanian, C. G. Palivan, Nano Lett. 2013, 13, 2875–2883. 
34  a) D. M. Vriezema, P. M. L. Garcia, N. S. Oltra, N. S. Hatzakis, S. M. Kuiper, R. J. M. Nolte, A. 
E. Rowan, J. C. M. van Hest, Angew. Chem. Int. Ed. 2007, 46, 7378–7382 b) K. Kita-Tokarczyk, 
J. Grumelard, T. Haefele, W. Meier, Polymer 2005, 46, 3540–3563 c) A. Mecke, C. Dittrich, W. 
Meier, Soft Matter 2006, 2, 751–759 d) T. S. Koblenz, J. Wassenaar, J. N. H. Reek, Chem. Soc. 
Rev. 2008, 37, 247–262 e) A. de la Escosura, R. J. M. Nolte, J. J. L. M. Cornelissen, J. Mater. 
Chem. 2009, 19, 2274 f) S. F. M. van Dongen, M. Nallani, J. Cornelissen, R. J. M. Nolte, J. C. M. 
van Hest, Chem. Eur. J. 2009, 15, 1107–1114 g) P. A. Monnard, M. S. DeClue, H. J. Ziock, Curr. 
Nanosci. 2008, 4, 71–87. 
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We define a nanoreactor as a compartment with a radius of ≤ 100 nm that encloses 
a volume of solvent in which a chemical reaction occurs (Figure 1.1). Substrates can 
enter the reactor through the confining layer while products either accumulate inside 
the nanoreactor or are released into the bulk medium. In most cases the reaction is 
confined to the nanoreactor because the catalyst is encapsulated there. Selective 
nanoreactors are considered to be those reaction compartments with a shell that 
discriminates among molecules, allowing certain molecular species to enter or leave 
the nanoreactor while others are blocked from entering the cavity (Figure 1.1a). This 
can be achieved either by means of the intrinsic, semipermeable properties of the 
boundary layer or by selective pores. While the intrinsic permeability of the confining 
layer, e.g. a membrane, selects molecules based on size or polarity, pores can also be 
selective, allowing only a certain kind of molecule with a distinct chemical identity to 
pass. Some membranes and pores can also change their permeability upon exposure to 
an external, triggering stimulus, and thus show gated, or switchable behavior (Figure 
1.1b). 
The most widely studied biomimetic nanocompartments are liposomes, which are 
vesicular structures formed by lipids in aqueous solution.35 These vesicles are 
spherical, self-closing structures with a lipid bilayer membrane that entrap a portion of 
aqueous phase in their interiors. The formation of these superstructures is based on the 
self-assembly of defined amphiphilic lipid building blocks in an aqueous system under 
osmotically-balanced conditions. Hence, liposomes can be employed as carriers by 
entrapping a hydrophilic cargo in their cavities or a hydrophobic cargo in their 
membranes. A large variety of liposome-based carrier systems have been developed,36 
especially for drug-delivery purposes, as liposomes are usually safe and 
biodegradable.37 Liposomes have also been employed as nanoreactors, e.g. by 
encapsulating different enzymes in their cavities while retaining their biocatalytic 
activity.38 However, liposomes have several drawbacks that hamper their applications. 
Structural defects and mechanical instability lead to significant leakage.39 In 
biomedical applications, the short circulation lifetime of liposomes and their interaction 
with lipo-proteins is a disadvantage.40 The fundamental characteristics of liposome 
                                           
35  Y. Barenholz, Curr. Opin. Colloid Interface Sci. 2001, 6, 66–77. 
36  a) A. Jesorka, O. Orwar, Annu. Rev. Anal. Chem. 2008, 1, 801–832 b) Y. Barenholz, Curr. Opin. 
Colloid Interface Sci. 2001, 6, 66–77. 
37  a) P. Goyal, K. Goyal, S. G. Vijaya Kumar, A. Singh, O. P. Katare, D. N. Mishra, Acta Pharm. 
2005, 55, 1–25 b) Y. Malam, M. Loizidou, A. M. Seifalian, Trends Pharmacol. Sci. 2009, 30, 
592–599 c) G. M. El Maghraby, B. W. Barry, A. C. Williams, Eur. J. Pharm. Sci. 2008, 34, 203–
222 d) S. Ganta, H. Devalapally, A. Shahiwala, M. Amiji, J. Controlled Release 2008, 126, 187–
204. 
38  A. Jesorka, O. Orwar, Annu. Rev. Anal. Chem. 2008, 1, 801–832. 
39  M. C. Woodle, D. D. Lasic, Biochim. Biophys. Acta, Biomembr. 1992, 1113, 171–199. 
40  Y. Barenholz, Curr. Opin. Colloid Interface Sci. 2001, 6, 66–77. 
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nanoreactors as well as their diverse applications have been reviewed extensively 
elsewhere41 and are beyond the scope of this thesis.  
In addition to liposomes, several other nanovessels have been investigated as 
potential nanoreactors. These nanoreactors range from swollen domains in polymer 
networks,42 to polymer vesicles.43 All these systems have in common that they enclose 
a catalyst, most often enzymes, inside a cavity surrounded by a shell or interface. This 
boundary layer is either selectively permeable for substrates and products, or they 
encompasse pores that allow for the exchange of matter between the inside and the 
outside of the nanoreactor. Thus, the activity and the substrate selectivity of the 
enclosed catalyst in such systems do not only depend on the intrinsic properties of the 
catalyst, but also on the tailored properties of the nanoreactor.44 Nature provides 
intriguing nanovessels with defined pores in the form of protein cages, the best known 
being ferritin and viral capsids.45 
                                           
41  a) A. Jesorka, O. Orwar, Annu. Rev. Anal. Chem. 2008, 1, 801–832 b) Y. Barenholz, Curr. Opin. 
Colloid Interface Sci. 2001, 6, 66–77 c) P. Goyal, K. Goyal, S. G. Vijaya Kumar, A. Singh, O. P. 
Katare, D. N. Mishra, Acta Pharm. 2005, 55, 1–25 d) Y. Malam, M. Loizidou, A. M. Seifalian, 
Trends Pharmacol. Sci. 2009, 30, 592–599 e) G. M. El Maghraby, B. W. Barry, A. C. Williams, 
Eur. J. Pharm. Sci. 2008, 34, 203–222 f) S. Ganta, H. Devalapally, A. Shahiwala, M. Amiji, J. 
Controlled Release 2008, 126, 187–204 g) M. C. Woodle, D. D. Lasic, Biochim. Biophys. Acta, 
Biomembr. 1992, 1113, 171–199 h) N. Düzgünes, Liposomes, Part B, Elsevier, Amsterdam, 2003 
h) D. D. Lasic, D. Papahadjopoulos, Eds., Medical Applications of Liposomes, Elsevier, 
Amsterdam, 1998. 
42  a) N. Bruns, J. C. Tiller, Nano Lett. 2005, 5, 45–48 b) K. Henzler, P. Guttmann, Y. Lu, F. Polzer, 
G. Schneider, M. Ballauff, Nano Lett. 2013, 13, 824–828. 
43  a) R. J. R. W. Peters, I. Louzao, J. C. M. van Hest, Chem. Sci. 2012, 3, 335 b) J. Gaitzsch, D. 
Appelhans, L. Wang, G. Battaglia, B. Voit, Angew. Chem. Int. Ed. 2012, 51, 4448–4451 c) A. Lu, 
R. K. O'Reilly, Curr. Opin. Biotechnol. 2012, 1–7. 
44  K. Renggli, P. Baumann, K. Langowska, O. Onaca, N. Bruns, W. Meier, Adv. Funct. Mater. 
2011, 21, 1241–1259. 
45  a) A. de la Escosura, R. J. M. Nolte, J. J. L. M. Cornelissen, J. Mater. Chem. 2009, 19, 2274 b) K. 
Renggli, P. Baumann, K. Langowska, O. Onaca, N. Bruns, W. Meier, Adv. Funct. Mater. 2011, 
21, 1241–1259 c) M. Uchida, M. T. Klem, M. Allen, P. Suci, M. Flenniken, E. Gillitzer, Z. 
Varpness, L. O. Liepold, M. Young, T. Douglas, Adv. Mater. 2007, 19, 1025–1042. 
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1.3 Scope of the Thesis 
The aim of the present thesis is the generation of new approaches to render atom 
transfer radical polymerization (ATRP) environmentally friendlier, e.g. by conjugating 
the ATRP catalyst to proteins that can be removed after polymerization. Furthermore, 
the conjugation of ATRP catalysts into the cavities of protein cages results in protein 
nanoreactors, where the catalytic species is enclosed in a confined space. Such 
nanoreactors could allow the modulation of controlled/living radical polymerization by 
external triggers. 
The first task is to identify potential proteins to be conjugated to ATRP catalysts. 
Proteins display different functionalities that could enhance the attached ATRP catalyst 
with  additional properties. Dependent on the protein and its desired functionality, an 
adequate conjugation chemistry has to be determined and the gained protein-catalyst 
conjugates have to be tested towards ATRP synthesis methods. With an established 
synthesis route for protein-catalyst conjugates and with a good performing 
polymerization technique, we will be able to screen for beneficial effects of proteins 
for ATRP. 
Globular proteins could act as handles for the catalyst which enable to precipitate 
the attached catalyst in order to reduce the final concentration of the transition metal 
catalyst in polymers synthesized by ATRP. Moreover, the conjugation of ATRP 
catalyst into the cavities of protein cages could beneficially affect the performance 
of the polymerization by the space constriction in the nanoreactor.  
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We report ATRP catalysts conjugated to proteins. By using ARGET ATRP we are 
able to polymerize NiPAAm and PEGA with a moderate control over the molecular 
weight and the polydispersity of the polymers. Further, globular proteins serve as a 
functional handle to remove the attached copper containing catalyst effectively from 
solution. Such systems allow for the drastic reduction in the residual copper content of 
polymers synthesized by ATRP in aqueous solution. 
                                           
46  Parts of this chapter were published in: a) K. Renggli, M. G. Nussbaumer, R. Urbani, T. Pfohl, N. 
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Kali, Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 2011, 52, 521–522 d) T. B. Silva, M. 
Spulber, M. K. Kocik, F. Seidi, H. Charan, M. Rother, S. J. Sigg, K. Renggli, G. Kali, N. Bruns, 
Biomacromolecules 2013, 14, 2703–2712. 
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2.1 Introduction 
Over the last two decades, synthesis techniques have been developed that allow a 
degree of control of radical polymerizations, such as atom transfer radical 
polymerization (ATRP), reversible addition-fragmentation chain transfer (RAFT) 
polymerization, and nitroxide-mediated radical polymerization (NMP).47 Each of these 
methods has its specific strengths and drawbacks. ATRP is one of the most popular 
controlled/living radical polymerizations because of its great versatility: It is applicable 
to most vinyl and styrene monomers, tolerates most functional groups, is compatible 
with proteins and other biomolecules and it results in halide-terminated polymer chains 
that can be easily converted into a multitude of other functional end-groups.48 ATRP 
relies on the reversible deactivation of propagating radicals by transition metal 
complex catalysts, most often copper(I)-copper(II) redox couples, thus lowering the 
radical concentration in a reaction and therefore the chances of chain termination, 
while still producing reactive chain ends.49 Without a doubt, ATRP and other 
controlled/living radical polymerizations are amongst the most important recent 
developments in the field of polymer chemistry and have spurred thousands of 
scientific publications and a multitude of industrial processes.50 Polymers prepared by 
ATRP can be used, e.g., as sealants, lubricants, oil additives, wetting agents, blend 
compatibilizers, surfactants and pigment stabilizers.50 However, ATRP also suffers 
some limitations. The catalysts are tedious to remove from a polymer product, causing 
unwanted coloration, toxicity and environmental issues.51 The problem of residual 
traces of transition metal or amine ligands in final products can hinder biomedical, 
food-grade, and electronic applications of the polymers. Several recent developments 
aim to make ATRP more environmentally friendly and the resulting polymers more 
compatible with biomedical, food grade and electronic requirements. Less toxic iron 
catalysts are being investigated as alternative to copper-based catalysts52 and variations 
of the experimental protocol of ATRP, such as Activators ReGenerated by Electron 
Transfer (ARGET) and Initiators for Continuous Activator Regeneration (ICAR) 
ATRP lead to a significant reduction in the concentration of catalysts required for this 
polymerization.53  
In order to remove the catalyst from the polymerization solution, several methods 
have been developed, e.g. simple filtration over aluminium oxide columns, scavenging 
                                           
47  a) K. Matyjaszewski, Macromolecules 2012, 45, 4015–4039 b) W. A. Braunecker, K. 
Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146. 
48  a) W. A. Braunecker, K. Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146 b) K. 
Matyjaszewski, Macromolecules 2012, 45, 4015–4039 c) N. V. Tsarevsky, K. Matyjaszewski, 
Chem. Rev. 2007, 107, 2270–2299 d) M. Ouchi, T. Terashima, M. Sawamoto, Chem. Rev. 2009, 
109, 4963–5050 e) K. Matyjaszewski, N. V. Tsarevsky, Nat. Chem. 2009, 1, 276–288. 
49  W. A. Braunecker, K. Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146. 
50  K. Matyjaszewski, Macromolecules 2012, 45, 4015–4039. 
51  N. V. Tsarevsky, K. Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299. 
52 a) M. Ouchi, T. Terashima, M. Sawamoto, Chem. Rev. 2009, 109, 4963–5050 b) F. di Lena, K. 
Matyjaszewski, Prog. Polym. Sci. 2010, 35, 959–1021. 
53  a) K. Matyjaszewski, Macromolecules 2012, 45, 4015–4039 b) N. V. Tsarevsky, K. 
Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299. 
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with ion exchange resins, and using Cu-complexes immobilized on solid supports.54 
However, quantitative removal of the metal ions down to concentrations in the parts 
per billion range remains a difficult task and novel concepts are highly sought after.  
We set out to investigate a catalyst system that could be readily purified. We 
focused on catalysts for ATRP that are conjugated to proteins. The protein acts as a 
soluble support for the catalyst. However, the biomolecule also provides a good handle 
to remove the catalyst from the polymerization solution with several of the purification 
methods known from the toolbox of biochemistry, e.g. precipitation and affinity tags. 
ATRP catalysts conjugated to proteins not only provide opportunities for effective Cu 
removal, but also allow conducting ATRP in confined reaction spaces. We will show 
this concept by using a protein-cage as a nanoreactor for ATRP. In such a nanoreactor, 
a higher degree of control over the polymerization was achieved compared to the 
polymerization in aqueous solution (see chapter 7). Using a system with CuI or CuII in 
combination with ascorbate can cause scission of proteins and DNA.55 By working in 
an oxygen-free environment this problem can be circumvented.56 Having only 
complexed copper or an addition of a chelating agent can reduce or even eliminate the 
problem since the scission requires free Cu-ions.57 Thus, conjugating catalysts to 
proteins with a purification before polymerization presents itself as an elegant solution 
to this issue. 
                                           
54  a) N. V. Tsarevsky, K. Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299 b) L. Mueller, K. 
Matyjaszewski, Macromol. React. Eng. 2010, 4, 180–185. 
55  a) S.-H. Chiou, Journal of Biochemistry 1983, 94, 1259–1267 b) J. Sereikaite, J. Jachno, R. 
Santockyte, P. Chmielevski, V.-A. Bumelis, G. Dienys, Protein J 2006, 25, 369–378. 
56  K. Kim, S. G. Rhee, E. R. Stadtman, J. Biol. Chem. 1985, 260, 15394–15397. 
57  J. Sereikaite, J. Jachno, R. Santockyte, P. Chmielevski, V.-A. Bumelis, G. Dienys, Protein J. 
2006, 25, 369–378. 
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2.2 Results & Discussion  
2.2.1 Preparation of Protein Conjugated ATRP Catalysts  
Bovine serum albumin (BSA) was used as functional support for ATRP catalysts. 
BSA is a cheap and remarkably stable protein with a molecular weight of 66.5 kDa and 
may be referred to as Cohn Fraction V serum albumin (Figure 2.1). Easy and efficient 
strategies to couple linkers to proteins or peptides can be found in bio-conjugation 
chemistry where a toolbox of methods is available ranging from click-chemistry to 
protein/peptide engineering.58 Typically the proteins are engineered to display a free 
cysteine or lysine. In peptides the C- or N-terminus is used while recombinant 
techniques are applied to introduce an unnatural amino acid into the whole protein for 
site-specific interaction with polymers.59 BSA displays one free and surface exposed 
cystein and is therefore an ideal candidate to attach a ligand to complex copper. 
 
 
 
Figure 2.1 Bovin Serum Albumin and its free cystein indicated in red. The structure of BSA 
(PDB: 3V03)60 was rendered using the Chimera program.61 
 
In order to attach ATRP catalysts to the protein, a ligand bound to a protein-
specific linker was synthesized. To this end, 4-formylbenzoic acid was protected to 
form a dimethoxy acetal. In a one-pot, two-steps synthesis the acetal was esterified 
with 2-hydroxyethyl acrylate, followed by a Michael-type addition of N,N,N',N'-
tetraethyldiethylene triamine (TEDETA) to the double bond of the acrylate. The 
resulting product was purified by flash chromatography and finally the acetal was 
cleaved under acidic conditions. The product comprises a tridentate ligand which is 
                                           
58  a) G. T. Hermanson, Bioconjugate Techniques, Academic Press, Maryland Heights, 2008 b) R. 
M. Broyer, G. N. Grover, H. D. Maynard, Chem. Commun. 2011, 47, 2212–2226. 
59  a) L. Wang, P. G. Schultz, Angew. Chem. Int. Ed. 2005, 44, 34–66 b) E. Baslé, N. Joubert, M. 
Pucheault, Chem. Biol. 2010, 17, 213–227 c) A. T. Krueger, B. Imperiali, ChemBioChem 2013, 
14, 788–799. 
60  K. A. Majorek, P. J. Porebski, A. Dayal, M. D. Zimmerman, K. Jablonska, A. J. Stewart, M. 
Chruszcz, W. Minor, Mol. Immunol. 2012, 52, 174–182. 
61  E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. 
Ferrin, J. Comput. Chem. 2004, 25, 1605–1612. 
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able to complex Cu ions and an aromatic aldehyde (compound 1 in Figure 2.2). The 
aldehyde moiety can react with heterobifunctional linkers comprising a 6-
hydraziniumpyridine functional group. Such linkers are commercially available from 
SoluLink, CA.  
 
 
 
Figure 2.2 Strategy to covalently attach an ATRP catalyst to albumin from bovine serum. The 
free cystein of BSA is functionlized using maleimide chemistry. The TEDETA ligand (1) forms  a 
stable bis-aryl hydrazone bond that has a distinct absorbtion at 354 nm. 
 
We used a 25-fold excess of 3-N-maleimido-6-hydrazinium hydrochloride 
(MHPH) to modify the thiol group of the sole surface exposed cysteine on BSA. The 6-
hydraziniumpyridine molar substitution ratio (MSR) for BSA was determined by 
adding an aliquot of a BSA-MHPH sample to a 4-nitrobenzaldehyde solution in buffer. 
The solution was incubated at 37°C for 1 h and the absorbance at 390 nm for the 
hydrazone was determined.62 The MSR for BSA resulted in 0.22 ± 0.01 modified 
cysteins per BSA (Figure 2.3). This relatively low molecular substitution ratio can be 
explained by the fact that in commercial BSA preparations, some cysteines are blocked 
or not surface exposed. 
 
                                           
62  SoluLink Company, Catalog and Reference Manual 2008. 
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Figure 2.3 Modification of BSA with MHPH versus the amount of reagent used (relative to 
surface-exposed thiol groups). A 25-fold excess of MHPH resulted in a MSR of 0.22 ± 0.01 MHPH 
per BSA. 
 
After modification of BSA with the MHPH-linker, the protein was incubated with 
an excess of the synthesized TEDETA derivative, upon which a stable bis-aryl 
hydrazone bond formed. This bond has a specific UV absorption band with a 
maximum at 354 nm, and thus the number of ligands bound to the proteins could be 
determined as 0.21 ± 0.01 bis-aryl hydrazone bonds and therefore ligands per BSA (see 
Figure 2.4). 
 
 
 
Figure 2.4 UV/Vis data of BSA-LxCu reveals a molar substitution ratio of 0.21 ± 0.1 bis-aryl 
hydrazone bonds (absorbtion at 354 nm) and therefore ligands per BSA.  
 
 The protein-ligand conjugate was then used to complex CuII in an aqueous 
buffered CuBr2 solution (Figure 2.2). Finally, the unbound copper was removed from 
the catalysts by size exclusion spin centrifugation. Neutron activation analysis (NAA) 
of 66Cu at 1039.2 keV showed that copper was retained by the protein throughout the 
purification where the TEDETA ligand was conjugated to the protein, but that native 
BSA did not bind CuII (Figure 2.5). Further, NAA confirms that when BSA is 
functionalized with the ligand (BSA-Lx) no trace amounts of copper are introduced to 
the system. 
 28 
 
 
 
Figure 2.5 Using neutron activation analysis, it was determined that only the BSA carrying the 
ligand retained copper, while native BSA after incubation with CuBr2 and purification was copper-
free. 
 
The UV/Vis spectrum of BSA-LxCu after subtraction of the BSA-Lx spectrum 
shows a broad absorption band at λ > 600 nm (Figure 2.6). This is characteristic for 
complexes of CuII and triamine ligands63 and also confirms the formation of a BSA-
LxCu complex.  
 
 
 
Figure 2.6 The formation of a copper complex with the BSA-ligand conjugate was also 
confirmed by UV/Vis spectroscopy, as the typical absorption band for CuII complexes with a 
maximum at 720 nm was observed.  
 
                                           
63  B. Kurzak, A. Kamecka, K. Bogusz, J. Jezierska, Polyhedron 2008, 27, 2952–2958. 
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In order to determine the  structural integrity of BSA upon introduction of the 
ATRP catalyst, the protein was analyzed by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS PAGE; Figure 2.7). The gels diplay the typical absorbtion bands 
for BSA, whether BSA is modified with an ATRP catalyst or not. Therfore, we can 
conclude that the protein remains stable after conjugation of the ATRP catalyst. 
 
 
Figure 2.7 SDS PAGE of BSA-LxCu shows that BSA is not affected by the conjugation of 
ligands and the complexation of CuII. 
2.2.2 ARGET ATRP with Protein-Catalyst Conjugates  
Polymerizations were carried out in aqueous solution. To this end, the water-
soluble initiator 2-hydroxyethyl-2-bromoisobutyrate (HEBIB), the monomer N-
isopropylacrylamide (NiPAAm) and the catalyst were dissolved in  aqueous buffer 
(100 mM sodium acetate, 150 mM NaCl, 80 mM MgCl2, pH 5.2) under Argon 
atmosphere in molar ratios of [monomer]:[initiator]:[BSA-LxCu] 67:1:1.5 x 10-5. The 
polymerization was initiated by adding the reducing agent ascorbic acid (AscA) to the 
reaction mixture (ratio [BSA-LxCu]:[AscA] 1:2.7 x 105; reaction scheme see Figure 
2.9). Under these conditions the catalytically active CuI species is generated in situ. 
Moreover, activators (i.e. catalysts) are continuously regenerated by electron transfer, a 
process named ARGET.64 After 20 h, the polymerization was stopped by adding non-
degassed water and exposing the catalyst to air.  
Gel permeation chromatography (GPC) resulted in poly(N-isopropylacrylamide) 
(pNiPAAm) with an apparent molecular weight Mn of 42600 g mol–1 (calibrated 
against poly(methyl methacrylate)) and a PDI of 1.94 for the ARGET ATRP with 
BSA-LxCu (Figure 2.8). This result indicates that the synthesis of pNiPAAm is 
intrinsically difficult to control in aqueous solution corroberating work previously 
reported by Millard et al.65 
                                           
64  K. Matyjaszewski, Macromolecules 2012, 45, 4015–4039. 
65  P.-E. Millard, N. C. Mougin, A. Böker, A. H. E. Müller, in Controlled/Living Radical 
Polymerization: Progress in ATRP, ACS Symp. Ser., American Chemical Society, Washington, 
D.C., U.S.A., 2009, pp. 127–137. 
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Figure 2.8 GPC trace of pNiPAAm synthesized by BSA-LxCu in aqueous buffer. 
 
In addition, we assessed BSA-LxCu as an ATRP catalyst for a different monomer. 
We used poly(ethylene glycol) methyl ether acrylate (PEGA), a water soluble 
monomer with a number average molecular weight of 480 g mol–1. The polymerization 
of PEGA with BSA-LxCu as catalyst was performed under the same ARGET ATRP 
conditions used for NiPAAm (reaction schemes see Figure 2.9). GPC analysis of the 
resulting poly(poly(ethylene glycol) methyl ether acrylate) (pPEGA) displayed a 
poly(ethylene oxide)-apparent Mn of 119400 g mol–1 and a PDI of 3.12.  
 
 
 
Figure 2.9 Reaction schemes for the synthesis of a) pNiPAAm in buffer solution b) pPEGA in 
buffer solution and  
2.2.3 Copper Removal after Polymerization 
The BSA samples were used to analyze the possibility to remove copper from the 
reaction mixture after polymerization with methods specific for proteins. Two different 
strategies to remove copper from the resulting polymer solution were explored. In a 
first approach we used protein precipitation, which is based on altering the solvation 
potential of the solvent, i.e. lowering the solubility of BSA by the addition of a reagent. 
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2.2.3.1 Protein-Catalyst Precipitation 
 Proteins are well known to precipitate in the presence of organic solvent. The 
ability of BSA to be precipitated by organic solvent was determined with methanol 
(MeOH), ethanol (EtOH) and formamide as organic co-solvent. 
Figures 2.11 and 2.12 show the UV/Vis absortion of BSA at 279 nm versus the 
percentage of added organic co-solvent. A drop in absorbance is equivalent with a loss 
of integrity of the protein and therefore precipitation. Surprisingly, BSA turned out to 
be very robust in organic solvent and showed no drastic change in absorbance for 
added EtOH or formamide. In the case of MeOH (Figure 2.11), a significant drop with 
high concentration of MeOH could be observed, indicating that BSA can be 
precipitated but only with rather harsh conditions. These experiments demonstrated the 
toughness of BSA towards organic co-solvent but without sufficient precipitation to 
allow for purification of the desired polymer by filtration. 
 
 
 
 
Figure 2.11 Precipitation of BSA due to MeOH concentrations between 0 and 100%, measured 
by the absorbtion at 279 nm with UV/Vis spectroscopy. 
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Figure 2.12 Precipitation of BSA due to organic solvent measured by the absorbtion at 279 nm 
with UV/Vis spectroscopy. Addition of organic co-solvent between 0 and 100% lead to the 
conclusion that BSA is extremely stable and is almost soluble in organic solvent.  
 
In order to remove the protein-catalyst conjugate from the final polymer solution 
we explored alternatives to BSA as a globular protein. We used bovine hemoglobin 
(Hb), a cheap and abundantly available tetrameric protein with four Fe-containing 
heme groups.66 We assessed the precipitation potential of Hb with EtOH as described 
for BSA. Figure 2.13 shows the UV/Vis absorbtion of Hb at 404 nm, corresponding to 
the heme group which correlates with the structural stability of the protein. The results 
indicated, in contrast to BSA, that Hb can be precipitated from solution with the 
addition of about 60% EtOH. 
 
                                           
66  a) S. N. Vinogradov, L. Moens, J. Biol. Chem. 2008, 283, 8773–8777 b) O. V. Kosmachevskaya, 
A. F. Topunov, Appl. Biochem. Microbiol. (Moscow, Russ. Fed.) 2009, 45, 563–587 c) B. J. 
Reeder, Antioxid. Redox Signaling 2010, 13, 1087–1123 d) M. T. Gladwin, J. R. Lancaster, B. A. 
Freeman, A. N. Schechter, Nat. Med. 2003, 9, 496–500 e) M. F. Perutz, M. G. Rossmann, A. F. 
Cullis, H. Muirhead, G. Will, A. C. T. North, Nature 1960, 185, 416–422 f) J. Everse, N. Hsia, 
Free Radic. Biol. Med. 1997, 22, 1075–1099. 
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Figure 2.13 Precipitation of Hb due to organic solvent measured by the absorbtion at 404 nm 
with UV/Vis spectroscopy. Addition of EtOH between 0 and 100% indicate that Hb can be 
precipitated with an addition of about 60% EtOH. 
 
 After the promising precipitation experiment with native Hb we functionalized Hb 
without an ATRP ligand. As Hb does not have any cysteins available for modification, 
we used the linker succinimidyl 6-hydrazinonicotinate acetone hydrazone (HyNic) to 
target the amino groups of lysine residues. After modification of the protein with the 
linker, Hb-HyNic was incubated with an excess of the synthesized TEDETA derivative 
described above, upon which a stable bis-aryl hydrazone bond was formed. The 
protein-ligand conjugate was then used to complex CuII in an aqueous buffered CuBr2 
solution. Finally, the unbound copper was removed from the catalyst by size exclusion 
spin chromatography. The resulting Hb-LxCu was intended to be used to polymerize 
NiPAAm under ARGET ATRP conditions described for BSA. As this tetrameric Hb 
protein has four Fe-containing heme groups, we decided to carry out a control reaction 
with native Hb under the ARGET ATRP conditions that we used to polymerize 
NiPAAm, but not expecting a polymerization to occur. The aqueous reaction mixture 
consisted of Hb, monomer, HEBIB as the alkyl bromide initiator and an excess of 
ascorbic acid. To our surprise, the reaction yielded pNiPAAm, as confirmed by 1H 
NMR (Figure 2.14). These observations indicated that the protein Hb is responsible for 
the polymerization. This ability of native enzymes to catalyze ATRP is discussed in 
chapters 3 to 5. Altough, we obtained exciting new results for Hb, we were still looking 
for a method to remove copper from a polymer solution and thus focused again to re-
evaluate the BSA-LxCu system. 
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Figure 2.14 1H-NMR spectrum of a purified pNiPAAm sample obtained from a polymerization 
catalyzed by native Hb. 1H-NMR (400.1 MHz, CDCl3) δ/ppm = 7.00 - 5.88 (bm, n.1H), 4.14 - 3.88 
(bm, n.1H), 2.33 - 1.94 (bm, n.1H), 1.94 - 1.24 (bm, n.2H), 1.24 - 0.88 (bm, n.6H). 
 
Another protein preciptation technique is salting out, whereby the protein 
undergoes interactions with the salt instead of the water due to increasing salt 
concentration, exposing the hydrophobic parts of the protein surface. This leads to an 
aggregation and precipitation of the protein. To this end, BSA was removed from 
solution by ammonium sulfate precipitation. Compared to the precipitation with 
organic solvent, the salting out gave better results. We polymerized NiPAAm using 
BSA-LxCu as a catalyst for ARGET ATRP with the conditions described above. 
Moreover, we removed the residual copper after polymerization by precipitation of the 
protein-catalyst conjugate using an addition of 25% saturated ammonium sulfate 
solution. Inductively coupled plasma atomic emission spectroscopy (ICP-AES) 
revealed that 76% of the copper was removed from solution by this technique, reducing 
the Cu content of the final polymer solution to 24 ± 3 ppb. Matyjaszewsky et al. have 
shown that ARGET ATRP can be perfomed with Cu catalyst concentrations as low as 
50 ppm.67 This concentration is still approximately 103 times higher than the end-
concentration we achieved, which could allow for biomedical and food grade 
applications.68 
2.2.3.2 Dynabead Removal of Protein-Catalyst Conjugate 
In a second approach we used Dynabeads to remove the residual copper from the 
final polymer solution. Dynabeads are commercially available, uniform, 2.8 µm 
superparamagnetic beads with recombinant Protein A (approximately 45 kDa) 
covalently coupled to the surface. We used rabbit IgG anti-BSA antibody to be added 
to the Dynabeads with Protein A. During a short incubation, the antibody binds to the 
Dynabeads. The tube was then placed on a magnet, where the beads migrated to the 
                                           
67  K. Matyjaszewski, W. Jakubowski, K. Min, W. Tang, J. Huang, W. A. Braunecker, N. V. 
Tsarevsky, Proc. Natl. Acad. Sci. 2006, 103, 15309–15314. 
68  N. V. Tsarevsky, K. Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299. 
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side of the tube facing the magnet. Next, the supernatant was removed by aspiration. 
The now bead-bound antibody was used to capture BSA-LxCu in the final polymer 
solution. The bound protein-catalyst conjugate was collected on a magnet, utilizing the 
unique magnetic properties of the Dynabeads, whereas the polymer solution could be 
removed by aspiration (see Figure 2.15).  
 
 
 
Figure 2.15 Strategy to remove BSA-LxCu after polymerization from the product solution to 
reduce the residual copper in the final polymer. Dynabeads were functionalized with rabbit IgG anti-
BSA antibody to capture BSA-LxCu in solution. 
 
The precipitation of BSA-LxCu using Dynabeads reduced of the copper 
concentration by 44%. The Cu content of the final polymer solution was 162 ± 4 ppb, 
as determined by ICP-AES. This very elegant precipitation solution has the advantage 
that the catalyst conjugate could be eluted from the antibody and therfore be recycled 
for additional experiments. However, compared to the copper concentration of the 
ammonium sulfate precipitated sample, the removal of copper is not as effective. 
2.3 Conclusions  
To the best of our knowledge, we were the first to report ATRP catalysts 
conjugated to proteins.69 We assessed BSA and Hb as potential proteins to attach a 
ligand to complex CuII by means of bioconjugation chemistry. Hb turned out to 
polymerize NiPAAm without engineered copper complex and is discussed further in 
chapters 3 and 5. Although we were not interested to improve the reaction but rather to 
reduce the residual copper, using ARGET ATRP we were able to polymerize NiPAAm 
and PEGA with BSA-LxCu with a moderate control over the molecular weight and the 
polydispersity of the polymers. Globular proteins could serve as a functional handle to 
remove the copper containing catalyst effectively from solution. Such systems allow 
for a drastic reduction in the residual copper content in polymers synthesized by ATRP 
to ppb levels, either by precipitation or by Dynabead removal. 
                                           
69  N. Bruns, K. Renggli, F. Seidi, G. Kali, Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 
2011, 52, 521–522. 
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3 ATRPases - Native Enzymes for Atom Transfer 
Radical Polymerization70 
 
The advent of controlled/living radical polymerizations has made polymer science 
a key discipline for the preparation of nano-, biomedical-, and high tech-materials. 
Atom transfer radical polymerization (ATRP) is one of the most widely applied 
controlled/living radical polymerization. However, an ongoing quest is to develop 
ATRP reaction conditions that allow reducing the amount of catalyst needed, or to 
replace the currently used transition metal complex catalysts with less toxic ones. 
Using enzymes as catalysts is a classic strategy in the green chemistry approach, and 
many enzymatic polymerizations are known. However, controlled/living radical 
polymerizations that are catalyzed by enzymes or proteins have not been reported until 
our discovery that the metalloproteins horseradish peroxidase and hemoglobin can 
polymerize vinyl-monomers under conditions of activators regenerated by electron 
transfer (ARGET) ATRP. 
                                           
70  Parts of this chapter were published in: a) K. Renggli, M. Spulber, J. Pollard, M. Rother, N. 
Bruns, ACS Symp. Ser. 2013, 1144, 163–171 b) G. Kali, T. B. Silva, S. J. Sigg, F. Seidi, K. 
Renggli, N. Bruns, ACS Symp. Ser. 2012, 1011, 171–181 c) T. B. Silva, M. Spulber, M. K. Kocik, 
F. Seidi, H. Charan, M. Rother, S. J. Sigg, K. Renggli, G. Kali, N. Bruns, Biomacromolecules 
2013, 14, 2703–2712 d) S. J. Sigg, F. Seidi, K. Renggli, T. B. Silva, G. Kali, N. Bruns, 
Macromol. Rapid Commun. 2011, 32, 1710–1715. 
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3.1 Discovery of ATRPase Activity  
In chapter 2 investigations of atom transfer radical polymerization (ATRP) 
catalysts were described that can be conjugated to proteins, in order to remove the 
residual copper after polymerization from the final polymer product. In the course of 
that research we were looking for a cheap and abundantly available protein to test the 
conjugation chemistry and the polymerization conditions as well as the precipitation 
ability. Our attention fell on bovine hemoglobin (Hb). As described in section 2.2.3.1, 
the control reaction with native Hb yielded polymer product, although we were not 
expecting a polymerization. Under the activators regenerated by electron transfer 
(ARGET) ATRP conditions native Hb with its four Fe-containing heme groups acted 
as catalyst for the polymerization of N-isopropylacrylamide (NiPAAm). The overnight 
reaction yielded a product that precipitated when the aqueous solution was heated 
above the lower critical solution temperature of poly(N-isopropylacrylamide) 
(pNiPAAm), i.e., over 32ºC, and that redissolved when the solution was cooled back to 
room temperature. Figure 3.1 shows a typical enzyme-catalyzed (in this case HRP) 
polymerization of pNiPAAM and the effect of elevated temperature.  
 
 
 
Figure 3.1 A typical HRP-catalyzed polymerization of NiPAAm under ARGET ATRP 
conditions after 16 h. Photos were taken at 20°C (left) and at 40°C (right). The brown color of a HRP 
solution is seen, as well as a precipitate at elevated temperatures. This precipitate is the 
thermoresponsive polymer pNiPAAm.  
 
To rule out the possibility that the polymerization was catalyzed by impurities on 
the glassware or in the commercial Hb preparation, we repeated the experiment several 
times with new glassware, with thoroughly cleaned glassware, and with Hb that was 
purified by size exclusion diafiltration (MWCO 10000 g mol–1) in order to remove all 
low molecular weight impurities. All reactions yielded pNiPAAm. In contrast, when 
Hb was omitted from the reaction mixture, no polymer was obtained. Replacing Hb 
with hemin, the iron(III) proto-porphyrin IX chloride complex of the protein, did not 
result in any polymerization of NiPAAm either, one reason being that hemin is 
insoluble in water under acidic conditions.71 These observations allow us to conclude 
that, indeed, the protein Hb is responsible for the polymerization. Further control 
reactions in which either HEBIB or AscA were left out of the reaction mixture yielded 
                                           
71  M. J. O'Neil, Ed., in The Merck Index: an Encyclopedia of Chemicals, Drugs, and Biologicals, 
Merck, Whitehouse Station, N.J., U.S.A., 2006, p. 04644. 
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no pNiPAAm, indicating that HEBIB and AscA are essential to initiate and drive the 
polymerization.72 
In many areas of synthetic chemistry, an environmentally friendly alternative to 
conventional catalysts is the use of enzymes.73 Enzymes have been extensively 
investigated as catalysts for most major polymerization techniques, e.g., 
polycondensations, ring-opening polymerizations, and free-radical polymerizations.74 
However, Nature’s catalysts were not known to mediate controlled/living radical 
polymerizations, despite the fact that several classes of proteins and enzymes contain 
transition metal ions at their active sites and therefore could potentially catalyze ATRP. 
Recently our group75 and di Lena and coworkers76 discovered concurrently and 
independently that some metalloproteins can mediate ATRP and named them 
ATRPases. These findings represent the first reports of biocatalytic, controlled/living 
radical polymerization. 
                                           
72  G. Kali, T. B. Silva, S. J. Sigg, F. Seidi, K. Renggli, N. Bruns, ACS Symp. Ser., American 
Chemical Society, Washington, DC, 2012. 
73  U. T. Bornscheuer, G. W. Huisman, R. J. Kazlauskas, S. Lutz, J. C. Moore, K. Robins, Nature 
2012, 485, 185–194. 
74  a) S. Kobayashi, A. Makino, Chem. Rev. 2009, 109, 5288–5353 b) K. Loos, Ed., Biocatalysis in 
Polymer Chemistry, Wiley-VCH Verlag GmbH & Co. KGaA, 2010. 
75  a) S. J. Sigg, F. Seidi, K. Renggli, T. B. Silva, G. Kali, N. Bruns, Macromol. Rapid Commun. 
2011, 32, 1710–1715 b) G. Kali, T. B. Silva, S. J. Sigg, F. Seidi, K. Renggli, N. Bruns, ACS 
Symp. Ser., American Chemical Society, Washington, DC, 2012 c) T. B. Silva, M. Spulber, M. K. 
Kocik, F. Seidi, H. Charan, M. Rother, S. J. Sigg, K. Renggli, G. Kali, N. Bruns, 
Biomacromolecules 2013, 14, 2703–2712. 
76  a) Y.-H. Ng, F. di Lena, C. L. L. Chai, Polym. Chem. 2011, 2, 589 b) Y.-H. Ng, F. di Lena, C. L. 
L. Chai, Chem. Commun. 2011, 47, 6464–6466. 
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4 Horseradish Peroxidase as Catalyst for Atom 
Transfer Radical Polymerization77 
Severin J. Sigg, Farzad Seidi, Kasper Renggli, Tilana B. Silva, Gergely Kali and 
Nico Bruns 
 
 
 
 
 
The hemoprotein horseradish peroxidase (HRP) catalyzes the polymerization of N-
isopropyl-acrylamide with an alkyl bromide initiator under conditions of activators 
regenerated by electron transfer atom transfer radical polymerization (ARGET ATRP) 
in the absence of any peroxide. This is a novel activity of HRP, which we propose to 
name ATRPase activity. Bromine-terminated polymers with polydispersity indices 
(PDIs) as low as 1.44 are obtained. The polymerization follows first order kinetics, but 
the evolution of molecular weight and the PDI upon increasing conversion deviate 
from the results expected for an ATRP mechanism. Conversion, Mn and PDI depend on 
the pH and on the concentration of the reducing agent, sodium ascorbate. HRP is 
stable during the polymerization and does not unfold or form conjugates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                           
77  This chapter was published in: S. J. Sigg, F. Seidi, K. Renggli, T. B. Silva, G. Kali, N. Bruns, 
Macromol. Rapid Commun. 2011, 32, 1710–1715. 
 40 
4.1 Introduction 
Hemoproteins such as horseradish peroxidase (HRP; EC 1.11.1.7) have been 
studied extensively as catalysts for free radical polymerization of vinyl monomer78 and 
aromatic compounds,79 because they catalyze the electron transfer from hydrogen 
peroxide to a co-substrate, effectively creating radicals that initiate polymerization.80 
HRP is a 44 kDa protein that contains a heme B prosthetic group.81 Reaction with 
hydrogen peroxide converts the FeIII resting state of the enzyme to an FeIV porphyrin 
radical cation (compound I), which then transfers electrons to substrates along several 
pathways, including one via an FeIV species (compound II). HRP-mediated free radical 
polymerization of vinyl monomers requires peroxide and often a co-substrate, like a β-
diketon, as initiator.82 It has been applied to the polymerization of a whole range of 
monomers including acrylamide,83 methacrylates,84 styrene,85 and styrene derivatives.86 
Despite this body of literature, catalytic activity of hemoproteins in ATRP was 
unknown. We propose naming enzymes that exhibit catalytic activity under ATRP 
conditions as ATRPase, in addition to their conventional names. 
4.2 Results & Discussion 
4.2.1 ARGET ATRP of NiPAAm with HRP as ATRP catalyst 
In our experiments, the reducing agent was planned to regenerate FeIII in the heme 
of HRP during the course of the polymerization under ARGET ATRP conditions. In 
typical experiments, HRP, the initiator 2-hydroxyethyl-2-bromoisobutyrate (HEBIB) 
and the monomer were dissolved in aqueous buffer under an argon atmosphere. Then, a 
                                           
78  a) A. Singh, D. L. Kaplan, J. Polym. Environ. 2002, 10, 85–91 b) A. Singh, D. L. Kaplan, in 
Advances in Polymer Science, Springer-Verlag, Berlin/Heidelberg, 2006, pp. 211–224 c) F. 
Hollmann, in Biocatalysis in Polymer Chemistry (Ed.: K. Loos), Wiley-VCH Verlag GmbH & 
Co. KGaA, 2010, pp. 143–163. 
79  a) M. Reihmann, H. Ritter, in Advances in Polymer Science, Springer-Verlag, Berlin/Heidelberg, 
2006, pp. 1–49 b) P. Walde, Z. Guo, Soft Matter 2011, 7, 316–331. 
80 F. Hollmann, I. W. C. E. Arends, Polymers 2012, 4, 759–793. 
81  a) A. M. Azevedo, V. C. Martins, D. M. Prazeres, V. Vojinović, J. M. Cabral, L. P. Fonseca, 
Biotechnol. Annu. Rev. 2003, 9, 199–247 b) N. C. Veitch, Phytochemistry 2004, 65, 249–259. 
82  F. Hollmann, I. W. C. E. Arends, Polymers 2012, 4, 759–793. 
83  a) R. A. Derango, L.-C. Chiang, R. Dowbenko, J. G. Lasch, Biotechnol. Tech. 1992, 6, 523–526 
b) O. Emery, T. Lalot, M. Brigodiot, E. Maréchal, J. Polym. Sci. A Polym. Chem. 1997, 35, 3331–
3333 c) T. Lalot, M. Brigodiot, E. Maréchal, Polym. Int. 1999, 48, 288–292 d) D. Teixeira, T. 
Lalot, M. Brigodiot, E. Maréchal, Macromolecules 2013, 32, 70–72 e) A. Durand, T. Lalot, M. 
Brigodiot, E. Maréchal, Polymer 2001, 42, 5515–5521 f) B. Kalra, R. A. Gross, Green Chem. 
2002, 4, 174–178 g) Q. Zhao, J. Sun, H. Ren, Q. Zhou, Q. Lin, J. Polym. Sci. A Polym. Chem. 
2008, 46, 2222–2232 h) R. L. Shogren, J. L. Willett, A. Biswas, Carbohydr. Polym. 2009, 75, 
189–191 i) A. Durand, T. Lalot, M. Brigodiot, E. Marechal, Polymer 2000, 41, 8183–8192. 
84  a) A. Singh, D. L. Kaplan, J. Macromol. Sci., Part A: Pure Appl. Chem. 2004, 41, 1377–1386 b) 
B. Kalra, R. A. Gross, Biomacromolecules 2000, 1, 501–505 c) R. A. Derango, L.-C. Chiang, R. 
Dowbenko, J. G. Lasch, Biotechnol. Tech. 1992, 6, 523–526. 
85  A. Singh, D. Ma, D. L. Kaplan, Biomacromolecules 2000, 1, 592–596. 
86  a) A. Singh, S. Roy, L. Samuelson, F. Bruno, R. Nagarajan, J. Kumar, V. John, D. Kaplan, J. 
Macromol. Sci., Part A: Pure Appl. Chem. 2001, 38, 1219–1230 b) A. Singh, D. L. Kaplan, Adv. 
Mater. 2003, 15, 1291–1294. 
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buffered solution of the reducing agent sodium L-ascorbate was added, and the reaction 
was stirred at room temperature. Formation of poly(N-isopropylacrylamide) 
(pNiPAAm) was easily detectable by the precipitate that formed when the solution was 
heated above the lower critical solution temperature of pNiPAAm (32.5°C; Figure 3.1). 
1H NMR confirmed the identity of the polymer (Figure 4.1). Gel permeation 
chromatography (GPC) revealed polymers with monomodal polymer weight 
distribution. The lowest PDI of 1.44  with a number average molecular weight (Mn) of 
99900 g mol–1 was observed for a reaction at pH 6.0 after 2.5 h (see below). No 
formation of pNiPAAm was observed in control reactions that lacked enzyme, initiator, 
or sodium ascorbate. 1H COSY NMR of a purified polymer revealed a pair of cross-
peaks, which arise from the initiator fragment at the chain start (Figure 4.1).  
 
 
 
Figure 4.1 a) 1H NMR spectrum and b) 1H COSY NMR spectrum of a purified pNiPAAm 
sample obtained from a polymerization catalyzed by HRP under ARGET ATRP conditions.  
 
The purified pNiPAAm was further analyzed by neutron activation analysis (NAA) 
for its bromine content: 575 ± 35 mg bromine per gramm polymer were detected 
(Figure 4.2). With a Mn of 92500 g mol–1 (GPC) this concentration translates to 67% of 
pNiPAAm chains carrying one bromine atom, most probably at their chain end. These 
results allow us to conclude that HRP reacted with the initiator in order to create a 
radical species, most probable by an atom transfer of the initiator's bromine to the 
enzyme. HRP would thus change its oxidation state from FeIII to FeIV. The 2-
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hydroxyethyl isobutyrate radical then started polymerization of the monomer. The 
degree of control in ATRP strongly depends on the ability of the catalyst to transfer the 
bromine back to the active chain end in order to form the dormant, bromine-terminated 
polymer species. The more the equilibrium is shifted toward the dormant chain and the 
reduced catalyst concentration, the more controlled or living is the polymerization.  
 
 
 
Figure 4.2 Neutron activation analysis: γ-Spectrum of a purified pNiPAAm sample obtained 
from a polymerization catalyzed by HRP under ARGET ATRP conditions. The spectrum shows 
characteristic 82Br-peaks, as well as the peak of the internal gold standard.  
 
The presence of a significant amount of bromine in the purified polymer proves 
that the reaction of the active chain toward the dormant species took place. Low PDIs 
indicate a controlled/living radical polymerization. However, some conditions (e.g., pH 
7.5, 16 h reaction time) also yielded poorer PDIs above 2. All obtained polymers have 
higher molecular weight than expected from the monomer to initiator ratio. This could 
be due to an initiation catalyzed by HRP, followed by polymerization with some 
degree of control and chain termination, e.g., by the recombination of two radicals or 
by a reaction of the polymer radical with the FeIII of another native HRP molecule. 
HRP in its FeIV state would then be regenerated to FeIII by reduction with ascorbate. A 
catalytic chain transfer mechanism can be ruled out, as this would produce double-
bond terminated chains, which were not detected in the 1H NMR spectra. A possible 
mechanism is shown in Scheme 4.1. 
 
 
 
Scheme 4.1 Putative mechanism of HRP-catalyzed polymerization under ARGET ATRP 
conditions. (Asc = ascorbate, DHA = dehydroascorbic acid) 
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As catalytic activity of enzymes can be strongly pH dependent, we systematically 
varied the pH of the polymerization between pH 5.2 and 10.5 (Figure 4.3). At highest 
and lowest pH no polymer formation was detected using 1H NMR. At intermediate pH, 
conversions from 3 to 78% were measured after a reaction time of 16 h, with a 
maximum at pH 7.0. The molecular weight followed a similar trend. Interestingly, PDI 
was around 1.7 between pH 6.0 and 7.0 and increased significantly in basic reaction 
conditions. Taking into account that HRP is stable over the analyzed pH range,87 and 
that neither the initiator nor the monomer are protonable, these results show that pH 
influences the activity of HRP differently than its degree of control over the 
polymerization. Most likely, the rates of the activation reaction of alkyl bromides as 
well as the deactivation and termination reaction of radicals vary independently with 
the electrostatic potential distribution on the enzyme, and the redox potential of the 
heme. As the polymerization at pH 6.0 yielded polymers with a relative low PDI and a 
molecular weight closest to the theoretically expected value, all further reactions were 
performed at this pH. 
 
 
 
Figure 4.3 Influence of pH on conversion (○), molecular weight (◊), and PDI (∆) in HRP-
catalyzed polymerizations of NiPAAm under ARGET ATRP conditions. (Ratio of 
HEBIB:NiPAAm:HRP 1:68:0.034; ratio ascorbate:HRP 33:1; reaction time: 16 h)  
 
The concentration of ascorbate was also found to influence the polymerization 
reaction (Figure 4.4). The conversion increased linearly with increasing ascorbate 
concentration, while PDI and Mn values increased and decreased, respectively. If 
deactivation reactions of radicals happened frequently during the polymerization, HRP 
accumulated in the non-active FeIV form. The reducing agent would then have been 
necessary to regenerate the native oxidation state and thus to increase conversion. An 
initiation by sodium ascorbate alone can be ruled out, due to the fact that no polymer is 
formed in the abscence of HEBIB and that NMR of purified polymers showed no 
signals charateristic of ascorbate or its derivatives. 
 
 
 
                                           
87  D. Schomburg, M. Salzmann, D. Stephan, Enzyme Handbook 7, Springer, 1993. 
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Figure 4.4 Influence of reducing agent/enzyme ratio on the HRP-catalyzed polymerization of 
NiPAAm under ARGET ATRP conditions. A) Conversion, B) molecular weight (○) and PDI (∆) as a 
function of equivalents sodium ascorbate. (Ratio of HEBIB:NiPAAm:HRP 1:68:0.034; pH 6.0; 
reaction time: 16 h) 
 
In order to gain further insight into the mechanism of the HRP-mediated 
polymerization, the reaction kinetics and the evolution of the molecular weight and 
molecular weight distribution were followed by 1H NMR and by GPC for a 
polymerization at pH 6.0 (Figure 4.5). One characteristic of controlled/living radical 
polymerizations is that they follow first order kinetics, which results in a linear 
correlation between reaction time and the negative natural logarithm of the conversion. 
Indeed, the corresponding graph shows a linear range from initiation to about 7 h 
reaction time. At longer reaction times, the reaction slowed down and the 
polymerization came to a stop at a conversion of 48% after 24 h, possibly due to the 
depletion of ascorbate. The number average molecular weight of the polymer was 
99900 g mol–1 at the first time point and then decreased with increasing conversion. 
However, the total signal intensity in the GPC increased with conversion. The PDI was 
1.44 at the beginning and increased during the course of the polymerization. These 
findings are not in agreement with the typical ATRP mechanism that results in a 
proportional increase of Mn with conversion and constant or slightly decreasing PDIs.88 
A detailed inspection of the GPC traces (Figure 4.5c) reveals that, at the beginning of 
the reaction, quite large and relatively narrowly distributed polymers were formed. In 
the course of the reaction, these chains did not grow significantly. More chains of the 
                                           
88  K. Matyjaszewski, W. Jakubowski, K. Min, W. Tang, J. Huang, W. A. Braunecker, N. V. 
Tsarevsky, Proc. Natl. Acad. Sci. 2006, 103, 15309–15314. 
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similar length formed in addition to some shorter chains. These shorter chains were 
responsible for lowering the average molecular weight and broadening the molecular 
weight distribution. Whether they were bromine terminated and would grow further or 
whether they were irreversibly terminated cannot be distinguished by GPC. The 
maximum chain length appears to be determined by the precise reaction conditions. 
One possible explanation would be that the accessibility of the enzyme's active site 
depends on the length of the polymer chain, with a lower probability of longer chains 
to reach the active site, possibly with an upper size limit. Another possibility could be 
that HRP itself acts as a chain termination agent by the addition of the radical of the 
growing chain to an HRP in its resting FeIII state. As the HRP was subsequently 
reduced back to its native redox state, this would have resulted in a catalytic chain 
termination that yielded H-terminated polymer chains. 
 
 
 
Figure 4.5 a) Kinetic plot, b) molecular weight (∆) and PDI (○) as a function of conversion, and 
c) selected GPC traces of a HRP-catalyzed polymerization of NiPAAm under ARGET ATRP 
conditions. (Ratio of HEBIB:NiPAAm:HRP 1:68:0.034; ratio ascorbate:HRP 33:1; pH 6.0) 
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4.2.2 Biochemical Characterization of HRP Before and After 
Polymerization  
A catalyst is defined as a reactant which is not consumed during the reaction (and 
which accelerates a reaction). From the data presented above, it cannot be derived if 
HRP acts as a catalyst in the polymerization. Several reactions are plausible that could 
permanently alter the structure of HRP. These include unfolding and denaturation, 
which could also lead to the dissociation of the heme from the protein, the permanent 
trapping of the iron in an oxidation state other than the native FeIII, and the formation 
of HRP-polymer conjugates. Therefore, several biochemical methods were applied to 
characterize the HRP before and after the polymerization (Figure 4.6). 
 
 
Figure 4.6 Characterization of HRP before (grey) and after (black) a polymerization of NiPAAm 
under ARGET ATRP conditions at pH 6.0 for 16 h. a) Circular dichroism spectra, b) UV/Vis spectra, 
c) native and SDS gel electrophoresis. d) MALDI-TOF mass spectrum of recycled HRP shows the 
molecular ion peak of HRP+ at m z–1 44000, HRP2+ at m z–1 22000, HRP dimer+ at m z–1 88000 and 
HRP trimer2+ weak at m z–1 66000. 
 
Circular dichroism (CD) spectroscopy is sensitive to the secondary structure of 
proteins. The CD spectra of native HRP and HRP purified from the polymerization 
mixture are typical for an α-helix-rich protein and do not show any significant 
differences to untreated HRP, indicating that the HRP did not unfold. The UV/Vis 
spectra of the two samples are very similar and have Soret maxima between 400 and 
402 nm, and two smaller maxima at 499 and 643 nm, respectively. Such spectra 
correspond to HRP in its FeIII resting state.89 The presence of compound II, compound 
III, or ferrous-HRP can be ruled out, as they possess Soret maxima between 415 and 
437 nm.90 Thus, HRP is in its native oxidation state before and after polymerization. 
                                           
89  W. E. Blumberg, J. Peisach, B. A. Wittenberg, J. B. Wittenberg, J. Biol. Chem. 1968, 243, 1854–
1862. 
90  a) J. B. Wittenberg, R. W. Noble, B. A. Wittenberg, E. Antonini, M. Brunori, J. Wyman, J. Biol. 
Chem. 1967, 242, 626–634 b) W. E. Blumberg, J. Peisach, B. A. Wittenberg, J. B. Wittenberg, J. 
Biol. Chem. 1968, 243, 1854–1862. 
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Formation of HRP-polymer conjugates, either by termination of a polymer chain with 
an HRP molecule or by grafting of a pNiPAAm chain from a radical on the enzyme, 
would result in an increase in the enzyme's molecular weight. SDS and native gel 
electrophoresis did not show any difference in the molecular mass of the two samples. 
Mass spectrometry analysis of the HRP after polymerization showed the typical 
molecular mass of 44 kDa of native HRP. We therefore conclude that no enzyme-
polymer conjugates formed during the polymerization. Overall, the characterization of 
the HRP showed that the enzyme is not altered under ARGET ATRP conditions, 
proving that HRP acts as a catalyst. 
4.3 Conclusion 
Horseradish peroxidase (HRP) catalyzes the polymerization of NiPAAm under 
aqueous ARGET ATRP conditions with an organobromine initiator in the absence of 
any peroxide. This is a novel enzymatic activity. Peroxidases were previously known 
to catalyze polymerizations in the presence of hydrogen peroxide and other peroxides. 
The HRP mediated polymerization under ARGET ATRP conditions yielded polymers 
with relative low, albeit not excellent PDIs down to 1.44 and number average 
molecular weights between 50000 and 220000 g mol–1. Signals from the initiator were 
detected in the NMR spectra of a purified polymer sample, and the sample was shown 
to contain a significant amount of bromine. 
We assume that several reactions compete with each other: the initiation by atom 
transfer of a bromine from the initiator (and from dormant chains) to the HRP, the 
radical chain propagation, the deactivation toward the dormant species in an ATRP 
equilibrium, a termination reaction with a second HRP molecule and other radical 
termination reactions such as recombination. As control over the radical 
polymerization is not perfect, we further assume that the ATRP equilibrium is shifted 
toward the radical site. Sodium ascorbate plays a crucial role and regenerates atom 
transfer inactive HRP. However, in this first report we did not quantify the individual 
rate constants or the ATRP equilibrium constant. Also, enzymatic reactions might 
follow a mechanism completely different from well-understood reactions in organic or 
polymer chemistry. To elucidate the exact mechanism of HRP mediated 
polymerization under ARGET ATRP conditions and to identify the parameters that can 
increase the controlled/living character of the polymerization is part of our ongoing 
research. Nevertheless, HRP is catalytically active in this polymerization and can 
therefore be called an ATRPase. As HRP is non-toxic and compatible with food-grade 
packaging, polymers synthesized with this protein will not have the toxicity problems 
encountered in conventional ATRP-based polymers. ATRPases might become a green 
alternative to conventional ATRP catalysts. Finally, we are also aware of the fact that a 
possible in vivo formation of radicals by the reaction of organohalogen compounds 
with peroxidases and related enzymes might be an explanation for the toxicity of many 
halogenated organic compounds and may be part of yet undiscovered metabolic 
pathways. 
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5 Hemoglobin and Red Blood Cells Catalyze Atom 
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Hemoglobin (Hb) is a promiscuous protein that not only transports oxygen, but 
also catalyzes several biotransformations. A novel in vitro catalytic activity of Hb is 
described. Bovine Hb and human erythrocytes were found to display ATRPase activity, 
i.e., they catalyzed the polymerization of vinyl monomers under conditions typical for 
atom transfer radical polymerization (ATRP). N-isopropylacrylamide (NiPAAm), 
poly(ethylene glycol) methyl ether acrylate (PEGA), and poly(ethylene glycol) methyl 
ether methacrylate (PEGMA) were polymerized using organobromine initiators and the 
reducing agent ascorbic acid in acidic aqueous solution. In order to avoid chain transfer 
from polymer radicals to Hb’s cysteine residues, the accessible cysteines were blocked 
by a reaction with a maleimide. The formation of polymers with bromine chain ends, 
relatively low polydispersity indices (PDI), first order kinetics and an increase in the 
molecular weight of poly(poly(ethylene glycol) methyl ether acrylate) (pPEGA) and 
poly(poly(ethylene glycol) methyl ether methacrylate) (pPEGMA) upon conversion 
indicate that control of the polymerization by Hb occurred via reversible atom transfer 
between the protein and the growing polymer chain. For pPEGA and pPEGMA, the 
reactions proceeded with a good to moderate degree of control. Sodium dodecyl sulfate 
(SDS) gel electrophoresis, circular dichroism spectroscopy, and time-resolved 
ultraviolet/visible (UV/Vis) spectroscopy revealed that the protein was stable during 
polymerization, and only underwent minor conformational changes. As Hb and 
erythrocytes are readily available, environmentally friendly, and nontoxic, their 
ATRPase activity is a useful tool for synthetic polymer chemistry. Moreover, this 
novel activity enhances the understanding of Hb’s redox chemistry in the presence of 
organobromine compounds. 
                                           
91  This chapter was published in: T. B. Silva, M. Spulber, M. K. Kocik, F. Seidi, H. Charan, M. 
Rother, S. J. Sigg, K. Renggli, G. Kali, N. Bruns, Biomacromolecules 2013, 14, 2703–2712. 
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5.1 Introduction 
Hemoglobin (Hb) is the main component of red blood cells of vertebrates. Perhaps 
the most commonly known function of the protein (even to the layman) is its capacity 
to bind and transport oxygen. This makes Hb essential for many life forms.92 Not 
surprisingly, Hb is one of the most widely investigated proteins. Since its discovery 
and the exploration of its primary functions in the middle of the 19th century,93 
countless papers have been published describing its physiological role and its 
biochemistry.94 Over the years, knowledge has emerged that Hb is a promiscuous 
protein that can play many more roles other than solely carrying oxygen. The iron-
containing heme protein is also directly and indirectly involved in the transport of CO2 
and can react with, bind to, and transport many other gaseous molecules, such as NO, 
H2S, or CO.95 Moreover, Hb is a redox enzyme with a distinct pseudoperoxidase 
activity in vitro and in vivo, because its iron can cycle between oxidation states II, III, 
and IV.96 Hb not only catalyzes the conversion of different inorganic peroxides, such as 
H2O297 and sodium perborate,98 but also of various alkyl peroxides and lipid 
hydroperoxides.99 Examples for Hb's peroxidase activity are the forensic luminol test 
for blood,100 oxidation of pyrogallol,101 or bisphenol A102 by H2O2 and the initiation of 
polymerization of aniline induced by H2O2.103 Hb is also known to react with 
                                           
92  a) A. I. Alayash, F. D'Agnillo, P. W. Buehler, Expert Opin. Biol. Ther. 2007, 7, 665–675 b) C. 
Natanson, S. J. Kern, P. Lurie, S. M. Banks, S. M. Wolfe, JAMA, J. Am. Med. Assoc. 2008, 299, 
2304–2312 c) F. E. Lui, R. Kluger, ChemBioChem 2010, 11, 1816–1824. 
93  a) F. L. Hünefeld, Der Chemismus in Der Thierischen Organisation, F. a. Brockhaus, Leipzig, 
1840 b) F. Hoppe-Seyler, Med. Chem. Untersuch. 1866, 1, 133–140. 
94  a) S. N. Vinogradov, L. Moens, J. Biol. Chem. 2008, 283, 8773–8777 b) O. V. Kosmachevskaya, 
A. F. Topunov, Appl. Biochem. Microbiol. (Moscow, Russ. Fed.) 2009, 45, 563–587 c) B. J. 
Reeder, Antioxid. Redox Signaling 2010, 13, 1087–1123 d) M. T. Gladwin, J. R. Lancaster, B. A. 
Freeman, A. N. Schechter, Nat. Med. 2003, 9, 496–500 e) M. F. Perutz, M. G. Rossmann, A. F. 
Cullis, H. Muirhead, G. Will, A. C. T. North, Nature 1960, 185, 416–422 f) J. Everse, N. Hsia, 
Free Radic. Biol. Med. 1997, 22, 1075–1099. 
95  a) O. V. Kosmachevskaya, A. F. Topunov, Appl. Biochem. Microbiol. (Moscow, Russ. Fed.) 
2009, 45, 563–587 b) B. J. Reeder, Antioxid. Redox Signaling 2010, 13, 1087–1123 c) M. T. 
Gladwin, J. R. Lancaster, B. A. Freeman, A. N. Schechter, Nat. Med. 2003, 9, 496–500. 
96  a) O. V. Kosmachevskaya, A. F. Topunov, Appl. Biochem. Microbiol. (Moscow, Russ. Fed.) 
2009, 45, 563–587 b) B. J. Reeder, Antioxid. Redox Signaling 2010, 13, 1087–1123 c) J. Everse, 
N. Hsia, Free Radic. Biol. Med. 1997, 22, 1075–1099. 
97  a) J. Everse, N. Hsia, Free Radic. Biol. Med. 1997, 22, 1075–1099 b) A. I. Alayash, R. P. Patel, 
R. E. Cashon, Antioxid. Redox Signaling 2001, 3, 313–327. 
98  T. I. Quickenden, P. D. Cooper, Luminescence 2001, 16, 251–253. 
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organobromine compounds,104 and many halocarbons have toxic effects on red blood 
cells.105 However, the mechanisms involved in these reactions have only been 
elucidated in some instances: Bromomalononitrile reacts in a noncatalytic redox 
reaction to yield the corresponding alkane, bromide ions, and oxidized Hb, i.e., 
methemoglobin.106 The reductive dehalogenation reaction proceeds via radicals that are 
thought to be quenched by reaction with another Hb. On the other hand, 
polyhalogenated compounds such as CF3CHBrCl and BrCCl3 react with the prosthetic 
group of Hb to form modified heme107 and protein-bound heme adducts.108 Despite this 
variety of reactions involving Hb and its availability in large quantities at low cost, this 
protein has not found widespread use as a catalyst or reagent in the field of synthetic 
chemistry. The main technological interest resides in its potential use as a blood 
substitute,109 or its application as a redox-active component on electrodes of sensing 
devices.110 
5.2 Results & Discussion 
We discovered the ability of bovine Hb and of human erythrocytes to act as 
ATRPase in the polymerizations of the monomers N-isopropylacrylamide (NiPAAm), 
poly(ethylene glycol) methyl ether acrylate (PEGA), and poly(ethylene glycol) methyl 
ether methacrylate (PEGMA) in aqueous solution with 2-hydroxyethyl-2-
bromoisobutyrate (HEBIB) or 2-bromopropionitrile (BPN) as water-soluble initiators. 
The reactions were performed under ARGET ATRP conditions with ascorbic acid 
(AscA) as the reducing agent. No peroxides are needed to drive this reaction, and its 
mechanism differs substantially from any previously reported catalytic activity of Hb. 
Our discovery of Hb’s ATRPase activity is described in chapter 3. 
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5.2.1 Chain Transfer to the Cysteins of Hb and Suppression of this 
Side Reaction  
The polymerizations catalyzed by Hb resulted in a brown solid when lyophilized 
(Figure 5.1). An additional purification step designed to remove all free Hb from the 
final polymerization product (redissolving in THF, followed by filtration over a plug of 
aluminum oxide and removal of the solvent), did not change the color of the product. 
PNiPAAm itself is a white solid, so that the color must derive from residual Hb. 
Furthermore, GPC revealed a bimodal molecular weight distribution of the polymer 
(Figure 5.1). The thiol group of surface-exposed cysteines in proteins can act as a chain 
transfer agent in radical polymerizations.111 Bovine Hb has one cysteine residue on 
each of its two β-subunits.112 These residues are located in conformational plastic 
domains and are accessible for reagents, as they react with maleimides.113 Hence, Hb’s 
cysteine residues could play the role of a chain transfer agent. Chain transfer would 
result in the formation of H-terminated pNiPAAm chains and Hb−pNiPAAm 
conjugates. This would explain the observation of the brown polymer, as made above. 
SDS gel electrophoresis confirmed this hypothesis, as it showed the presence of a 
smeared band at high molecular weights, indicative of protein−polymer conjugates 
(Figure 5.1). 
 
 
 
Figure 5.1 Comparison of pNiPAAm obtained from polymerizations catalyzed by native Hb or 
Cys-blocked Hb under ARGET ATRP conditions. a) Photographs of purified polymers, b) GPC 
traces, c) SDS electrophoresis gel of polymerization mixtures. Experimental conditions: Ratio of 
HEBIB/NiPAAm/Asc/Hb 1:77:3:0.015.  
 
In order to suppress chain transfer to the Hb, the cysteines on the protein were 
blocked by reaction with N-(2-hydroxyethyl)maleimide (HEMI). This reagent reacts 
with thiols in a Michael-type addition, resulting in thioether bonds that are not prone to 
attack by free radicals. All accessible cysteines were modified, as determined by 
Ellman's tests. The UV/Vis and the CD spectra of the Cys-blocked Hb do not show 
significant differences to the spectra of native Hb (Figure 5.2). These findings allow us 
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to conclude that the modification of the Hb did not alter the protein's structure. 
Polymerization of NiPAAm with Cys-blocked Hb yielded white products with 
monomodal molecular weight distributions (Figure 5.1). A typical sample had a 
number average molecular weight (Mn) of 45800 g mol–1 and a polydispersity index 
(PDI) of 1.48 (GPC), while with native Hb yielded a polymer with a Mn of 70200 g 
mol–1 and a PDI of 1.80. Moreover, no polymer-protein conjugates were detected in 
SDS gel electrophoresis (Figure 5.1). Thus, chain transfer occurred with native Hb, but 
not with Hb in which cysteines were chemically blocked. As chain transfer is an 
unwanted reaction in ATRP, further reactions were carried out with Cys-blocked Hb. 
 
 
 
Figure 5.2 Characterization of native Hb and Cys-blocked Hb. a) UV/Vis spectra, b) circular 
dichroism spectra, c) SDS gel electrophoresis. 
5.2.2 Effect of pH on the ATRPase Activity of Cys-Blocked Hb  
Since any catalytic activity of proteins are pH dependent, the polymerization of 
NiPAAm with Cys-blocked Hb was carried out within a pH range of 1.5 to 7.6. At pH 
1.5 and pH 7.6 no polymer formed during a reaction time of 24 h, whereas 
polymerization occurred from pH 3.2 to 5.8 with a maximum conversion of 66% at pH 
4.0. The conversion of polymerizations conducted at pH ≥ 4.5 varied considerably 
between multiple runs and were not reproducible. Furthermore, a color change from 
brown to green was observed for these reactions. This color change may be due to 
heme-to-protein covalent bond formation between a porphyrin radical and a radical on 
a nearby amino acid,114 or due to the conversion of one of the pyrrole rings in the heme 
to pyrroline.114 Such degradation of Hb's redox centers can explain the low and 
inconsistent conversions observed at these pH values. At pH 3.2 and 4.0, the reaction 
mixtures retained their brown color, and conversion of multiple runs was similar. 
Interestingly, the pH of reactions carried out with AscA in unbuffered water is 3.7. By 
chance, this pH is close to the optimal conditions (with respect to conversion) 
determined by systematic variation of pH. In conclusion, the polymerization catalyzed 
by Hb has a pH optimum in acidic conditions. To keep the reaction conditions as 
simple as possible, all further polymerizations were carried out in pure water with in 
situ acidification by the reducing agent, AscA. 
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5.2.3 Proof that Br-Transfer is Involved in ATRPase Activity 
To provide evidence for Br-atom transfer involvement in the mechanism of the 
polymerization, a NiPAAm polymerization catalyzed by Cys-blocked Hb was 
quenched after 45 min. The resulting polymer was purified by passage through neutral 
aluminum oxide, followed by extensive dialysis in order to remove all traces of 
bromine ions and nonreacted initiator. The bromine content of the polymer was 
determined to be 300 ± 11 µg g–1 by NAA. Combining this number with Mn = 95400 g 
mol–1 (PDI = 1.47) from GPC reveals that approximately 36% of polymer chains carry 
one bromine atom, most likely at their chain end. Additional evidence for Br-
terminated chain ends came from a chain extension experiment. The purified polymer 
was used as a macroinitiator for conventional ATRP of NiPAAm in water, using a 
TEDETA copper(I)bromide complex as catalyst. The reaction was stopped after 24 h, 
and the molecular weight as well as the PDI of the polymer was determined by GPC 
(Figure 5.3). Compared to the macroninitiator, the Mn of the pNiPAAm increased to 
121700 g mol–1, while the molecular weight distribution became broader, resulting in 
an increase in the PDI to 1.83. These are clear indications that further chain growth 
occurred in the second polymerization and confirms the presence of Br-terminated 
chain ends in the pNiPAAm obtained from the protein-catalyzed polymerization. The 
increase in PDI indicates that not all chains were able to initiate the chain extension 
polymerization, which fits the NAA results of nonquantitative bromination. A 
nonquantitative chain end functionalization is most probably due to side and 
termination reactions that compete with the ATRP equilibrium during the Hb-catalyzed 
polymerization, such as the reaction of radicals with a Hb(FeII) species. 
 
 
 
Figure 5.3 GPC traces of a chain extension experiment. A polymerization of NiPAAm catalyzed 
by Cys-blocked Hb under ARGET ATRP conditions yielded a polymer that was used as a 
macroinitiator for a second polymerization of NIPAAm catalyzed by a conventional ATRP catalyst. 
Experimental conditions for the preparation of the pNiPAAm macroinitiator: Ratio of 
HEBIB/NiPAAm/AscA/Hb 1:79:1:0.008.  
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5.2.4 Kinetic Investigations 
In order to gain insight into the mechanism of the polymerizations catalyzed by 
Cys-blocked Hb, kinetics as well as the evolution of molecular weight and PDI were 
followed by 1H NMR and GPC, respectively. First order kinetics is one of the premises 
of ATRP. A high degree of control of the polymerization manifests itself in a linear 
increase in molecular weight with conversion and low PDIs.115 The semilogarithmic 
plot of ln([M]0/[M]) versus reaction time of NiPAAm polymerization is linear up to a 
reaction time of approximately 4 h (73% conversion) (Figure 5.4a). This proves that 
the polymerizations followed first order kinetics and indicates that the radical 
concentration was constant during the first hours of the reaction.  
 
 
 
Figure 5.4 Kinetic investigations of polymerizations catalyzed by Cys-blocked Hb under 
ARGET ATRP conditions. a) NiPAAm, b) PEGA, and c) PEGMA. Kinetic plots, and the evolution of 
molecular weight and PDI as a function of conversion are shown. Experimental conditions: a) ratio of 
HEBIB/NiPAAm/AscA/Hb 1:79:1:0.008, b) ratio of HEBIB/PEGA/AscA/Hb 1:78:3:0.007, c) ratio of 
HEBIB/PEGMA/AscA/Hb 1:75:1.5:0.008. 
 
At longer reaction times, the polymerizations stopped. However, such a reaction 
could be restarted by the further addition of AscA (Figure 5.5), indicating that the 
polymerization stopped due to depletion of reducing agent and not due to irreversible 
inactivation of the biocatalyst. The second, restarted reaction also followed first-order 
kinetics, as indicated by a linear slope in the semilogarithmic plot. GPC revealed that, 
at the beginning of the reaction, pNiPAAm of rather high molecular weight (Mn = 
292500 g mol–1) and a PDI of 1.73 formed (Figure 5.4a). 
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Figure 5.5 Kinetic plot of a polymerization of NiPAAm catalyzed by Cys-blocked Hb under 
ARGET ATRP conditions. An additional degased aliquot of AscA (20 mg dissolved in 2 ml of water) 
was added to the reaction mixture after 7 h. Initial experimental conditions: Ratio of 
HEBIB/NiPAAm/AscA/Hb 1:78:1:0.008.   
 
While the reaction still proceeded, more of these polymer chains formed, but also 
shorter chains that caused the average molecular weight to drop and the molecular 
weight distribution to broaden. The evolution of Mn and PDI with conversion during 
the polymerization of NiPAAm suggests a low degree of control over the 
polymerization due to the presence of irreversible chain termination reactions,116 e.g., 
caused by a low deactivation efficiency, or by reaction of a growing polymer radical 
with an Hb subunit in its FeII state. 
 
 
 
Figure 5.6 a-b) Selected GPC traces of kinetic experiments in Figure 5.4: a) NiPAAm, b) PEGA, 
c) PEGMA. d) Selected GPC traces of the kinetic in Figure 5.9 (As monomer and polymer were not 
separated prior to GPC measurements during kinetic experiments, the non-reacted monomers PEGA 
and PEGMA give rise to a GPC signal below log M ≈ 3.2). 
 
NiPAAm is well-known to be difficult to polymerize in a controlled/living way by 
means of ATRP in aqueous solution.117 Therefore, polymerizations were also carried 
out with the monomers PEGA and PEGMA (Figure 5.4b, c). Both monomers 
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polymerized with first order kinetics, however, the acrylate only reacted after an 
induction period of approximately 30 min. The molecular weights of both polymers 
increased linearly with conversion up to PS-apparent Mn of 6150-6530 g mol
–1. The 
polydisperties were relative low: The PDI of PEGA rose from 1.14 at the beginning of 
the polymerization to 1.42 at 58% conversion, while the PDI of PEGMA stayed below 
1.17 throughout the reaction. These findings show that the polymerization of PEGA 
and PEGMA was controlled/living by Cys-blocked hemoglobin. The increase in PDI at 
higher conversions suggests, however, that the degree of control is not perfect. The 
GPC traces show shoulders at lower molecular weight (Figure 5.6), indicating that 
chain termination reactions occurred. 
 
 
 
Figure 5.7 Kinetic investigations of a BPN-initiated polymerization of PEGA catalyzed by Cys-
blocked Hb under ARGET ATRP conditions. The kinetic plot, and the evolution of molecular weight 
and PDI as a function of conversion are shown. Experimental conditions: Ratio of 
BPN/PEGA/AscA/Hb 1:74:1:0.007.  
 
The induction time observed in polymerizations of PEGA could be due to slow 
initiation. However, PEGA polymerizations that were initiated with the more reactive 
initiator 2-bromopropionitrile (BPN)118 also showed this lag phase (Figure 5.7). It is 
therefore likely that the Hb needs to undergo some structural changes caused by 
interactions between protein, monomer, and polymer before it efficiently mediates the 
polymerization of PEGA. The BPN-initiated polymerization resulted in first-order 
kinetics, an increase in molecular weight with conversion, and the PDI stayed below 
1.11. 
5.2.5 Polymerizations Catalyzed by Erythrocytes  
As Hb was found to be a catalyst for polymerizations under ARGET ATRP 
conditions, the question arose as to whether a similar polymerization could be 
catalyzed by fresh erythrocytes. To this end, red blood cells were obtained according to 
standard hospital procedures from blood samples of the Corresponding Author. 
Oxygen was then removed from the erythrocytes by treatment with argon, and the cells 
were added to reaction mixtures of HEBIB, AscA, and NiPAAm or PEGA, 
respectively, in water. Analytical samples of the NiPAAm polymerization were taken 
                                           
118  W. Tang, K. Matyjaszewski, Macromolecules 2007, 40, 1858–1863. 
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after 2 and 4 h. After 24 h, the mixture was probed for the presence of pNiPAAm by 
heating above 32ºC. A precipitate formed and redissolved when the mixture was 
cooled to room temperature, indicating that indeed pNiPAAm had been formed. Figure 
5.8 provides photographic documentation of such an experiment. 1H NMR showed a 
conversion of 40% after 2 h, 78% after 4 h and full conversion after 24 h. The polymer 
was purified from the reaction mixture, yielding a brown solid after lyophilization. 
SDS electrophoresis confirmed the presence of polymer-protein conjugates along with 
unmodified Hb (Figure 5.8). GPC analysis revealed pNiPAAm with a Mn of 55100 g 
mol–1 and a PDI of 2.09 after 2 h. With increasing reaction time, Mn decreased to 
23900 g mol–1, and the PDI increased to 3.48 at full conversion (Figure 5.8). A full 
kinetic was recorded for the erythrocyte-catalyzed polymerization of PEGA (Figure 
5.9). The polymerization proceeded to 58% conversion within 4 h, after which it 
slowed down. It roughly followed first-order kinetics. In the course of the reaction the 
molecular weight of pPEGA increased linearly to a Mn of 9240 g mol
–1. However, the 
PDI also increased from 1.18 at 1 h reaction time to 1.68 at 6 h, indicating a lower 
degree of control in the later stages of this polymerization. 
 
 
 
Figure 5.8 Polymerization of NiPAAm under ARGET ATRP conditions using human 
erythrocytes as catalyst. a-h) Photographic documentation: a) Fresh sample of erythrocytes from the 
corresponding author, b) deoxygenation of erythrocytes by purging with argon, c) reaction mixture at 
the beginning of the polymerization, d) reaction mixture after overnight stirring, e) a precipitate 
formed upon gentle heating of the reaction mixture, indicating the presence of pNiPAAm, f) 
precipitate at approx. 40°C, g) upon cooling to room temperature, the precipitate dissolved, h) 
reaction mixture after filtration through a plug of neutral aluminium oxide, i) SDS gel electrophoresis 
of reaction mixture and native Hb, j) evolution of GPC traces during polymerization (trxn = 2 h: Mn = 
55100 g mol–1, PDI = 2.09, conversion = 40%; trxn = 4 h: Mn = 39900 g mol–1, PDI = 2.37, conversion 
= 78%; trxn = 24 h: Mn = 23900 g mol1, PDI = 3.48, conversion = 100%). 
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Both polymerizations show that red blood cells are able to catalyze 
polymerizations of vinyl-type monomers under ARGET ATRP conditions. The 
erythrocytes exhibited some control over the radical polymerization in the case of 
PEGA, but a lack of control in the case of NiPAAm. Moreover, protein-polymer 
conjugates were also formed. The lower degree of control compared to Cys-blocked 
Hb is not surprising, considering that crude erythrocyte samples contain many other 
molecules and proteins apart from Hb that could interfere with ATRP, e.g., by 
providing thiols that react with radicals. Furthermore, human Hb has six cysteine 
residues119 that were not blocked with appropriate reagents. Nevertheless, the 
polymerizations with erythrocytes suggest that dehalogenation reactions that result in 
radical formation might also happen under anaerobic conditions in vivo. 
 
 
 
Figure 5.9 Kinetic investigation of the polymerization of PEGA catalyzed by erythrocytes under 
ARGET ATRP conditions. The kinetic plot and the evolution of molecular weight and PDI as a 
function of conversion are shown. Experimental conditions: ratio of HEBIB/PEGA/AscA 1:78:3, 2 ml 
erythrocytes. 
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5.2.6 Characterization of Hb Before, During, and After the 
Polymerization 
If Hb acts as a catalyst in ARGET ATRP, it should be stable during the reaction 
and not suffer structural degradation. Reports in the literature show that some 
organohalides denaturate Hb,120 while Hb is also reported to be structurally stable in 
the presence of other alkyl halides.121 The heme is prone to attack by radicals;122 
however, covalent modifications to the heme do not necessarily impede catalytic 
activity of hemeproteins.123 ARGET ATRP at pH 3.7 did not cause the protein to 
precipitate. As discussed above, SDS gel electrophoresis revealed that the Cys-blocked 
Hb subunits did not change in molecular weight during the reaction (Figure 5.1c), i.e., 
the protein did not form conjugates with polymers. CD spectroscopy was used to probe 
the secondary structure of the protein. The CD spectra of Cys-blocked Hb and of a 
protein sample that was recovered from a typical polymerization run of NiPAAm are 
presented in Figure 5.10a. Both far-UV spectra resemble each other and are typical of 
proteins rich in α-helices. However, the recovered Hb has slightly lower ellipticity. 
Thus, the overall structure of Hb was conserved during the polymerization, but minor 
changes occurred that decrease the helix content of the protein in favor of an irregular 
structure. Apart from these structural rearrangements, Cys-blocked Hb is stable under 
the acidic ARGET ATRP conditions. 
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Figure 5.10 Characterization of Cys-blocked Hb before, during and after a polymerization of 
NiPAAm under ARGET ATRP conditions. a) Circular dichroism spectra, b) UV/Vis spectra, c) Time 
dependent Vis spectra of Cys-blocked Hb during a reduction with AscA in the absence of initiator and 
monomer. The first spectrum was recorded after the addition of AscA. Spectra were recorded every 
45 s. Experimental conditions: Ratio of AscA/Hb 1:0.03, pH 3.7.  d) Time dependent Vis spectra of 
Cys-blocked Hb during a polymerization of NiPAAm under ARGET ATRP conditions. The first 
spectrum was recorded after the addition of AscA. Spectra were recorded every 45 s. Experimental 
conditions: Ratio of HEBIB/NiPAAm/AscA/Hb 1:79:1:0.008. 
 
 
UV/Vis spectroscopy allows a determination of the oxidation state of the Fe in 
Hb.124 Furthermore, it has been used to assess whether and how radicals covalently 
alter the structure of the heme,125 lead to heme-to-protein cross-links,126 or lead to the 
formation of hemichromes.127 The spectrum of Cys-blocked Hb before polymerization 
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(Figure 5.10) shows a maximum of the Soret band at 406 nm, two minor maxima at 
500 and 630 nm, and two shoulders at 538 and 576 nm. This corresponds to the typical 
absorption pattern of methemoglobin.128 This is not surprising, because lyophilized 
hemoglobin is readily oxidized in air, and the commercial preparation of Hb was 
therefore predominantly methemoglobin.  
In order to follow the oxidation state changes during the polymerization, reactions 
were run with Cys-blocked Hb in a sealed, argon-filled cuvette in a UV/Vis 
spectrometer. While the Soret band was too intense to be monitored, the visible range 
of the spectrum could be followed over time. When Cys-blocked Hb was treated with 
AscA in the absence of monomer and organo-bromide initiator, a spectrum evolved 
with a peak at 627 nm and a broad absorption band comprising peaks at 509 and 541 
nm (Figure 5.10c). Such a spectrum is characteristic of intermediate hemoglobin, a 
valency hybrid in which the α-chains are in the FeIII state and the β-chains in the FeII 
state (αIIIβII).129 Indeed, methemoglobin has been reported to be reduced by ascorbic 
acid to this species.130 The evolution of Cys-blocked Hb’s spectrum during ARGET 
ATRP showed different results. In Figure 5.10d, the first three hours of a 
polymerization are reported at intervals of 45 s, while Figure 5.11 shows the evolution 
of spectra over a period of 13 h at intervals of 4 min. During the first 4.5 min of the 
reaction, the maximum at 500 nm transformed into a broad adsorption band with a 
shoulder at 536 nm. The maxima at 627 nm became less pronounced. This spectrum 
was dominant during the initial hours of the polymerization. Most likely, it resulted 
from the combined presence of αIIIβII and methemoglobin: Initially, methemoglobin 
was reduced by AscA but, at the same time, organobromine compounds are efficient 
oxidizing agents for reduced Hb.131 Thus, the reaction of αIIIβII with organo-bromine 
initiator and Br-terminated dormant polymer chains yielded methemoglobin, which 
was converted back to αIIIβII by transfer of Br to the polymer radical, or by reduction 
with AscA. After 4-6 hours of polymerization (c.f. Figure 5.11), the shoulder at 536 nm 
disappeared, and a spectrum with an adsorption band at 510 nm, and two minor bands 
at 627 and 686 nm evolved.  
                                           
128  a) B. J. Reeder, Antioxid. Redox Signaling 2010, 13, 1087–1123 b) W. G. Zijlstra, A. Buursma, 
Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol. 1997, 118, 743–749. 
129  A. Tomoda, M. Takeshita, Y. Yoneyama, J. Biol. Chem. 1978, 253, 7415–7419. 
130  a) A. Tomoda, M. Takeshita, Y. Yoneyama, J. Biol. Chem. 1978, 253, 7415–7419 b) A. Tomoda, 
A. Tsuji, S. Matsukawa, M. Takeshita, Y. Yoneyama, J. Biol. Chem. 1978, 253, 7420–7423. 
131  a) W. A. Braunecker, K. Matyjaszewski, Prog. Polym. Sci. 2007, 32, 93–146 b) E. W. Bartnicki, 
N. O. Belser, C. E. Castro, Biochemistry 1978, 17, 5582–5586. 
 62 
 
Figure 5.11 Time dependent Vis spectra of a NiPAAm polymerization catalyzed by Cys-blocked 
Hb under ARGET ATRP conditions. Experimental conditions: Ratio of HEBIB/NiPAAm/AscA/Hb 
1:79:1:0.008. The first spectrum was recorded after the addition of AscA. Spectra were recorded 
every 4 min.  
 
This reaction time corresponds to the time at which the polymerization stopped 
(Figure 5.11). Unfortunately, it was not possible to assign the spectra of this Hb 
unambiguously to a known derivative of Hb. However, a UV/Vis spectrum of Cys-
blocked Hb that was purified at the end of a typical polymerization and exposed to air 
shows the characteristics of methemoglobin, albeit with a slightly reduced molar Soret 
absorption (Figure 5.10b). The presence of the Soret band proves that the heme groups 
were not destroyed by radical-induced cleavage of the porpyhrin ring. The Soret band’s 
position at 406 nm and the absence of a shoulder at longer wavelengths, a feature of the 
spectrum of αIIIβII,132 indicate that all iron was in a FeIII oxidation state. Thus, the 
concentration of αIIIβII decreased during the reaction, and Hb accumulated in a ferric 
state that resulted in a methemoglobin-like species after purification. Moreover, the 
spectrum indicates that the recovered Hb neither contained hemichromes nor did it 
have heme-to-protein cross-links, as these species have other distinctive absorption 
patterns in the visible region.133 The formation of covalently modified prosthetic hemes 
cannot be ruled out, because some are reported to have a methemoglobin-like 
absorption spectrum.134 This could also account for the lower Soret adsorptivity of the 
recovered protein. 
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5.2.7 Mechanistic Discussion 
In summary, the experimental results allow us to draw the following, putative 
mechanistic picture of the Hb-catalyzed polymerization (Scheme 5.2). The reaction 
starts with methemoglobin being reduced to intermediate hemoglobin by AscA. Then, 
αIIIβII activates the alkylbromide initiator yielding Hb-iron(III)bromide and an alkyl 
radical. This radical starts the chain propagation. The presence of bromine-terminated 
polymers proves that Hb can transfer Br back to the organo radical, yielding a dormant 
polymer chain and Hb-iron(II). Thus, an ATRP equilibrium between dormant species 
and activated, propagating radical species evolves. With the monomers PEGA and 
PEGMA, the deactivation is efficient enough to allow a good to moderate degree of 
control of the polymerization. Hb-iron(III) species accumulate due to termination 
reactions of polymer radicals, and due to the reaction of radicals with Hb-iron(II). The 
activating species αIIIβII is regenerated through the reduction of Hb-iron(III) by the 
excess of AscA, until the reducing agent is consumed. As the oxidation of 
deoxyhemoglobin to methemoglobin by alkyl-bromides is known to be an axial inner 
sphere process,135 it is likely that the redox reactions involved in the Hb-catalyzed 
polymerization follow an inner-sphere electron transfer. 
 
 
 
Scheme 5.2 Possible mechanism of Hb-Catalyzed Polymerization under ARGET ATRP 
Conditions. 
 
5.3 Conclusion 
Bovine Hb and human erythrocytes were found to be catalysts for the 
polymerization of vinyl-type monomers under ARGET ATRP conditions, using alkyl 
bromides as an initiators and the reducing agent AscA. Therefore, Hb is an ATRPase. 
The kinetics of the polymerization were of first order, and the reaction yielded partially 
bromine-terminated polymers with relative low polydispersity indices. Moreover, the 
polymerization of PEGA and PEGMA resulted in an increase in molecular weight with 
conversion. These are signs of a controlled/living character of the reaction. The 
mechanism of the polymerization, although not yet fully elucidated, resembles the 
redox and atom transfer reactions encountered in conventional ARGET ATRP. 
                                           
135  a) R. S. Wade, C. E. Castro, J. Am. Chem. Soc. 1973, 95, 231–234 b) E. W. Bartnicki, N. O. 
Belser, C. E. Castro, Biochemistry 1978, 17, 5582–5586. 
 64 
The reversible interplay of dehalogenation and halogenation reactions involved in 
the ATRPase activity of hemoglobin is a novel aspect in the wide and rich landscape of 
functions and reactions associated with this protein. Moreover, ATRPase activity of Hb 
and other suitable enzymes complement the existing repertoire of biocatalytic 
polymerizations, being the first examples of native enzymes that are able to catalyze 
controlled/living radical polymerizations. From a technological point of view, the 
newly discovered ATRPase activity of Hb and erythrocytes could provide a green, 
nontoxic, and even edible alternative to conventional ATRP catalysts, especially if the 
catalytic performance of the protein is further increased. An entire plethora of 
biocatalyst engineering methods, such as directed evolution, rational design, 
immobilization, and the use of enzymes in organic solvents, stands ready to achieve 
this goal. Apart from revealing a useful synthetic activity of Hb for in vitro 
biotransformations, our findings have significance beyond polymer sciences. The 
possibility that certain reactions of the polymerase activity of hemoglobin and of 
erythrocytes could happen in vivo, in particular the reversible, catalytic creation of 
radicals from halogenated small- and macro-molecules, might lead to a deeper 
understanding of the toxicity
 
of organohalogen compounds and their metabolic 
pathways. 
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6 Nanoreactors136 
 
Kasper Renggli, Patric Baumann, Karolina Langowska, Ozana Onaca, Nico Bruns 
and Wolfgang Meier 
 
 
 
 
 
Chemical reactions can be confined to nanoscale compartments by encapsulating 
catalysts in hollow nano-objects. Such reaction compartments effectively become 
nanoreactors when substrate and product are exchanged between bulk solution and 
cavity. In this chapter, natural nanoreactors that include protein-based bacterial 
microcompartments, protein cages, and viruses are discussed. Our work focuses on the 
group II chaperonin thermosome from the archaea Thermoplasma acidophilum as 
protein nanoreactor for atom transfer radical polymerization in aqueous solution. 
Nanoreactors hold promise for applications ranging from selective and size-
constrained organic synthesis to biomedical advances (e.g. artificial organelles, 
biosensing) and as analytical tools to study reaction mechanisms.  
                                           
136  This chapter was published as part of: K. Renggli, P. Baumann, K. Langowska, O. Onaca, N. 
Bruns, W. Meier, Adv. Funct. Mater. 2011, 21, 1241–1259. 
 66 
6.1 Introduction 
Confined reaction spaces that span various length scales ranging from the 
macroscopic world down to nanosized structures are found abundantly in biological 
systems. The controlled and selective exchange of substances across the confining 
layer is a characteristic hallmark of life. Every organism is a macroscopic entity with a 
distinct inner volume in which complex chemical transformations occur. This internal 
volume is separated from the environment by a boundary layer, e.g. the skin. Likewise, 
cells can be regarded as very complex microreactors. The cell membrane encloses 
catalytically active species, i.e. enzymes, in a confined volume. It controls access and 
release of substances into and out of the cell by a variety of pores and active and 
passive mechanisms. Moreover, organelles within cells provide another, smaller level 
of compartmentalization. Organelles are also equipped with various means to 
selectively exchange materials with the cytosol. Nature manages to stabilize and 
protect catalytically active species by separating the reaction space within cells and 
organelles from the surrounding environment. Furthermore, the reaction conditions, 
e.g. pH or concentration of certain substrates in the compartments, are controlled in 
order to influence the course of reactions. Another important feature of Nature’s micro- 
and nanocompartments is spatial control of individual reaction steps in various 
complex reaction cascades. 
6.2 Nature’s Nanoreactor 
Most of the compartmental boundaries of cells and cellular organelles are lipid-
based membranes. However, a variety of protein-based compartments have attracted 
great attention recently.137 Cage-like proteins such as ferritins or chaperonins provide 
cavities that can sequester metal oxides or partially unfolded proteins from the cytosol. 
Protein-based compartments of bacteria and archea provide isolated environments 
within cells that do not possess membrane-enclosed organelles. Viruses, on the other 
hand, protect their genetic material outside the context of a typical cell by enclosure 
inside a cavity formed by a protein coat of virus particles.   
Protein containers consist of multiple copies of individual protein subunits that 
self-assemble into structures that are often highly symmetric (Figure 6.1). Only one or 
a few different protein building blocks are necessary to create structures that comprise 
between 14 and several thousand individual subunits. The structures span a broad 
scope of shapes and sizes, ranging from the spherical DNA-binding protein of starved 
cells (Dps) with a diameter of 9 nm,138 to the carboxysomes, polyhedral proteinaceous 
shells with a diameter of 80 nm to 150 nm,139 to viral capsids with diameters between 
                                           
137  a) A. de la Escosura, R. J. M. Nolte, J. J. L. M. Cornelissen, J. Mater. Chem. 2009, 19, 2274 b) C. 
M. Niemeyer, Angew. Chem. Int. Ed. 2001, 40, 4128–4158 c) S. Kang, T. Douglas, Science 2010, 
327, 42–43 d) M. Uchida, M. T. Klem, M. Allen, P. Suci, M. Flenniken, E. Gillitzer, Z. Varpness, 
L. O. Liepold, M. Young, T. Douglas, Adv. Mater. 2007, 19, 1025–1042. 
138  M. Uchida, M. T. Klem, M. Allen, P. Suci, M. Flenniken, E. Gillitzer, Z. Varpness, L. O. Liepold, 
M. Young, T. Douglas, Adv. Mater. 2007, 19, 1025–1042. 
139  S. Q. Cheng, Y. Liu, C. S. Crowley, T. O. Yeates, T. A. Bobik, BioEssays 2008, 30, 1084–1095. 
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18 nm and 500 nm.140 Examples of rod-shaped containers are the tobacco mosaic virus, 
with dimensions of 18 nm to 300 nm, and the M23 bacteriophage, with a diameter of 
6.5 nm and a length of 860 nm.140 
 
 
 
Figure 6.1 Structures and models of some nanoreactors found in Nature: Protein cages, a virus, 
and microbial protein microcompartments. a) DNA-binding protein from starved cells (Dps) (PDB: 
1QGH),141 b) small heat-shock protein (sHSP) (PDB: 1SHS),142 c) apoferritin (PDB: 1DAT),143 d) 
thermosome (THS) (PDB: 1A6D),144 e) encapsulin (PDB: 3DKT),145 f) cowpea chlorotic mottle virus 
(CCMV) (PDB: 1CWP),146 g) proposed model of carboxysome,147 h) proposed model of 
ethanolamine utilization (Eut) microcompartment.148 Structures of a-g were rendered using the 
Chimera program,149 models in g and h are reproduced from 147 and from 148, respectively, with 
permission from AAAS. 
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149  S. Litvinchuk, Z. Lu, P. Rigler, T. D. Hirt, W. Meier, Pharm. Res. 2009, 26, 1711–1717. 
 68 
Protein-based cages have attracted the attention of scientists as potential 
nanoreactors because of their extensive size-range. Moreover, these biological entities 
often possess the capacity to gate access to their cavities in a precise way. As more and 
more structures are resolved, protein cages are being seen as offering the unique 
opportunity for site-selective modification by chemical conjugation or by using genetic 
engineering techniques. Many protein cages are remarkably stable, despite the fact that 
they are self-assembled structures with, often, no covalent linkage between subunits. 
As an example, ferritin is stable to 85°C150 and to 6 M guanidine at pH 7.151 Thus, 
protein cages have the potential for use as nanoreactors in technical applications or 
under normal lab conditions. Stability can be further increased by chemical 
modifications e.g. by PEGylation, by genetic engineering or by using protein cages 
derived from organisms that live in extreme environments, such as hydrothermal deep 
sea vents or hot springs.152  
The protein shell encloses one or (in the case of chaperonins) two central cavities 
with primarily hydrophilic walls. Static and gated pores in the shell allow access to the 
cavities. These gaps of a defined size are formed at the interface between subunits. The 
diameters of the ‘static’ pores range from 0.4 nm in ferritin153 to approximately 3 nm in 
the small heat-shock protein (sHSP).154 These pores are big enough to allow water, 
ions, low molecular weight molecules, and small polymers to enter and leave the 
protein container. Larger molecules, however, are not able to pass through the pores. 
Thus, these pores act as a size-exclusion gate. Furthermore, some of the pores are lined 
by charged amino acid residues, rendering them selectively permeable to charged 
molecules. Protein shells are not static or rigid vessels, but rather flexible entities that 
react to variations in their external environments. 
However, the catalytic species are usually too large to be enclosed through the 
pores in the protein shell. A method to encapsulate and release these macromolecules 
and into the cavity of protein containers is the reversible assembly/disassembly of the 
protein containers from/into subunits. Some RNA plant viruses exhibit such 
behavior.155 This can be exploited to load a virion in vitro with guest molecules such as 
proteins,156 inorganic nanoparticles,157 and anionic polymers.158 CCMV disassembles 
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into protein dimers and RNA when exposed to pH above 7.5. After purification of the 
protein subunits and adjustment of the pH to 5.0, the virion self-assembles into empty 
or, in the presence of cargo, cargo-filled viral capsids.159 Another example of reversible 
assembly/disassembly is ferritin, which disassembles at pH 2 and reassembles at pH 
7.160 
6.2.1 Protein-Based Microbial Microcompartments 
Although the biological role of many protein containers is either the storage or 
transport of cargo, e.g. in the case of ferritin and viruses, some examples are known 
whereby substrates enter the confined volume, encounter a catalytically active species 
and are converted to products that subsequently leave the cage. Thus, Nature uses 
hollow protein assemblies as nanoreactors in much the same sense as envisaged by us. 
Furthermore, there is some evidence that access to the cavity of the cages is selective 
or even gated.161 Prime examples for Nature’s gated nanoreactors are bacterial 
microcompartments that function as protein-based organelles in otherwise non-
compartmentalized bacterial cells.162 Typically, a few thousand proteins form a shell 
with a polyhedral shape and a diameter between 80 nm to 150 nm that contain several 
different enzymes. Carboxysomes are such microcompartments.163 They are found in 
all cyanobacteria and some chemoautotrophs and enhance CO2 fixation by 
encapsulating the sequential metabolic enzymes carbonic anhydrase and ribulose-1,5-
bisphosphate carboxylase-oxygenase (RuBisCO). The shell of the carboxysome is 
thought to be a diffusion barrier to the intermediate metabolite, CO2, thus increasing 
the local substrate concentration for the CO2-converting RuBisCO. Ethanolamine 
utilization (Eut) microcompartments164 and propandiol utilization (Pdu) 
microcompartments165 are found in bacteria such as E. coli and S. enterica. They 
sequester metabolizing enzymes that convert ethanolamine into ethanol or 1,2-
propanediol into propionyl-CoA, respectively. The metabolic intermediates 
acetaldehyde or propionaldehyde are consumed before they can escape the shell and 
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thus are prevented from being released into the cytosol at toxic levels.166 Furthermore, 
volatile aldehydes are not lost as a carbon source to the bacteria by diffusion across the 
cell-membrane.167 
Smaller protein-based microcompartments that enclose enzymes or are themselves 
catalytically active have been identified and their structures characterized. These 
include the 24 nm diameter encpasulin from Th. maritioma,168 B. subtilis lumazine 
synthase,169 the eukaryotic pyruvate dehydrogenase complex,170 and 2-hydroxy-
pentadienoic acid hydratase from E. coli.171 They possess pores in their shells, but it 
remains to be determined whether these pores selectively control or even gate substrate 
access to the biocatalysts in a way other than by imposing a size restriction on the 
molecules capable of entering and leaving the compartment. Furthermore, bacterial 
microcompartments and the smaller enzymatically active protein compartments have 
not been used as nanoreactors in vitro thus far.  
6.2.2 Protein Cages 
In contrast to protein microcompartments, protein cages have been applied as 
nanoreactors in a non-biological context. Ferritins were the first protein cages used as 
catalysts172 for in vitro reactions and continue to be the most widely explored protein-
based nanoreactors.173 Members of the family of ferritins are found in all realms of life. 
Their biological function is to sequester and store iron in a soluble, bioavailable, and 
safe form.174 Ferritins are spherical cages 12 nm in diameter, composed of 24 
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subunits.175 A hydrated ferric oxide (or phosphate) forms within their 8 nm-diameter 
cavity. They possess eight pores with a diameter of 0.4 nm and a constriction of 0.33 
nm. They were long considered static, but experimental evidence has shifted this 
thinking to possibly active or gated pores.176 A local unfolding of the pores due to heat 
or to low concentration of chaotropes (such as 1 mM urea or guanidine) results in an 
opening of the pores.177 This increases the accessibility of the iron core to chelating 
agents that facilitate release of Fe2+ from the ferritin.  
Here, we will highlight examples where ferritins have been used as nanoreactors in 
the sense described above. As their natural role is the mineralization of iron, they have 
also been used extensively to prepare inorganic nanoparticles inside their cavities. The 
use of ferritins as templates for inorganic nanoparticle synthesis is beyond the scope of 
this thesis and was reviewed recently.178 A natural step beyond preparing ferritins with 
inorganic cores was to employ them as catalysts. Ferritin, with its native and/or 
reconstituted oxyhydroxide ferrihydrite core, was shown to catalyze the photoreduction 
of cytochrome C and viologens,179 as well as to reduce an aqueous chromium(VI) 
species to chromium(III)180 and copper(II) to copper(0)181 while being illuminated with 
UV- or visible light, respectively. As cytochrome C and viologen are too big to enter 
the pores, electron transfer was proposed to occur through the protein shell. In the case 
of Cr, mechanistic uncertainties remain as to whether the substrates entered the ferritin 
or not while the Cu0 particles formed inside the protein cage. More recently, Au-Ag 
alloy nanoparticles formed inside apo-ferritin, i.e., a ferritin deprived of its native core, 
were used to catalyze the reduction of 4-nitrophenol to corresponding 4-aminophenol 
in the presence of NaBH4.182 However, putative selective properties of the pores with 
respect to substrates were not investigated in these works. These properties were first 
described by Watanabe and coworkers, who used ferritin encapsulating Pd nanoclusters 
as size-selective hydrogenation catalysts.183 To this end, PdII ions were concentrated at 
the interior of apo-ferritin, i.e., a ferritin deprived of its native core, and reduced 
chemically to form Pd particles of 2.0 ± 0.3 nm diameter. The reactivity of the 
resulting catalyst to various olefins such as acrylamide and tert-butyl acrylamide 
roughly correlated with the volume of the olefins, indicating that the pores discriminate 
among substrate sizes. In subsequent work, the authors improved catalytic performance 
by using Au-Pd alloy nanoparticles and Au-Pd core-shell nanoparticles generated 
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inside of the ferritin.184 Furthermore, noncovalent coordination of Pd(allyl) complexes 
onto the interior surface of genetically engineered apo-ferritin yielded active species 
that catalyzed the Suzuki coupling reaction between 4-iodoaniline and phenylboronic 
acid to yield 4-phenylaniline.185 A similar approach allowed incorporation of various 
ferrocene derivatives into apo-ferritin. However, no organic reaction was catalyzed 
using these potential catalysts.186 In further work by the Watanabe group, 
Rh(norbornadiene) was complexed onto the metal-complexing sites of apo-ferritin.187 
These systems catalyzed the polymerization of phenylacetylene inside the confined 
volume of the cage, yielding polymers of restricted molecular weight and a narrower 
molecular weight distribution compared to a free Rh complex (inside cage: Mw/Mn = 
2.1 to 2.6 vs. free catalyst Mw/Mn = 21.4). The polymers were extracted from the 
protein shell by disassembling the ferritin into individual subunits at pH 2. The 
selectivity of the pores was investigated by using derivatives of phenylacelytene as 
monomers. While a monomer carrying an amino group as a substituent was 
polymerized, phenlyacetylenes bearing carboxylic acid or phosphonic acid groups were 
not polymerized, indicating that anionic monomers are hindered from entering the 
pores, which are lined with a negative electrostatic potential. 
Young, Douglas, and coworkers investigated several protein cages, namely 
ferritin,188 small heat-shock protein (sHSP) from M. jannaschii,189 and DNA binding 
protein from starved cells (Dps) of L. innocua190 as hosts for the formation of platinum 
nanoclusters that are able to catalyze hydrogen formation. Dps is a mini-ferritin that 
protects DNA during starvation from oxidative damage by accumulating iron atoms in 
its cavity. In comparison to ferritin, it is smaller and composed of only 12 subunits. 
The cage has an outer diameter of 9 nm and an inner diameter of 5 nm.191 Hydrophilic 
pores 0.8 nm in diameter along the three-fold axis are lined with negatively charged 
residues and allow access to the cavity. sHSP is a chaperone that assembles from 24 
subunits into a 12 nm cage.192 The interior cavity of 6.5 nm diameter is accessible 
through eight trigonal and six square-planer pores, their edges being 3 nm and 1.7 nm 
long, respectively. Thus, these pores are considerably larger than those of ferritins and 
Dps, presumably allowing for easier access to and egress from the cage. The Pt 
nanoclusters inside the cages efficiently catalyzed the reduction of H+ to H2 when this 
reaction was coupled to a light-activated photosystem outside of the nanoreactor. The 
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photocatalytic oxidation of simple organic compounds such as EDTA by ruthenium 
trisbypiridine was coupled to hydrogen formation via methyl viologen. This mediator 
had to cycle in and out of the cage.193 In a slightly simpler reaction, a photosystem 
based on an Ir complex was used as a mediator-less photocatalyst in conjunction with 
the Pt clutser.194 Here, the photocatalyst was assumed to cycle in and out of the cage. 
The initial catalytic activity of the Pt clusters inside sHsp and ferritin nanoreactors was 
better than the initial activity obtained for protein-free Pt particles, illustrating the 
enhancement of catalytic performance due to the protein nanoreactor, possibly by 
isolating and protecting the clusters from agglomeration.195 Although three different 
protein cages were used, only the catalytic performance of the sHsp and the ferritin 
system were compared under identical conditions.196 Hydrogen production rates are 
higher for the Pt-ferritin than for Pt-sHsp. This finding was attributed to the smaller 
size of Pt nanoparticles in ferritin compared with the particles in sHsp. Thus, it remains 
to be seen whether the size of the pores has an influence on the reaction.  
Chaperonins are very promising candidates as nanoreactors because of their built-
in lids that gate large openings. Archaeal thermosomes (THS) are self-assembled 
spheres approximately 15.8 nm in diameter in their closed conformation. The sphere is 
formed of two stacked, eight-membered rings that each enclose an ovaloid cavity with 
inner diameters of 5.4 and 8.6 nm.197 Each cavity can hold globular proteins up to 50 
kDa197 and can be accessed through approximately 8-10 nm wide pores when THS is in 
an open state.198 Our group used a covalent linker strategy to entrap proteins that 
diffused through the open gate into the thermosome of Th. acidophilum.199 Two 
different fluorescent proteins were encapsulated simultaneously into the two cavities of 
the cage, as proven by their ability to carry out a fluorescence resonance energy 
transfer (FRET). The strategy is generic and allows for the encapsulation of a variety of 
proteins, including enzymes such as horseradish peroxidase (HRP). The enzymes were 
catalytically active inside the THS. Moreover, given that the function of THS in vivo is 
to refold denatured proteins, the cage stabilized the guest to thermal degradation, 
increasing the half-live of the enhanced yellow fluorescent protein and of HRP at 70°C 
by up to 2.3-times.200  
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6.2.3 Viruses 
Despite the vast library of known viral protein cages,201 only two capsids have 
been used to date as an in vitro-nanoreactor. The work by Nolte and coworkers on the 
cowpea chlorotic mottle virus (CCMV) as a single-enzyme nanoreactor is a beautiful 
example of the opportunities that emerge when such systems are explored.202 The 
capsid of CCMV has an outer diameter of 28 nm. It consists of 180 coat proteins that 
enclose a cavity of 18 nm in diameter. As mentioned above, it reversibly disassembles 
at low pH. Furthermore, CCMV undergoes pH-dependant swelling that is accompanied 
by an opening of pores. The virus was loaded with the horseradish peroxidase by 
disassembly/reassembly of the capsid in the presence of enzyme. The experimental 
protocol ensured that the reassembled virion contained either one or no enzyme 
molecule, thus permitting the study of single enzyme kinetics. The peroxidase was 
used to catalyze the oxidation of a non-fluorescent substrate added to the surrounding 
solution, into a fluorescent product inside of the nanoreactor. The product diffused 
from the virus into solution through pores. By measuring the diffusion rate of the 
fluorophores as a function of pH with fluorescence correlation spectroscopy, it was 
shown that the diffusion rate of the product increased by a factor of 2-3 above pH 5.7, 
which was attributed to the opening of pores. Indeed, the pore size is known to be 
small at low pH and increases to a diameter of approximately 2 nm at pH > 6.5.203 In 
subsequent work, the group developed a method to encapsulate a controlled number of 
protein molecules inside of CCMV via interactions of coiled-coil peptide domains.204 
Enhanced green fluorescent protein (eGFP) was used as the guest, but the method also 
lends itself to the encapsulation of active enzymes. The second, very recent, approach 
by Douglas and coworkers encapsulates alcohol dehydrogenase D into the cavity of the 
bacteriophage P22.205 By changing to different morphological states of P22 and 
thereby altering the volume of the cavities, they demonstrated a change in the overall 
activity of the encapsulated enzyme. 
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7 A Chaperonin as Protein Nanoreactor for Atom 
Transfer Radical Polymerization206 
 
Kasper Renggli, Martin G. Nussbaumer, Raphael Urbani, Thomas Pfohl and Nico 
Bruns 
 
 
 
 
 
The group II chaperonin thermosome (THS) from the archaea Thermoplasma 
acidophilum is reported as nanoreactor for atom transfer radical polymerization 
(ATRP). A copper catalyst was entrapped into the THS in order to confine the 
polymerization into this protein cage. THS possesses pores that are wide enough to 
release polymers into solution. The nanoreactor favourably influenced the 
polymerization of N-isopropyl acrylamide and poly(ethylene glycol) methyl ether 
acrylate. 
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7.1 Introduction 
We introduced the above mentioned thermosome (THS), a group II chaperonin 
from the archaea Thermoplasma acidophilum,207 as a nanoreactor for polymerization 
reactions. THS is a hexadecameric protein complex that consists of eight α- and eight 
β- subunits. In its closed conformation is a spherical protein cage about 16 nm in 
diameter that encloses two cavities of approx. 130 nm3 each (Figure 7.1a).208 It 
provides a folding chamber to refold denatured proteins and can cycle between open 
and closed states by the consumption of ATP.207 The advantage of using THS as a 
nanoreactor compared to other established nanoreactor systems is that the chaperonin, 
when in its open conformation, possesses pores that are large enough to allow 
macromolecules to enter and leave the cavities (Figure 7.1b).209 Thus, it should be an 
ideal nanoreactor to synthesize polymers in its interior with the possibility to release 
the formed macromolecule into solution. 
 
 
 
Figure 7.1 Structure of THS a) Representation of THS in its closed conformation.208 b) Cryo-
electron microscopy (cyro-EM) density map of a thermosome in its open conformation (Data from 
Methanococcus maripaludis in its wild-type open conformation,210 since no structural data of the THS 
in this conformation is available in the databases. This structure is in good agreement with the cyro-
EM data of the THS.211)  
 
The chaperonin confines the chemical reaction into a defined volume. On the 
macroscopic scale, this is important to control and modulate the reaction through 
parameters such as the temperature, stirring, and feeding rates of substrates. If, 
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however, a reaction is confined in a vessel with dimensions on the nanoscale, i.e. into a 
yocto liter volume of the THS, the course of a chemical reaction can be influenced in 
unique ways.212 Reaction rates can be enhanced by bringing substrate and catalyst in 
close proximity,213 side reactions can be suppressed by limiting the number of reactive 
species that encounter each other,214 the reactor can act as a template that defines the 
size of the formed products,215 and the nanoreactor can provide a cavity to influence 
single chain folding of synthetic polymers.216 Furthermore, reactions can be carried out 
in environments where the reaction would normally not occur, such as biocatalysis in 
organic solvents217 or in living cells.218 Nanoreactors also offer the possibility to 
investigate reactions on the single molecule level in order to gain insight into reaction 
mechanisms and catalysis.219  
In the field of polymer synthesis, atom transfer radical polymerization (ATRP) has 
proven to be one of the most versatile and successful controlled/living radical 
polymerization techniques, as it tolerates the presence of numerous functional groups, 
biomacromolecules, and reaction media.220 As discussed in chapter 1, it enables 
synthesis of polymers with a good control over the molecular weight, narrow molecular 
weight distribution, and advanced architectures. Polymers synthesized by ATRP have 
been used as building blocks for nanostructures,221 to form protein-polymer 
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conjugates,222 and in drug-delivery systems.223 Synthesis in aqueous media has also 
been successfully demonstrated.224 Working in pure water still presents a challenge as 
the polymerization is often fast and side reactions tend to play a more important role 
than in other reaction media.225 Confining the reaction space within the small volume 
of a nanoreactor should increase the degree of control over the polymerization and 
increase the end-functionality of the products.226 Further, the reaction rate can be 
increased in comparison to homogenous systems.227 
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7.2 Results & Discussion 
7.2.1 Preparation of THS-LxCu 
A proposed strategy to sequester ATRP into a protein nanoreactor is to conjugate 
initiators to protein cages.228 However, this grafting-from approach does not allow for a 
continuous production of polymers since only one polymer chain per protein-bound 
initiator is formed and the chain is covalently attached to the protein. In order to use 
THS as a nanoreactor for ATRP, we therefore chose to entrap an ATRP catalyst into 
the THS and start chain growth from soluble initiators that diffuse into the THS, i.e. 
they would not be covalently bound to the protein. Thus, polymer chains that form in 
the protein cage are able to leave the cavity and make room for further chains to grow. 
 
 
  
 
Figure 7.2 Coupling strategy to covalently bind a TEDETA derived ligand (1) into the cavities 
of THS. This ligand is used to complex CuII resulting in a protein-catalyst conjugate, i.e. a 
nanoreactor for ATRP. 
 
A catalyst was conjugated into the cavities of the THS using bis-aryl hydrazone 
linker chemistry, similar to our previously reported method to entrap fluorescent 
proteins into THS.229 To this end, a THS mutant that displays one free cysteine residue 
on the inside surface of each β-subunit was expressed in E. coli BL21 (DE3) Codon 
Plus-RIL. Fermentations in nutrient rich Terrific Broth medium were carried out at 
30°C. Purification of THS with a 1:1 ratio of both subunits was performed in three 
chromatography steps. An anion-exchange chromatography to capture the THS from 
                                           
228  J. Lucon, S. Qazi, M. Uchida, G. J. Bedwell, Ben LaFrance, P. E. Prevelige Jr, T. Douglas, Nat. 
Chem. 2012, 4, 781–788. 
229  N. Bruns, K. Pustelny, L. M. Bergeron, T. A. Whitehead, D. S. Clark, Angew. Chem. Int. Ed. 
2009, 48, 5666–5669. 
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the cell lysate was followed by size-exclusion chromatography to remove low 
molecular mass assemblies and single subunits. The remaining cell sample was further 
purified by a second, high-resolution anion-exchange chromatography to yield fully 
assembled α8/β8 THS.230 The corresponding fractions were identified by SDS-PAGE 
and native gel electrophoresis (Figure 7.3c and d), which resulted in proteins with 960 
kDa in mass.  
 
 
 
Figure 7.3 Characterization of THS-LxCu. a) UV/Vis data reveals a molar substitution ratio of 
3.9 ± 0.1 bis-aryl hydrazone bonds and therefore ligands per THS. b) SAXS data of THS-LxCu in 
comparison to non-modified THS shows a higher contrast induced by the electron-dense copper that 
is bound to the ligand in the THS. c) SDS gel electrophoresis of the THS-LxCu, d) native gel 
electrophoresis, and e) TEM images of THS-LxCu show that the cage structure of the THS is not 
affected by the conjugation of ligands and the complexation of CuII. 
 
The β-subunit displaying a free cystein residue was completely modified with a 25-
fold excess (with respect to thiol groups) of 3-maleimido-6-hydraziniumpyridine 
hydrochloride (MHPH) as determined by UV/Vis spectroscopy. After purification, the 
modified THS was reacted with (1), a derivative of the ligand N,N,N',N'-
                                           
230  N. Bruns, K. Pustelny, L. M. Bergeron, T. A. Whitehead, D. S. Clark, Angew. Chem. Int. Ed. 
2009, 48, 5666–5669. 
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tetraethyldiethylene triamine (TEDETA) featuring an aromatic aldehyde moiety 
(Figure 7.2). The reaction yielded a stable bis-aryl hydrazone bond between the protein 
and the ligand.231 The formation of this linker is traceable by UV/Vis spectroscopy, as 
it has a characteristic absorption band with a maximum at 354 nm. Figure 7.3a shows 
the UV/Vis spectrum of the conjugate. The typical adsorption band of proteins with a 
maximum at 280 nm as well as the band of the bis-aryl hydrazone link are clearly 
observable. The deconvolution of this spectrum allows calculation of the average 
number of bis-aryl hydrazone bonds and therefore ratio of ligands per THS to be 3.9 ± 
0.1. 
 
 
 
Figure 7.4 Comparison of SAXS data of non-modified THS and non-modified THS that was 
incubated with CuBr2 and purified by the steps as performed for the THS with engineered ligand. The 
data show no differences in shape and therefore indicates that copper is not complexed at the THS 
itself. 
 
The attached ligand was used to complex CuII ions, followed by purification of the 
modified THS (THS-LxCu) by size exclusion spin centrifugation. The linker can only 
have formed inside the THS due to the location of the engineered cysteine residues. 
Therefore, the TEDETA-Cu complex must be entrapped in the cavity of the 
chaperonin. This was confirmed by small angle X-ray scattering (SAXS) 
measurements. THS-LxCu showed an increased contrast compared to the non-modified 
THS (Figure 7.3b). This indicates that the former is a nano-object with higher electron 
density than the THS alone, i.e. the engineered THS contained copper ions. The fit 
resulted in a diameter of 17.2 nm for THS-LxCu, which is in agreement with the 
diameter of the protein in the apo state.232 Therefore, it can be concluded that the 
                                           
231  a) G. T. Hermanson, Bioconjugate Techniques, Academic Press, Maryland Heights, 2008 b) A. 
Grotzky, T. Nauser, H. Erdogan, A. D. Schlüter, P. Walde, J. Am. Chem. Soc. 2012, 134, 11392–
11395. 
232  a) G. Schoehn, E. Quaite-Randall, J. L. Jiménez, A. Joachimiak, H. R. Saibil, J. Mol. Biol. 2000, 
296, 813–819 b) M. Nitsch, J. Walz, D. Typke, M. Klumpp, L. O. Essen, W. Baumeister, Nat. 
Struct. Biol. 1998, 5, 855–857. 
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electron rich copper ions reside in the inner cavities of the THS. In order to elucidate 
whether the THS alone, i.e. without a TEDETA ligand, also binds copper, non-
modified THS was incubated in a CuBr2 solution and purified as described above. The 
comparison of SAXS data of this sample with data of THS that had not been exposed 
to CuII shows no difference in shape (Figure 7.4). This indicates that copper is not 
complexed by the THS itself. 
The SAXS data give a first indication that THS maintains its structural integrity 
upon introduction of the ATRP catalyst. In order to further prove this, the protein cage 
was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS 
PAGE) and by native PAGE (Figure 7.3c and d). Both gels show the same bands for 
THS, independent of their modification with the ATRP catalyst. Furthermore, 
transmission electron microscopy (TEM) images of the protein-catalyst conjugate show 
spherical objects approx. 16 nm in diameter, which are typical for fully assembled THS 
(Figure 7.3e).233 Thus, the overall structure of THS appears to not be affected by the 
encapsulated ATRP catalyst. 
7.2.2 Polymerization of NiPAAm with THS-LxCu 
 
 
Figure 7.5 Reaction schemes for the synthesis of a) pNiPAAm in buffer solution b) pPEGA in 
buffer solution and c) pPEGA in a ddH2O/THF (7:3 v/v) solution mixture under ARGET ATRP 
conditions.  
                                           
233  a) G. Schoehn, E. Quaite-Randall, J. L. Jiménez, A. Joachimiak, H. R. Saibil, J. Mol. Biol. 2000, 
296, 813–819 b) M. Nitsch, J. Walz, D. Typke, M. Klumpp, L. O. Essen, W. Baumeister, Nat. 
Struct. Biol. 1998, 5, 855–857 c) M. G. Bigotti, A. R. Clarke, J. Mol. Biol. 2005, 348, 13–26. 
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Polymerizations were conducted by adding THS-LxCu to an aqueous buffered 
solution (100 mM sodium acetate, 150 mM NaCl, 80 mM MgCl2, pH 5.2) of the water-
soluble initiator 2-hydroxyethyl-2-bromoisobutyrate (HEBIB) and the monomer N-
isopropylacrylamide (NiPAAm) in molar ratios of [Monomer]:[Initiator]:[THS-LxCu] 
67:1:1.5 x 10-5 under argon atmosphere (reaction scheme see Figure 7.5). An excess of 
ascorbic acid (AscA) (ratio [THS-LxCu]:[AscA] 1:2.7 x 10-5) was added to reduce CuII 
in situ to its catalytically active form THS-LxCuI and to regenerate CuII that could 
accumulate during the polymerization, according to the activators regenerated by 
electron transfer (ARGET) ATRP method.234 The polymerization was stopped after 20 
hours by exposure to ambient air and addition of non-deoxygenated buffer solution. 
Polymerizations were performed using the THS nanoreactor in its apo state, i.e. in the 
absence of ATP. In this state both lids of the protein cage are open.235 Thus, any 
macromolecules that are synthesized within the THS can leave the cavities after 
polymerization.  
 
 
 
Figure 7.6 MALDI-ToF MS data of pNiPAAm synthesized with THS-LxCu in aqueous buffer. 
 
Poly(N-isopropyl acrylamide) (pNiPAAm) was separated from the protein cage by 
size exclusion spin centrifugation (100k MWCO) leaving the THS in the supernatant 
while the polymer could be collected from the flow-through. Matrix assisted laser 
desorption/ionization time of flight mass spectrometry (MALDI-ToF MS) of the latter 
showed a series of signals spaced 113.2 m z–1, with a number average molecular 
weight of 1500 g mol–1 and a polydispersity index (PDI) of 1.11 (Figure 7.6). As the 
molecular weight of the monomer is 113.16 g mol–1, this data shows that the reaction 
yielded pNiPAAm. The low PDI indicates that the polymerization proceeded with a 
good degree of control. Peak analysis of the MALDI-ToF MS spectra reveals a 
                                           
234  K. Matyjaszewski, Macromolecules 2012, 45, 4015–4039. 
235  a) J. Zhang, M. L. Baker, G. F. Schröder, N. R. Douglas, S. Reissmann, J. Jakana, M. Dougherty, 
C. J. Fu, M. Levitt, S. J. Ludtke, et al., Nature 2010, 463, 379–383 b) M. G. Bigotti, A. R. Clarke, 
Arch. Biochem. Biophys. 2008, 474, 331–339. 
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repeating set of peaks separated from adjacent sets by the monomer molecular weight 
of 113.16 Da. Under the applied MALDI-ToF MS conditions, adducts with three 
different ions H+, Na+ and K+ and the polymer are formed. A detailed analysis of the 
attributed peaks and a comparison to the calculated values is shown in Figure 7.7. 
 
 
 
Figure 7.7 The Figure shows a zoom of the main spectra (Figure 7.6) being a repeating set of 
peaks starting with HO-iBu-R-Br/Na+ where R = (NiPAAm)n. In the chosen MALDI-ToF MS 
conditions, adducts of the polymer with three different ions H+, Na+ and K+ are formed. In addition, 
the peaks correspond to chains bearing a hydroxyethyl isobutyrate (HO-iBu) or due to the acidic 
conditions of MALDI-ToF MS sample preparation an isobutyric acid (iBu) residue from the initiator 
at one end and an H, ene, OH, Br, Cl or a lactone residue at the other chain end. Although in radical 
polymerization -H or unsaturated analogue -ene end groups might be the result of a disproportionation 
during the reaction, halogen-terminated polymers products tend to yield -H, -ene, -OH and -lactone 
end groups next to the halogens in mass spectrometric measurements.236 These end groups are 
presumed to be generated during the ionization process in the MS rather than by poor control over the 
polymerization reaction. We also observe chloride terminated polymers next to the bromine 
termination. This is expected due to the presence of MgCl2 and NaCl in the buffer that was used for 
the polymerization. 
 
To set our findings into perspective, polymerizations were conducted under the 
same conditions, but with the ATRP catalyst conjugated to the outside of a globular 
protein, bovine serum albumin (BSA), instead of the protein nanoreactor, as described 
in chapter 2. The synthesis of NiPAAm was performed under ARGET ATRP 
conditions with BSA-LxCu as catalyst. Gel permeation chromatography (GPC) 
                                           
236  a) Y. Xia, X. Yin, N. A. Burke, H. D. Stöver, Macromolecules 2005, 38, 5937–5943 b) F. 
Ganachaud, M. J. Monteiro, R. G. Gilbert, M.-A. Dourges, S. H. Thang, E. Rizzardo, 
Macromolecules 2000, 33, 6738–6745. 
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determined pNiPAAm with an apparent molecular weight Mn of 42600 g mol–1 
(calibrated against poly(methyl methacrylate)) and a PDI of 1.94 (GPC trace see Figure 
2.8). By comparing the two different catalytic systems, THS as protein nanoreactor 
versus the globular protein BSA, we can draw the conclusion that the synthesized 
polymers are substantially shorter and have a lower PDI if produced in the nanoreactor. 
This indicates that the synthesis of pNiPAAm, which is intrinsically difficult to control 
in aqueous solution,237 benefits from the confined reaction space and exerts greater 
control over the polymerization. Further, the lower Mn indicates that the polymer 
synthesis is slower (e.g. due to diffusion limitations) and stops at shorter chain lengths. 
This is most probably due to either the space constriction within the cavities of the 
THS nanoreactor or the diffusion of polymer chain out of the nanoreactor. A reason for 
the low degree of control with the BSA-LxCu may derive from the very low 
concentration of catalyst in the system. This can be neglected in the THS since the 
growing polymer chain stays in close proximity to the catalyst inside of the 
nanoreactor. 
7.2.3 Polymerization of PEGA with THS-LxCu 
The scope of THS as nanoreactor for polymerizations was further explored by 
conducting the experiments with a different monomer. Poly(ethylene glycol) methyl 
ether acrylate (PEGA) with a number average molecular weight of 480 g mol–1 was 
polymerized with THS-LxCu under the same ARGET ATRP conditions used for 
pNiPAAm, yielding poly(Poly(ethylene glycol) methyl ether acrylate ) (pPEGA) with a 
poly(ethylene oxide)-apparent Mn of 14700 g mol–1 and a PDI of 1.95, as analyzed by 
GPC (reaction schemes see Figure 7.5). In comparison, the BSA-conjugated catalyst 
produced pPEGA with apparent Mn of 119400 g mol–1 and a PDI of 3.12. In addition, 
the polymerization of PEGA with THS-LxCu was run in the presence of ATP. By the 
hydrolysis of ATP the THS cycles between open and closed states.238 The reaction 
resulted in pPEGA with an apparent Mn of 17500 g mol–1 and a PDI of 2.50. As the 
addition of ATP had no beneficial effect on the polymerization, the following reactions 
were carried out without ATP. 
Addition of organic co-solvents to aqueous ATRP can result in better performance 
of a given catalyst, since side reactions, e.g. disproportionation of the ATRP activator, 
loss of the halide ligand by the ATRP deactivator as well as fast chain propagation are 
suppressed, thus resulting in better-controlled polymerizations.239 Therefore, PEGA 
was also polymerized in a 7:3 v/v mixture of double distilled water (ddH2O) and THF, 
using THS-LxCu as catalyst (reaction schemes see Figure 7.5). The product of this 
experiment resulted in an apparent Mn of 1400 g mol–1 and a PDI of 1.06 (Figure 7.8). 
BSA-LxCu yielded pPEGA with an apparent Mn of 14900 g mol–1 and a PDI of 1.84. 
The PDI and the average molecular weight of pPEGA synthesized in the presence of 
                                           
237 P.-E. Millard, N. C. Mougin, A. Böker, A. H. E. Müller, in Controlled/Living Radical 
Polymerization: Progress in ATRP, ACS Symp. Ser., American Chemical Society, Washington, 
D.C., U.S.A., 2009, pp. 127–137. 
238  M. G. Bigotti, A. R. Clarke, Arch. Biochem. Biophys. 2008, 474, 331–339. 
239 N. V. Tsarevsky, K. Matyjaszewski, Chem. Rev. 2007, 107, 2270–2299. 
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organic co-solvent are lower compared to the ones obtained without co-solvents. In 
addition, these experiments confirm that reactions carried out in nanoreactors yield a 
narrower distribution of polymers. 
 
 
 
Figure 7.8 Comparison of GPC traces from pPEGA synthesized with THS-LxCu or with BSA-
LxCu in a ddH2O/THF (7:3 v/v) mixture. 
 
For the ATRP to be confined into the THS, the protein cage has to be stable during 
the polymerization. The most harsh reaction condition was the one with THF as co-
solvent. It was therefore assessed whether or not the THS retained its structure in a 
typical PEGA polymerization in this water/THF mixture. For that purpose a sample of 
the reaction mixture after polymerization was characterized by gel electrophoresis and 
TEM. SDS and native PAGE (Figure 7.9a and b) show the distinct bands of the two 
subunits and of the fully assembled THS without residues of degraded protein. 
Moreover, TEM (Figure 7.9c) indicates that the shape and size of the protein cage 
remains intact. Thus, the protein cage was stable under these reaction conditions. 
 
 
  
Figure 7.9 Characterization of THS-LxCu after the polymerization in a 7:3 v/v mixture of water 
and THF. a) SDS gel electrophoresis, b) native gel electrophoresis and c) TEM images of THS-LxCu 
recovered after polymerization (THSrec-LxCu). The data allows the conclusion that THS remains 
stable during polymerization and retains its structure. 
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A set of control reactions was carried out to ensure that only the Cu-TEDETA 
complex in the THS bears copper that is catalytically active in ATRP. Non-modified 
THS was incubated with CuBr2 solution. Then, size exclusion spin centrifugation was 
used to remove the unbound copper. The resulting THS was used to polymerize 
NiPAAm and PEGA under the conditions described above. The reactions did not yield 
polymer products as checked by 1H NMR and GPC. These experiments, in 
combination with the SAXS data discussed above (Figure 7.4), indicate that copper 
ions are not complexed by the protein. Further, we assessed whether the bis-aryl 
hydrazone linker could complex copper ions in an ATRP-active form. For this purpose 
an analogue of the BSA-Lx was produced that incorporated the linker, but no TEDETA 
ligand. BSA was modified with MHPH, followed by reaction with methyl 4-
formylbenzoate (4FB) (Figure 7.10). The modified protein BSA-4FB was mixed with 
CuBr2 solution. After size exclusion spin centrifugation it was used as a catalyst for 
ARGET ATRP of NiPAAm with the same reaction conditions as described above. The 
polymerization with BSA-4FB did not yield any polymer as checked by 1H NMR and 
GPC. This control reaction with BSA-4FB indicates that, even though copper ions 
might be complexed by the linker, only TEDETA in combination with copper ions 
results in complexes that are able to catalyze ATRP. This underscores the necessity for 
conjugating a suitable Cu-binding ligand into the THS in order to obtain an ATRP 
catalyst inside of the protein cage. 
 
 
 
Figure 7.10 Reaction with BSA-4FB. a) BSA-MHPH was modified with methyl 4-
formylbenzoate to yield BSA-4FB b) Reaction scheme for the synthesis of pNiPAAm with BSA-4FB 
in buffer solution under ARGET ATRP conditions.  
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7.3 Conclusion 
We introduced the chaperonin THS as a nanoreactor and conducted ATRP in the 
protein cage by binding an ATRP catalyst to the inner cavities of the protein. THS is 
particularly appealing for this application as it has pores that are large enough to allow 
macromolecules to enter and leave the cavities. The synthesized polymers are therefore 
released into the surrounding solution without having to disassemble the protein cage 
into its subunits. We showed that the confined space within the nanoreactor results in 
polymers with a narrower molecular weight distribution compared to a system where 
the catalyst is conjugated to a globular protein. Such a positive effect on the 
polymerization is most probably due to the proximity of the ATRP reagents and is 
consistent with simulations of other nanoreactor systems.240  
Protein nanoreactors could influence polymerizations in some unique ways, e.g. by 
imparting selectivity for certain monomers, or by modulating the rate of the 
polymerization through triggers that close and open pores in the protein wall. As 
chaperonins are Nature’s folding chambers, they could beneficially affect the folding 
of (block)copolymers when sequestered single polymer chains are synthesized within 
their cavity. In addition, the use of protein nanoreactors could enable mechanistic 
studies of ATRP on a single molecule level. 
                                           
240  P. B. Zetterlund, Polym. Chem. 2011, 2, 534. 
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8 Incorporation of ATRPases into Protein 
Nanoreactors241 
 
Kasper Renggli, Nora Sauter, Martin G. Nussbaumer, Raphael Urbani, Mohamed 
Chami, Thomas Pfohl and Nico Bruns 
 
 
 
 
 
In a first experimental approach we demonstrated the incorporation of ATRPases, 
i.e. horseradish peroxidase, into the cavities of the chaperonin thermosome. The 
resulting nanoreactor was used to polymerize PEGA under ARGET ATRP conditions 
in a mixture of 7:3 v/v water and THF under an argon atmosphere. The resulting 
polymers benefit from the confined space of the nanoreactor. 
 
 
                                           
241  Parts of this chapter were published in: a) N. Bruns, S. Lörcher, K. Makyla, K. Renggli, M. 
Spulber, Chimia 2013, 67, 777–781 b) K. Renggli, P. Baumann, K. Langowska, O. Onaca, N. 
Bruns, W. Meier, Adv. Funct. Mater. 2011, 21, 1241–1259. 
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8.1 Introduction 
Nanoreactors provide a confined reaction space with dimensions on the 
nanoscale.242 Chemical reactions are confined to these yocto liter volumes when 
catalysts are enclosed into the nanoreactors. Compartmentalization and confinement of 
reactions into defined reaction spaces is a very common principle in nature. For 
example, cells and organelles provide microscopic reaction space, while in lipid 
vesicles, the iron-storage protein ferritin and bacterial protein microcompartments are 
examples of nanoscale reaction compartments. In addition, the confinement of 
reactions into nanoscale reaction volumes offers several advantages for technological 
applications and enhanced synthetic chemistry.243 For example, side reactions can be 
suppressed, as the confined volume brings reagent and catalysts into closer spatial 
proximity.244 Moreover, the selectivity of a reaction can be altered by controlling the 
type of substrates which can permeate into the nanoreactor.245 Also, a nanoreactor 
provides a protective shell that shields the enclosed catalyst from degrading agents 
outside of the nanoreactor, therefore allowing it to function in otherwise prohibitive 
environments. Examples of this can be found in the non-native enzymatic reactions 
within living cells.246 Moreover, nanoreactors can be used to study catalytic reactions 
on the single molecule level.247 The catalytic species within the confined volume are 
frequently enzymes. We have been studying two kinds of nanoreactors recently, 
polymersomes248 and protein cages.249 
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Nanoscale 2010, 2, 844. 
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Chem. Soc. Rev. 2012, 42, 512. 
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2011, 21, 1241–1259. 
246  P. Tanner, V. Balasubramanian, C. G. Palivan, Nano Lett. 2013, 13, 2875–2883. 
247  a) M. Comellas Aragonès, H. Engelkamp, V. I. Claessen, N. A. J. M. Sommerdijk, A. E. Rowan, 
P. C. M. Christianen, J. C. Maan, B. J. M. Verduin, J. J. L. M. Cornelissen, R. J. M. Nolte, Nat. 
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An intriguing possibility for responsive nanoreactors is the use of protein cages. 
Examples are ferritin,250 viral capsids,251 and bacterial microcompartments.252 These 
hollow nanostructures self-assemble from various protein subunits, and range in 
diameter from < 10 nm to more than 500 nm. Some of them assemble or disassemble in 
response to changes in their environment253 and others possess pores that open, widen 
or close in the presence of certain triggers.254 We have explored the thermosome 
(THS), a chaperonin from the archea Thermoplasma acidophilum, as a functional 
nanostructure. For example, we have entrapped a pair of fluorescent proteins and used 
the thermosome as a scaffold that brings the proteins into defined proximity to enable 
fluorescence resonance energy transfer (FRET) between the two proteins.255 As 
reported in chapter 7, we have focused on the possibility of using the thermosome as a 
nanoreactor for polymerization reactions, as it has pores that are large enough to allow 
macromolecules and synthetic polymers to enter and leave the protein cage. We have 
encapsulated a copper complex as catalysts for atom transfer radical polymerization 
(ATRP) into the cavity of THS and conducted ATRP of N-isopropyl-acrylamide 
(NiPAAm) and poly(ethylene glycol) methylacrylate (PEGA) within the cage.256 The 
effect of the confined reaction space, as predicted by simulations,257 manifested itself 
in smaller but more narrowly dispersed polymer products compared to polymers 
synthesized under comparable conditions with a catalyst conjugated to a globular 
protein.256 
By combining the advantages of the THS nanoreactor with the functionalities of 
the ATRPases described in chapters 3 to 5, we aim to replace the copper catalyst with a 
more environmentally friendly catalyst, rendering the resulting polymers more 
compatible with biomedical, food grade and electronic device requirements. For this 
purpose we encapsulated horseradish peroxidase (HRP) into the thermosome with a 
similar approach as previously reported by Bruns et al.255 
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8.2 Results & Discussion 
8.2.1 Preparation of THS-HRP  
To encapsulate horseradish peroxidase into the thermosome, specific chemical 
attachment points had to be engineered into the cavities of the THS complex. A 
mutation at K316C of the β-subunit introduced four cysteine residues into the inner 
cavity of each hemisphere, which enabled selective coupling of protein guests inside 
the THS. To avoid attachment of HRP on the outside of the THS, the surface exposed 
cysteines of each subunit on the native THS were replaced by alanines.258 The mutated 
α-­‐	
  and	
  β-subunit genes were co-expressed in E. coli, as described in section 7.2.1.  
 
 
 
Figure 8.1 Coupling strategy to covalently bind a HRP inside the cavities of THS. The free 
cysteins on the β-subunits of THS are modified with MTFB, using maleimide chemistry. The HRP is 
modified with HyNic which targets the lysine residues with succinimidyls. The resulting THS-HRP 
includes up to two HRP molecules into the cavities of one THS. 
 
In Figure 8.1 the strategy to covalently enclose the guest enzyme HRP into the 
cavities of the THS is shown. In a first step, the four free cystein on the β-subunits in 
each cavity of the the THS were modified with the heterobifunctional linker maleimido 
trioxa-6-formyl benzamide (MTFB) to introduce an aromatic aldehyde by the means of 
maleimide chemistry. The HRP on the other hand was modified via its lysins with 
succinimidyl 6-hydrazinonicotinate acetone hydrazine (HyNic), a second 
heterobifunctional linker that introduced a hydrazine residue.  
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Figure 8.2 Characterization of THS-HRP. a) SDS-PAGE of THS, THS-HRP and HRP. The 
presence of bands at approx. 100 kDa and 160 kDa indicate that THS can be functionlized with HRP  
(Subunit 58 kDa + HRP 44 kDa). b) Averaged cryo-electron microscopy images of THS-HRP display 
the typical hexadecameric structure of THS, indicating that the THS-HRP remains stable after 
formation. Furthermore, the enclosed HRP can be suspected in the center of the structure. 
 
The modified THS protein cage and the modified enzyme HRP were conjugated in 
a simple incubation step. A 25-fold excess of HRP with respect to THS was used to 
couple the host and guest in buffer by mixing for 14 h at room temperature. The guest-
host complex was purified by size-exclusion chromatography that separated the 
unreacted HRP from the THS-HRP. The SDS-PAGE in Figure 8.2a indicates that THS 
is functionlized with HRP by displaying bands at approx. 100 and 160 kDa for the β-
subunit-HRP dimer and the α/β-subunit-HRP trimer. Cryo-electron microscopy images 
of THS-HRP (averaged over several hundred structures to increase the signal-to-noise 
ratio) display the typical hexadecameric structure of THS, indicating that the THS-
HRP remains stable after formation (Figure 8.2b). Furthermore, the enclosed HRP can 
be suspected in the center of the structure. The complex was further confirmed by 
UV/Vis spectroscopy (Figure 8.3a) and showed three distinct bands corresponding to 
THS and HRP (280 nm), HyNic-MTFB (354 nm) and HRP (402 nm) allowing for 
calculation of the molecular substitution ratio of 0.3 ± 0.1 HRP per THS. In addition, 
small angle X-ray scattering (SAXS) confirms that the HRP is located inside the THS 
since the intensity is lower compared to an unfunctionalized and therefore empty THS 
(Figure 8.3b). This indicates that the former is a structure with higher electron density 
compared to THS-HRP, i.e. the empty THS contained in the cavities water molecules 
that possess a higher electron density than the encapulated HRP. 
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Figure 8.3 Characterization of THS-HRP. a) UV/Vis spectrosopy of THS-HRP revealed a 
molecular substitution ratio of 0.3 ± 0.1 HRP per THS using the absorbtion of THS and HRP (280 
nm), HyNic-MTFB (354 nm) and HRP (402 nm). b) SAXS measurements of empty THS and THS-
HRP indicate an incorporation of HRP due to different electron density contrast.   
8.2.1 Polymerization of PEGA with THS-HRP 
As indicated by the results of THS-LxCu, addition of organic co-solvents to 
aqueous ATRP can result in better performance of a given catalyst. By adding organic 
co-solvent, side reactions tend to play a less domiant role and therefore the 
polymerization is better-controlled/living.259 Therefore, a 7:3 v/v mixture of double 
distilled water (ddH2O) and THF under argon atmosphere was used as reaction media 
to polymerize poly(ethylene glycol) methyl ether acrylate (PEGA) with a number 
average molecular weight of 480 g mol–1. The polymerization under ARGET ATRP 
conditions with THS-HRP as catalyst and 2-hydroxyethyl-2-bromoisobutyrate 
(HEBIB) as initiator in molar ratios of [Monomer]:[Initiator]:[THS-HRP] 67:1:2 x 10–2 
was performed with sodium ascorbate as reducing agent. GPC revealed pPEGA with a 
poly(styrene) apparent Mn of 4400 g mol–1 and a PDI of 1.08 (reaction scheme see 
Figure 8.4). 
 
 
 
Figure 8.4 Reaction scheme of the polymerization of PEGA using HEBIB as initiator, sodium 
ascorbate as reducing agent and THS-HRP as the catalyst under ARGET ATRP conditions in aqueous 
solution with 3:7 v/v THF/ddH2O.  
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To assess the effect of the confined space in the THS nanoreactor, polymerizations 
with free HRP were performed in comparison (HRP characterization see chapter 4). 
ARGET ATRP with HRP yielded pPEGA with an poly(styrene) apparent molecular 
weight Mn of 5500 g mol−1 and a PDI of 1.50 as determined by GPC (Figure 8.5). The 
comparison of the THS-HRP nanoreactor versus the free ATRPase indicates that the 
resulting polymers are about the same length and have a lower PDI if produced in the 
nanoreactor. This indicates that the synthesis of pPEGA benefits from the confined 
reaction space and exerts greater control over the polymerization, indicated by a 
narrower molecular weight distribution. A reason for the higher degree of control with 
THS-HRP may derive from the close proximity of the growing polymer chain to the 
ATRPase inside the nanoreactor. This indicates that THS-HRP also benefits from the 
confined space of the nanoreactor, as demonstrated for THS-LxCu,260 when we 
incorporate HRP. 
 
 
 
Figure 8.5 GPC traces of pPEGA synthesized with THS-HRP in a ddH2O/THF (7:3 v/v) mixture. 
 
In comparison, the THS-conjugated catalyst THS-LxCu produced pPEGA with 
poly(ethylene oxide) apparent Mn of 1400 g mol–1 and a PDI of 1.06. In addition, the 
polymerization of PEGA with the BSA-conjugated catalyst produced pPEGA with 
apparent Mn of 119400 g mol–1 and a PDI of 3.12 (see chapter 7).  
8.3 Conclusion 
In a first experimental approach we demonstrated the incorporation of ATRPases, 
i.e. horseradish peroxidase, into the cavities of the chaperonin thermosome. The 
resulting nanoreactor was used to polymerize PEGA under ARGET ATRP conditions 
in a mixture of 7:3 v/v water and THF under argon atmosphere. The resulting polymers 
benefit from the confined space of the nanoreactor as demonstrated in chapter 7 by 
                                           
260  K. Renggli, M. G. Nussbaumer, R. Urbani, T. Pfohl, N. Bruns, Angew. Chem. Int. Ed. 2014, 53, 
1443–1447. 
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THS-LxCu.261 These results are consistent with simulations of other nanoreactor 
systems.262 Such a positive effect on the polymerization in comparison to BSA-LxCu 
(chapter 2) but also to our data with free HRP ins solution,263 as reported in chapter 4, 
is most probably due to the close proximity of the ATRP reagents. However, the scope 
of THS-HRP has to be extended in order to draw further conclusions, e.g. biological 
stability of the THS-HRP complex, different monomers, kinetic experiments. 
Protein nanoreactors with incorporated ATRPases allow for environmentally 
friendly polymerization with enzymes. The study of single molecule ATRP 
experiments with  THS-incorporated ATRPases could lead to a better understanding of 
the reaction mechanisms behind ATRPases. Moreover, the THS-HRP system could be 
used to investigate the influences of external triggers, e.g ATP that open and closes  the 
cavities of the THS nanoreactor, on the polymer product. 
Protein cages have been shown to be useful nanoreactors in many cases. 
Nevertheless, their full potential is merely starting to emerge, as many hollow protein 
structures have not been studied as nanoreactors. Moreover, the intrinsic gating 
properties of protein cages and viruses have only been exploited in a few cases. A 
further possibility to enhance their potential is their site-selective modification. Either 
naturally occurring points of modification, such as the termini of the peptide chains, 
can be used, or specific attachment points can be engineered into the protein structure 
by, e.g. site-directed mutagenesis. Using such methods, it might be possible to 
selectively modify both the exterior and interior surfaces of cages to create 
multifunctional nanosystems. Furthermore, the location of a modification can be 
selected, e.g. whether it is close to a pore in the shell, or spaced apart. No other 
nanoreactor system allows targeting attachment points with such spatial precision.  
Many reactions in organic synthesis require solvents other than water as reaction 
media. For example, esterifications are commonly carried out in organic solvents in 
order to drive the equilibrium of the reaction towards the formation of the ester. Also, 
many synthetic targets are only soluble in non-polar media. Thus, making protein cages 
compatible with non-aqueous solvents will greatly enhance their applicability as 
synthetic tools. Promising first steps toward this goal are the solubilisation of a viral 
capsid in organic solvents,264 and the genetic modification of the inner surface of DNA 
binding protein from starved cells (Dps) from hydrophilic to hydrophobic.265  
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9 The Archaeal Chaperonin Thermosome as ATP 
Triggerable Protein Nanoreactor266 
Kasper Renggli, Martin G. Nussbaumer, Michael Walther, Blaise Tardy, Nora 
Sauter, Martina Garni, Douglas S. Clark, Martin U. Hegner and Nico Bruns 
 
 
 
 
 
Reaction compartments on the nanoscale  effectively become nanoreactors when 
substrate and product are exchanged between bulk solution and the cavity. 
Nanoreactors exhibit responsiveness if access can be modulated by external triggers. 
In this chapter, natural nanoreactors that include protein-based bacterial 
microcompartments, protein cages, and viruses are discussed. The protein cage 
thermosome was assessed as an ATP triggerable nanoreactors by the means of 
biological and nanomechanical sensing techniques. 
                                           
266  Parts of this chapter were published in: K. Renggli, P. Baumann, K. Langowska, O. Onaca, N. 
Bruns, W. Meier, Adv. Funct. Mater. 2011, 21, 1241–1259. 
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9.1 Introduction 
Selective access by substrates to the interior of protein microcompartments is 
believed to be a key property responsible for resolving a paradox that is encountered in 
metabolic cascade reactions in cages:267 On the one hand, a function of the cages is to 
retain small molecules, such as CO2, acetaldehyde, or propionaldehyde within the 
cavities. On the other hand, larger substrates and cofactors must be able to enter the 
compartments through pores in the protein shell. A means to resolve this paradox is the 
provision of pores that control the selective movement of small molecules across the 
microcompartment shell. The protein structures of some carboxysome pores reveals a 
positive electrostatic potential in the pore, created by charged side chains.268 This 
potential is proposed as a discriminator between charged and uncharged molecules, 
which could facilitate the diffusion of negatively charged substrates and products of 
carbon fixation (bicarbonate, 3-phosphoglycerate, and ribulose-1,5-bisphosphate) 
through the shell, while the uncharged intermediate CO2 remains trapped inside the 
carboxysome. A spatial arrangement of certain enzymes around the pore on the inside 
of the shell has also been presented as a mechanistic solution to the paradox.269 Recent 
crystallographic data on a carboxysome shell protein270 and on the Eut 
microcompartment271 point to an additional, active gating mechanism. In these studies 
shell subunits were found that assemble into pseudo hexamers or trimers, respectively, 
with a central pore that undergoes conformational changes. Most pores in 
carboxysomes appear to be constitutively open. However, the recently characterized 
carboxysome shell-protein forms a pore that is either open or closed, depending on the 
side chain conformation of two residues. The open pore is approximately 1.4 nm in 
diameter.270 The open pore of the Eut microcompartment has a diameter of 0.8 nm at 
the narrowest point, large enough to allow penetration of cofactors, but it can also 
exists in a closed state.271 Thus, these pores may be able to cycle between an open, 
presumably permeable state, and a closed, non-permeable state. One putative 
mechanism would then involve a coupling between cofactor binding and pore opening.  
Although nature uses protein-based microcompartments efficiently as reactors, our 
understanding of the functioning, molecular structures, and mechanisms involved in 
these systems is still developing. For example, the conditions that favor an open or a 
closed pore configuration of the Eut microcompartments are not yet known. 
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Kerfeld, J. Mol. Biol. 2009, 392, 319–333. 
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Figure 9.1 Examples of gated pores in protein-based nanoreactors. A) Carboxysome, B) Eut 
microcompartment, C) cowpea chlorotic mottle virus, D) cut away models of a thermosome based on 
cryo-electron microscopy data. A: adapted from272 with permission from Elsevier, B: adapted from273 
with permission from AAAS, C: rendered from X-Ray data (PDB: 1CWP) using the Chimera 
program and from a model fitted to cryo-electron microscopy data274 (VIPER entry: 
CCMW_swln_1), D: adapted from275 with permission from Elsevier.  
 
Some pores in protein microcompartments have been crystallized in a closed and in 
an open conformation, although the trigger that induces the transition has not yet been 
identified (Figure 9.1a and b).276 Some, but not all, viral capsids undergo pH- and 
metal-ion dependent reversible structural transitions that induce a “swelling” of the 
                                           
272  M. G. Klein, P. Zwart, S. C. Bagby, F. Cai, S. W. Chisholm, S. Heinhorst, G. C. Cannon, C. A. 
Kerfeld, J. Mol. Biol. 2009, 392, 319–333. 
273  S. Tanaka, M. R. Sawaya, T. O. Yeates, Science 2010, 327, 81–84. 
274  F. Tama, C. L. I. Brooks, J. Mol. Biol. 2002, 318, 733–747. 
275  G. Schoehn, M. Hayes, M. Cliff, A. R. Clarke, H. R. Saibil, J. Mol. Biol. 2000, 301, 323–332. 
276  a) M. G. Klein, P. Zwart, S. C. Bagby, F. Cai, S. W. Chisholm, S. Heinhorst, G. C. Cannon, C. A. 
Kerfeld, J. Mol. Biol. 2009, 392, 319–333 b) S. Tanaka, M. R. Sawaya, T. O. Yeates, Science 
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particle and an opening of the pores. When the pH of a solution of the Cowpea 
Chlorotic Mottle Virus (CCMV) is raised above pH 6.5 in the absence of metal ions, 
the capsid increases its diameter by 10% and 60 separate pores open to diameters of 2 
nm each (Figure 9.1c).277 The presence of metal ions such as Ca2+ and Tb3+ induces the 
closed conformation of the capsid by binding of the metal to coordination sites at the 
quasi-three-fold axis of CCMV, i.e. in the openings.278 The pores in the swollen form 
allow the free exchange of molecules between the inside and the outside of the capsid. 
In contrast, there is no apparent exchange of large molecules in the non-swollen 
form.279 Gated pores of much larger size are found in heat-shock protein (Hsp 60) 
molecular chaperones, the chaperonins. These are hollow, spherical or cylinder-like 
protein cages formed from two rings stacked back to back. They sequester denatured 
proteins from solution in order to assist in protein refolding. Group II chaperonins such 
as eukaryotic TRiC/CCT or archaeal thermosomes possess built-in lids that cover the 
central cavities (Figure 9.1d). The gated pore is large enough (up to approximately 10 
nm in diameter) to allow the uptake of guest proteins into the cavity.280 The lids are 
formed by helical protrusions at the tip of the apical domain of the subunits. Their 
opening and closing proceeds in a two stroke-cycle, in which one ring opens in a 
cooperative movement while the other ring closes.281 The conformational changes are 
driven by the hydrolysis of adenosine triphosphate (ATP). Depending on the 
experimental conditions, fully closed or open conformations are obtained as well.282 
TRiC uses an iris-like conformational change, where apical and intermediate domains 
rotate in a coordinated manner to close off access to the central cavity.283  
Here, we investigate the different conformations of thermosome (THS), a group II 
chaperonin from the archaea Thermoplasma acidophilum in response to ATP and its 
analogues. The THS in its closed conformation is a protein cage that self-assembles 
from eight α- and eight β-subunits into a spherical complex approx. 15.8 nm in 
diameter, comprising two stacked, eight-membered rings. Each ring encloses a cavity 
measuring between 8.6 and 5.4 nm in diameter and approx. 4.5 nm in height.284 The 
native role of the THS is to refold unfolded or partially unfolded proteins, especially 
upon heat shock of a cell. To accomplish this, the THS can uptake proteins into its 
                                           
277  a) J. A. Speir, S. Munshi, G. Wang, T. S. Baker, J. E. Johnson, Structure 1995, 3, 63–78 b) F. 
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cavities. The access of macromolecules to the THS is granted by two pores approx. 8-
10 nm in diameter at the poles of the spherical THS.285 These pores are gated by lids, 
which are formed by helical protrusions in the apical domains of the subunits. The 
built-in lids of chaperonins open and close in an iris-like movement, which is fueled by 
the hydrolysis of ATP.286 The opening of the lid is accomplished by a concerted 
rotational movement of the apical and intermediate domains of the subunits in one ring. 
The crystal structure of the THS in its closed conformation reveals sixteen small pores 
in the wall of the THS that are formed by adjacent subunits. These irregular shaped 
windows, potentially allowing for water, ions and small molecular weight organic 
compounds to enter and leave the cavities. However, their exact permeability has still 
to be elucidated and may not only depend on the size of the permeating molecules. 
 
  
Figure 9.2 Fits of the domain atomic structures to three cryo-EM maps of THS. a) and d) Closed 
form; b) and e) bullet form; c) and f) open form. a)-c) The front surfaces; d)-f) sections through the 
maps. The angle of the intermediate domain helix is indicated by arrows, showing the change in tilt 
relative to the equatorial domain (and thus nucleotide binding pocket) between open and closed rings. 
Figure reproduced from Schoehn et al.287 with permission from Elsevier. 
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In the absence of nucleotides THS rests in the apo state, which is characterized by 
the two hemispheres being in an open conformation (Figure 9.2c and f). When ATP is 
added to a THS solution in the presence of Mg2+ the protein starts its ATPase reaction 
cycle. This cycle is thought to be a two-stroke mechanism in which one ring closes 
upon hydrolysis of ATP to ADP and Pi, while the opposing ring binds ATP and opens 
(Figure 9.2b and e). Detailed studies with several group II chaperonins such as the 
eukaryotic TRiC/CCT and the archaeal Methanococcus maripaludis Chaperonin (Mm-
cpn) have shown that ATP binding causes domain movements and the trigonal 
bipyramidal transition state of ATP hydrolysis triggers lid closure.288 Thus, one or both 
lids can be closed by incubation of group II chaperonins with the transition state mimic 
ADP-AlFx or in the presence of ATP and AlFx which is converted in situ by the 
chaperonins to ADP-AlFx (Figure 9.2a and d). The non-hydrolysable ATP analogues 
adenosine 5’-[β,γ-imido]triphosphate (AMP-PNP) as well as adenosine 5’-[γ-thio] 
triphosphate (ATP-γ-S) failed to close TRiC/CCT, however other studies report lid 
closure of group II chaperonins with AMP-PNP. The discrepancy in these findings 
might be explained by hydrolyzed impurities in the nucleotide preparation used, but 
also due to structural differences between the chaperonins. 
9.2 Characterization of Conformational Changes in 
Thermosome by Biological Methods 
We characterized the effect of nucleotides and their transition state mimics on the 
thermosome from Thermoplasma acidophilum. To this end we encapsulated the 
enzyme horseradish peroxidase (HRP) into thermosome as described in section 8.2.1 
and explored the activity of the biocatalyst in comparison to the free enzyme. The 
biocatalytic property of HRP was then used to assess the different conformational 
states of THS. 
9.2.1 Enzymatic Activity and Half-Life of THS-HRP  
In a first step we assessed the enzymatic activity of the encapsulated horseradish 
peroxidase and the half-life of the complex. We compared the activity of the 
encapsulated HRP with the activity of the native free enzyme with an UV/Vis 
spectroscopic activity assay. Horseradish peroxidase catalyzes the transformation of 
2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) to its 
radical, positively charged form in the presence of hydrogen peroxide.  
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The formation of product can be measured with colorimetric UV/Vis assay at an 
absorbance wavelength of 420 nm,289 which allows for the calculation of the enzymatic 
activity. The temperature dependent activity of the free native form of HRP compared 
to the THS-HRP complex is shown in Figure 9.3. 
 
 
 
Figure 9.3 Temperature dependent enzymatic activity in the presence of ATP of free native HRP 
in comparison to encapsulated HRP. The specific activity was determined by a colorimetric ABTS 
assay. THS-HRP shows lesser activity due to the shielding effect of the THS protein cage. 
 
The graph shows a lesser activity of the THS-HRP complex compared to the native 
enzyme, which we excepted due to the fact that the encapsulated enzyme is 
significantly shielded by the protein cage and only accessible through the openings of 
the thermosome. This is an advantage in the case of the half-life of HRP (Figure 9.4), 
since the encapsulated enzyme can maintain its function also in the higher temperature 
regimes, similar to a PEGylated enzyme.290 The activity plot is the confirmation that 
the enzymatic activity of the encapsulated HRP remains intact and the protein cage 
only has the effect of lowering the enzymatic activity. 
 
 
 
Figure 9.4 Temperature dependent half-life of HRP in the presence of ATP. The free native HRP 
displays a shorter half-life compared to the encapsulated and therefore shielded HRP. 
                                           
289  J. Pütter, R. Becker (Eds.), Peroxidases, 3rd Edn., Verlag Chemie, Deerfield Beach, FL, 1983. 
290  G. DeSantis, J. B. Jones, Curr. Opin. Biotechnol. 1999, 10, 324–330. 
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9.2.2 Effect of ATP Analogues on THS-HRP 
Having proof of the successful encapsulation and enzymatic activity of the 
horseradish peroxidase we were able to assess the different conformations of the THS 
induced by nucleotides and their analogues. For our purpose we used the catalytic 
activity of HRP and measured the transformation of the non-fluorescent dihydro 
rhodamine 6G (dhRh6G) to the fluorescent form rhodamine 6G (Rh6G). DhRh6G is 
only transformed to Rh6G in the presence of HRP and hydrogen peroxide.291 It 
therefore serves very well as a tool to assess the opening and closing of the lids of THS 
in presence of nucleotides. This can then be used to modulate the THS as a triggerable 
nanoreactor. As mentioned above, in the absence of nucleotides THS rests in the apo 
state, which is characterized by the two hemispheres being in an open conformation. 
Different studies with archaeal group II chaperonins showed that adenosine 
triphosphate (ATP) starts the ATPase reaction cycle in the presence of Mg2+.292   
For our purposes we studied the effect of no additive, ATP, ATP-γ-S and 
ATP/AlFx on the lid opening of thermosome. The guest molecule HRP is linked to 
THS and sits in the cavity of the thermosome. Thus, if the lids of the thermosome are 
open, HRP can efficiently catalyze H2O2 to H2O and transform DhRh6G to its 
fluorescent state Rh6G. If the lids are closed, HRP cannot catalyze any H2O2 and no 
fluorescence will be measured. Thermosome was incubated for 30 min with ATP or its 
analogon and the conversion of dhRh6G to Rh6G by H2O2 was assessed in the 
fluorescence cuvette for 30 min. In order to assess how much H2O2 can also degradate 
dhRh6G in the absence of HRP, a no-HRP control was performed and the resulting 
intensity deducted. Fluorescence measurements of Rh6G were performed at an 
excitation wavelength of 205 nm and an emission wavelength of 535 nm. 
The fluorescence results (Figure 9.5) show the highest activity for HRP if the THS 
lies in its apo state. This native conformation of THS without any additives should 
result in an unimpeded catalyzing activity of the encapsulated enzymes since the two 
cavities are completely exposed to the surrounding media without any movement of the 
THS lids. These results confirm our hypothesis that THS is in a fully open state when 
no ATP derivatives are added.  
 
                                           
291  L. Edman, Z. Földes-Papp, S. Wennmalm, R. Rigler, Chem, Phys. 1999, 247, 11-22. 
292  a) C. R. Booth, A. S. Meyer, Y. Cong, M. Topf, A. Sali, S. J. Ludtke, W. Chiu, J. Frydman, Nat. 
Struct. Mol. Biol. 2008, 15, 746–753 b) G. Schoehn, M. Hayes, M. Cliff, A. R. Clarke, H. R. 
Saibil, J. Mol. Biol. 2000, 301, 323–332 c) J. Zhang, M. L. Baker, G. F. Schröder, N. R. Douglas, 
S. Reissmann, J. Jakana, M. Dougherty, C. J. Fu, M. Levitt, S. J. Ludtke, et al., Nature 2010, 463, 
379–383. 
 105 
 
 
Figure 9.5 Influence of ATP derivatives on thermosome activity. HRP is linked to the 
thermosome and catalyzes the degradation of H2O2, which then transforms DhRh6G to its fluorescent 
state Rh6G. HRP can only catalyze the degradation of H2O2 if the lids of the thermosome are open.  
 
When ATP is added, it causes the thermosomes to alternately open and close its 
lid,293 which can be seen by a reduced HRP activity in Figure 9.5. When ATP-AlFx is 
added, the lids are blocked and stay closed, displayed by no HRP activity (Figure 9.5). 
ATP-AlFx stabilizes the transition state, since AlFx forms a pentavalent structure that 
mimics the trigonal-bipyramidal conformation of the γ-phosphate undergoing hydro- 
lysis.294 If the non-hydrolysable ATP-γ-S is added to the THS-HRP system, we observe 
a lower HRP activity, compared to ATP (Figure 9.5). This indicates an increased 
duration of closed lids compared to ATP, hindering HRP activity more than with ATP 
as an additive.  
These experiments indicate that THS can be modulated by the means of ATP 
analogues, i.e. that the opening and closing mechanism of THS can be controlled to a 
certain extent. Our results for ATP and ATP-AlFx are also in good agreement with 
results from THS295 and Mm-cpn.296 In the case of ATP-γ-S, small-angle neutron-
scattering (SANS) studies have suggested that 5’-[β,γ-imido]triphosphate (p[NH]ppA), 
a similar ATP analogue, can effect the conformational changes in the THS, which were 
interpreted as an open-to-closed transition upon binding of ATP.297 This phenomena 
was also described for the group II chaperonin Mm-cpn by the use of p[NH]ppA.298 
They describe a rhodanese enzymic activity of 70% for ATP and an activity of approx. 
                                           
293  G. Schoehn, M. Hayes, M. Cliff, A. R. Clarke, H. R. Saibil, J. Mol. Biol. 2000, 301, 323–332. 
294  A. M. Gulick, C. B. Bauer, J. B. Thoden, I. Rayment, Biochemistry 1997, 36, 11619–11628. 
295  L. Ditzel, J. Lowe, D. Stock, K. O. Stetter, H. Huber, R. Huber, S. Steinbacher, Cell 1998, 93, 
125–138. 
296  J. Zhang, M. L. Baker, G. F. Schröder, N. R. Douglas, S. Reissmann, J. Jakana, M. Dougherty, C. 
J. Fu, M. Levitt, S. J. Ludtke, et al., Nature 2010, 463, 379–383. 
297  I. Gutsche, J. Holzinger, N. Rauh, W. Baumeister, R. P. May, J. Struct. Biol. 2001, 135, 139–146. 
298  A. Kusmierczyk, J. Martin, Biochem. J. 2003, 371, 669–673. 
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40% for p[NH]ppA in comparison to the apo state, which is comparable with our 
results for THS-HRP. In TRiC/CCT, cryo-electron-microscopic reconstruction in the 
presence of p[NH]ppA revealed the chaperonin to be in a closed conformation,299 
indicating ATP hydrolyzation differences between group II chaperonins. The ability of 
THS-HRP to maintain enzymic activity in the presence of the non-hydrolysable ATP-
γ-S indicates that ATP-γ-S hydrolysis is blocking the THS in an intermediate state 
between open and closed conformations, as described by SANS experiments.300 
Another explanation could be that ATP-γ-S is slowing down the THS movement due to 
the non-hydrolysable part of the analogue, thus resulting in a lower HRP activity. Thus, 
to modulate the THS, ATP-γ-S is not an ideal choice. 
We can conclude that the THS can be modulated with ATP analogues. The most 
interesting analogue ATP-AlFx has the potential to close the protein cages completely, 
indicated by no HRP activity. Further, the addition of ATP and ATP-γ-S lowers the 
catalytic activity of HRP, indicating that the THS cycles between an open and closed 
conformation. Moreover, the absence of additives allows for the highest catalytic 
activity of HRP, indicating that the THS lies in a completely open conformation. 
 
 
 
 
                                           
299  O. Llorca, J. Martín-Benito, J. Grantham, M. Ritco-Vonsovici, K. R. Willison, J. L. Carrascosa, J. 
M. Valpuesta, EMBO J. 2001, 20, 4065–4075. 
300  I. Gutsche, J. Holzinger, N. Rauh, W. Baumeister, R. P. May, J. Struct. Biol. 2001, 135, 139–146. 
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9.3 Nanomechanical Sensing of Conformational Changes in 
Thermosome 
9.3.1 Introduction 
A more recent approach of our group to assess the question of what mechanism lies 
behind the opening and closing of the protein involves the use of cantilever arrays. In 
collaboration with the group of Martin Hegner at Trinity College Dublin. An ideal 
biosensor should be able to measure label-free, in real-time and in parallel to avoid 
falsified results. Numerous label-free techniques were developed for biological, 
medical and chemical research to detect and characterize interactions between 
molecular partners, e.g. surface plasmon resonance,301 ellipsometry,302 and quartz 
micro balance (QCM).303 These systems are only dependant on the immobilization of 
one of the partners on the transducer interface. Another promising technique involves 
the use of miniaturized silicon cantilevers that require no external probes or labeling 
and can operate autonomously.304  
 
 
 
Figure 9.6 Detailed scheme of the static system where structural changes are detected by the 
static bending of asymmetrical functionalized cantilevers. An optical readout is used where a laser 
beam is reflected on top of the cantilever and pointed towards a position sensitive detector (PSD). 
Adapted from Braun et al.305 Copyright 2005 by the American Physical Society. 
 
Applications with cantilever arrays range from antibody-antigen interactions306 to 
the detection of gene mutation in total RNA.307 In static mode, the cantilever is 
sensitive to surface stress differences between the two cantilever surface areas. If the 
upper and lower surface areas experience different stress the cantilever will bend. An 
asymmetric coating with a reactive layer on one surface of the cantilever favors 
                                           
301  C. E. Jordan, R. M. Corn, Anal. Chem. 1997, 69, 1449–1456. 
302  Z. H. Wang, G. Jin, Anal. Chem. 2003, 75, 6119–6123. 
303  K. A. Marx, Biomacromolecules 2003, 4, 1099–1120. 
304  J. Fritz, M. K. Baller, H. P. Lang, H. Rothuizen, P. Vettiger, E. Meyer, H.-J. Güntherodt, C. 
Gerber, J. K. Gimzewski, Science 2000, 288, 316–318.
305  T. Braun, V. Barwich, M. K. Ghatkesar, A. H. Bredekamp, C. Gerber, M. Hegner, H. P. Lang, 
Phys. Rev. E 2005, 72, 031907. 
306  G. Wu, R. H. Datar, K. M. Hansen, T. Thundat, R. J. Cote, A. Majumdar, Nat. Biotechnol. 2001, 
19, 856–860. 
307  F. Huber, H. P. Lang, N. Backmann, D. Rimoldi, C. Gerber, Nat. Nanotechnol. 2013, 8, 125–129. 
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preferential adsorption of molecules on this surface. In most cases, the intermolecular 
forces in the adsorbed molecule layer produce a compressive stress, i.e. the cantilever 
bends down if its reactive surface is its upper one. A more detailed scheme of our static 
system is shown in Figure 9.6. The group of Martin Hegner previously demonstrated 
the feasibility of nanomechanical sensing of conformation changes in proteins by the 
means of subunit loss in bacteriorhodopsin due to denaturation.308 
9.3.2 Results & Discussion 
We attached THS covalently to Si cantilever arrays with eight cantilevers from 
IBM Research Laboratory (Figure 9.7).  The cantilevers had a pitch of 250 µm and 
were 500 µm long, 100 µm wide and 1 µm thick. They were coated on one side with a 
layer of 2 nm titan and on top a 20 nm thick layer of gold. 
 
 
 
Figure 9.7 Scanning electron microscope image of a typical cantilever array used for 
nanomechanical sensing. Adapted from Huber et al.309 with permission from AIP Publishing LLC. 
 
Dithio-bis-(succinimidyl undecanoate) (DSU)310 was used to functionalize the gold 
surface of cantilever 2, 4, 6 and 8, enabling them to covalently attach THS via the 
amine groups of the lysine present on the surface of the protein (see Figure 9.8 and 
9.9). As reference, an alternative thiol coating of gold on cantilever 1, 3, 5 and 7 was 
made with 11-mercapto-1-unedecanol, which is protein repellent. 
 
 
Figure 9.8 the cantilevers were functionalized with 2 nm Ti and 20 nm Au. Sample cantilevers 
were functionalized with DSU and reference cantilever with 11-mercapto-1-unedecanol. 
                                           
308  T. Braun, N. Backmann, M. Vögtli, A. Bietsch, A. Engel, H.-P. Lang, C. Gerber, M. Hegner, 
Biophys. J. 2006, 90, 2970–2977. 
309  F. Huber, H.-P. Lang, M. Hegner, M. Despont, U. Drechsler, C. Gerber, Rev. Sci. Instrum. 2008, 
79, 086110. 
310  P. Wagner, P. Kernen, M. Hegner, E. Ungewickell, G. Semenza, FEBS Lett. 1994, 356, 267–271. 
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Figure 9.9 Strategy to covalently attach THS via lysines to the DSU coated surface of the 
cantilever array. Adapted from 311 with permission from Dojindo Molecular Technologies. 
 
The setup shown in Figure 9.10 was operated in static mode and all measurements 
were performed in the 7.5 µl fluid cell in MES buffer at pH 5.2 (100 mM MES, 150 
mM NaCl, 20 mM MgCl2). The induced bending of the cantilever was measured by 
reflecting a laser beam on top of the cantilever and pointing it towards a position 
sensitive detector (PSD).312 Surface stress was induced by the conformation changes of 
the immobilized protein due to ATP or its analogues. Various forces such as 
intermolecular interactions, electrostatic forces as well as changes in the electronic 
density may contribute to the resulting surface stress.313   
 
 
Figure 9.10 Experimental setup for nanomechanical sensing with cantilever arrays. 
 
                                           
311 Dojindo Molecular Technologies, http://www.dojindo.com/store/p/795-Amine-Coupling-Kit.html,
accessed June 19, 2014. 
312  H. P. Lang, R. Berger, C. Andreoli, J. Brugger, M. Despont, P. Vettiger, C. Gerber, J. K. 
Gimzewski, J. P. Ramseyer, E. Meyer, Appl. Phys. Lett. 1998, 72, 383–385. 
313  M. Godin, V. Tabard-Cossa, Y. Miyahara, T. Monga, P. J. Williams, L. Y. Beaulieu, R. Bruce 
Lennox, P. Grutter, Nanotechnology 2010, 21, 075501. 
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We monitored the deflection signal of the fixed cantilever array with the 
immobilized THS. After reaching a stable signal we injected a solution of ATP in MES 
buffer (30 min under constant flow) into the fluid chamber where the cantilever array 
was placed. After this injection phase, the flow was stopped and the deflection signal 
was measured again. Our results show a clear change in surface stress due to the 
presence of ATP, which is expected to cycle the THS between open and closed 
conformations (Figure 9.11). The surface stress is measured in a bending of the 
cantilever by 50 nm. This value is the difference between the averaged signal of the 
four sample cantilevers and the averaged signal of the four reference cantilevers.  
 
 
 
Figure 9.11 Change in cantilever deflection of 50 nm induced by surface stress of THS as a 
reaction to the addition of ATP. This value is the difference between the averaged signal of the four 
sample cantilevers and the averaged signal of the four reference cantilevers. 
 
The effect of ATP-AlFx, which should close and block the THS completely, on the 
surface stress is shown in Figure 9.12 The same procedure described for ATP was 
adapted to the measurements with ATP-AlFx. The surface stress resulted in a bending 
of the cantilever by 75 nm. This value is the difference between the averaged signal of 
the four sample cantilevers and the averaged signal of the four reference cantilevers.
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Figure 9.12 Change in cantilever deflection of 75 nm induced by surface stress of THS as a 
reaction to the addition of ATP-AlFx. This value is the difference between the averaged signal of the 
four sample cantilevers and the averaged signal of the four reference cantilevers. 
 
The preliminary nanomechanical sensing results in a combination with the 
enzymatic assays of THS-HRP reported before allow the conclusion that a difference 
in surface stress induced by different ATP analogues can be seen. This might display 
the first results where conformation changes of a protein were nanomechanically 
measured. It is exciting to measure a difference in cantilever bending dependent on 
conformational changes of THS induced by the ATP analogue. However, we are still 
looking for an explanation of how the surface stress is induced by the different 
movements of the subunits. Further studies with established methods, i.e. digestion- 
and ATPase assays have to be performed in order to draw further conclusions. 
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9.4 Conclusions 
By the means of nanomechanical sensing and enzymatic assays we demonstrated 
the effect of ATP analogues on the archaeal chaperonin THS. Whereas ATP displays 
typical cyclic movements between open and closed conformation for the group II 
chaperonin, the ATP-γ-S seems to slow down the cycling process or blocks the THS in 
an intermediate state. ATP-AlFx possesses the most interesting ability to close and 
block the THS completely. The use of ATP analogues renders the THS an ATP 
triggered protein cage or even nanoreactor. 
Nanoreactors are ideal vessels for reactions within living tissue in the context of 
drug-delivery, or when immobilized on surfaces as e.g. sensors. However, the greatest 
challenge at the nanoscale is to control the influx of substrates and the release of 
products from the nanoreactor, as no conventional openings, valves or lids can be 
engineered into the reactors. 
This chapter showed a way to render protein cages as gated nanoreactors. Nature 
leads the way, both in providing a multitude of reaction compartments, e.g. cells, lipid-
based organelles, protein microcompartments and protein cages, and in the degree of 
control over accessibility to the compartments. Gated nanoreactors found in nature 
have pores that are determined by the structure of proteins. These can be dedicated 
membrane proteins that allow controlled access through a lipid bilayer, or pores 
between subunits of a multi-subunit protein assembly. Some pores act merely as size-
selective openings, some discriminate between substances according to their charge or 
molecular identity, and some are actively gated, i.e. an external stimulus, like ATP 
leads to a change in conformation of the proteins and therefore to an opening or closing 
of the pore. Some of the microcompartments found in nature have been used in a non-
biological context, e.g. chaperonins.314  
Triggered nanoreactors show promising potential in applications in the areas of 
medicine, sensing, synthesis of drugs and other chemical products, and as analytical 
tools to study reaction mechanisms in confined volumes. 
 
 
 
 
 
 
 
 
 
 
 
                                           
314  N. Bruns, K. Pustelny, L. M. Bergeron, T. A. Whitehead, D. S. Clark, Angew. Chem. Int. Ed. 
2009, 48, 5666–5669. 
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10 General Conclusion & Outlook 
The present PhD thesis entitled Protein Nanoreactors and Native Enzymes for 
Controlled/Living Radical Polymerization began with the hypothesis that protein-
catalyst conjugates are able to beneficially influence controlled/living radical 
polymerization, i.e. atom transfer radical polymerization (ATRP). The general 
motivation for this work is driven by problems that occur when transition metal 
catalyst are used for ATRP. These most commonly used catalyst are only 
biocompatible to a limited extend and the resulting polymers show unwanted 
coloration due to the remaining catalyst. Moreover, by conjugating the catalyst into the 
cavities of a protein cage, we could gain insights into the catalytic mechanism of ATRP 
as well as into effects of the confined space. Polymer chemistry in particular enables us 
to perform successful research with proteins since synthetic strategies in a 
biocompatible environment, i.e. aqueous solution are well established. 
Inspired by problems addressed earlier in our research group, we developed a 
robust conjugation and purification method to attach transition metal catalysts to 
proteins or enclose them into protein cages using bis-aryl hydrazone linker chemistry. 
Successively, we determined good performing ATRP conditions that allowed for 
significant lower catalyst concentrations. Thus, activators regenerated by electron 
transfer (ARGET) ATRP was used to constantly regenerate the catalyst into its active 
form by the means of a reducing agent. 
Chapter 2 described one of these protein-catalyst conjugates in full detail. The 
ATRP catalyst was conjugated to the globular protein bovine serum albumin (BSA) 
and the complex was extensively characterized using biological and physical methods. 
The resulting conjugate was used to polymerize N-isopropyl acrylamide (NiPAAm) 
and poly(ethylene glycol) methyl ether acrylate (PEGA) in aqueous solution and was 
subsequently analyzed upon its structural integrity after polymerization. The ARGET 
ATRP of NiPAAm and PEGA yielded polymers with a moderate control over the 
molecular weight and the polydispersity of the polymers. However, our focus was to 
reduce the residual copper in polymers. Thus, BSA that served as a functional handle 
was used to remove the copper containing catalyst effectively from solution. We 
showed a reduction of residual copper to ppb levels, either by precipitation or by 
Dynabead removal. 
Chapters 3 to 5 dealed with our findings that some metalloproteins can mediate 
ATRP. Enzymes have been introduced into synthetic chemistry as green and very 
selective alternatives to conventional catalysts. In polymer chemistry enzymes have 
been used as catalysts for polycondensation, ring-opening polymerizations, free radical 
polymerizations of vinyl-type monomers and the polymerization of aromatic 
compounds by radical-induced oxidative coupling. However, controlled/living radical 
polymerizations catalyzed by enzymes have not been exploited. Our results and the 
ones from di Lena represent the first reports of biocatalytic, controlled/living radical 
polymerization. Bringing those enzymes into organic solution, e.g. by conjugation of 
end-group-reactive polymers such as PEG, poly(oxazolines) and amphiphilic 
blockcopolymers to the surface-exposed lysines or cysteins of the enzymes, could lead 
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to interesting new routes towards environmentally friendly catalysis, functional 
materials or functional nanosystems. 
In Chapter 7 The group II chaperonin thermosome (THS) from the archaea 
Thermoplasma acidophilum is reported as protein nanoreactor for ATRP. For that 
purpose, a copper catalyst was entrapped into the THS. The confined space within the 
protein nanoreactor favorably influenced the polymerization of NiPAAm and PEGA 
under ARGET ATRP conditions in comparison to polymerizations carried out with the 
globular protein BSA. In chapter 8 this concept was adapted and instead of the copper-
complex, we covalently entrapped an enzyme as ATRP catalyst. We demonstrated that 
the space constriction in the THS has similar effects on the final polymer product, as 
shown for THS-LxCu. Further studies of the polymerization, i.e. kinetic experiments, 
are needed to explore the compartmentalization effect and the mechanism behind it. In 
addition, the use of protein nanoreactors could enable mechanistic studies of ATRP on 
a single molecule level. Moreover, protein nanoreactors with encapsulated enzymes, 
i.e. ATRPases, could help to understand the reaction mechanisms behind ATRPases. In 
addition, the nanoreactor could be used as a template to synthesize polymer 
nanoparticles with defined shape and size. 
Chapter 9 described a way to render protein cages, i.e. THS, gated nanoreactors. 
The gated behavior of THS driven by the hydrolysis of ATP and ATP analogues was 
shown by enzymatic assays. The incorporation of HRP into THS allowed to study the 
opening and closing of the cage by converting the non-fluorescent dihydro rhodamine 
6G into its fluorescent form rhodamine 6G. In addition, nanomechanical sensing with 
cantilever arrays measured the surface stress induced by the opening and closing of the 
protein cage in response to ATP analogues. Additional experiments are needed, i.e. 
digestion- and ATPase assays to confirm the gated behavior of our system. 
Furthermore, cycle experiments with cantilever arrays could show that a 
polymerization can be temporary stopped, i.e. by closing the protein cage, and started 
again with the addition of the appropriate ATP analogue. The field of gated 
nanoreactors is still in its infancy and leaves plenty of room for new developments. 
Thus, gated nanoreactors could be used in the areas of medicine, sensing, synthesis of 
drugs and other chemical products, and as analytical tools to study reaction 
mechanisms in confined volumes. 
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A Experimental Section 
A.1 Atom Transfer Radical Polymerization with    Protein 
Conjugated Catalysts 
A.1.1 Materials 
Commercially available chemicals were purchased from Sigma-Aldrich and used 
without further purification unless otherwise noted. The linker 3-N-maleimido-6-
hydraziniumpyridine hydrochloride (MHPH) was obtained from SoluLink (San Diego, 
USA). NMR solvents were obtained from Cambridge Isotope Laboratories. Buffers 
were produced using double-distilled water. N-isopropyl acrylamide (NiPAAm) was 
recrystallized from a mixture of hexane and toluene (2:1 v/v). Poly(ethylene glycol) 
methylether acrylate (PEGA) with a number average molecular weight of 480 g mol–1 
was filtered over a neutral aluminium oxide column. 2-hydroxyethyl acrylate (HEA) 
and N,N,N',N'-tetraethyl-diethylenetriamine (TEDETA) were purified by vacuum 
distillation. Albumin from bovine serum (BSA) was purchased from Sigma-Aldrich 
(Switzerland) which was prepared using heat shock fractionation and may be referred 
to as Cohn Fraction V serum albumin. 
A.1.2 Methods  
The Mn and the PDI of the polymers were determined by gel permeation 
chromatography (GPC) unless otherwise noted. Samples for GPC (0.1 ml) were 
removed from the reaction mixture without separation of the protein and filtered over a 
small plug of basic aluminium oxide in order to remove salts and protein. The plug was 
washed with additional 0.2 ml of water and the filtrates were combined. Then the 
sample was lyophilized and redissolved in the appropriate GPC eluent to 
concentrations of 1 mg ml–1. The measurements of pNiPAAm were performed on an 
Agilent 1100 Series instrument equipped with Viscotek I-columns (I-GUARD-0478 
(40 mm x 7.8 mm), I-MBHMW-3078 (300 mm x 7.8 mm, exclusion limit > 10 106 g 
mol–1), and I-MBMMW-3078 (300 mm x 7.8 mm, exclusion limit > 2 105 g mol–1)) 
thermostated to 45°C and a refractive index detector maintained at 35°C. N,N-
dimethylformamide (DMF) containing 20 mM lithium bromide was used as mobile 
phase with a flow rate of 1.0 ml min–1. Poly(methyl methacrylate) standards (PSS, 
Mainz) were used for calibration. The measurements and analysis of pPEGA was 
performed on an Agilent 1100 Series instrument equipped with Agilent PL aquagel-OH 
columns (PL aquagel-OH Guard 8 µm (50 mm x 7.5 mm), and PL aquagel-OH 
MIXED-M 8 µm (300 mm x 7.5 mm, exclusion limit > 6 105 g mol–1)) thermostated to 
30°C and a refractive index detector maintained at 35°C. 100 mM NaNO3 and 10 mM 
NaH2PO4 in aqueous solution at pH 7.0 containing 4:1 (v/v) MeOH was used as mobile 
phase with a flow rate of 1.0 ml min–1. Polyethylene oxide ReadyCal standards (PSS, 
Mainz) were used for calibration. UV/Vis analyses were performed on a Lambda 35 
spectrometer (Perkin Elmer) with 1 cm quartz cuvettes (Hellma, Germany) and on a 
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NanoDrop (Thermo Scientific). Protein concentrations were determined from the 
absorption at 280 nm, using an extinction coefficient of 43824 M–1 cm–1 for BSA.315 1H 
NMR spectroscopy was carried out on a Bruker DPX-NMR (400 MHz) instrument. All 
experiments were performed at room temperature. Neutron activation analysis (NAA) 
was performed on a nuclear research reactor in the Department of Physics, University 
of Basel. Samples (1 ml) were activated by thermal neutrons at 2 kW for 15 min and 
measured with a Ge-detector. Qualitative analysis was performed using the 66Cu-Peak 
at 1039.2 keV. Quantitative analysis was performed in collaboration with the 
Kantonslabor Basel-Stadt using the 66Cu-Peak at 1039.2 keV with respect to an internal 
calibrated gold standard and validated against standard solutions of CuBr2. The distinct 
gamma energy of the resulting nucleide was measured after 2 hours with a Ge-detector. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed with self-casted 12% polyacrylamide gels and tris-HCl as running buffer in 
a Biorad Miniprotean 3 cell setup at 200 V for 70 min. Novex BenchMark Protein 
Ladder (Invitrogen) was used as molecular weight marker. Native gel electrophoresis 
was carried out using ready-casted 5% polyacrylamide gels (Biorad) and tris-glycine as 
running buffer. The gel was run for 180 min at 80 V. NativeMark Unstained Protein 
Standard (Invitrogen) was used as molecular weight marker. All gels were Coomassie 
stained with SimplyBlue SafeStain (Invitrogen). Gels were scanned on a Gel Doc EZ 
imager (Biorad). 
A.1.3 Synthesis of 2-((3-(bis(2-(diethylamino) ethyl)amino) 
propanoyl)oxy) ethyl 4-formylbenzoate  
4-(dimethoxymethyl)benzoic acid was synthesized by refluxing a solution of 4-
formyl benzoic acid in MeOH. After cooling to room temperature, crystals of the 
product were collected by filtration, washed with MeOH and dried under vacuum. 300 
mg 4-(dimethoxymethyl)benzoic acid (1.53 mmol) and 910 mg 2-(6-chloro-1-H-
benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate (HCTU; 2.19 
mmol, 1.43 equiv.) were dissolved in 40 ml acetonitrile (p.A.) in a 100 ml 2-neck 
round bottom flask under argon atmosphere. 557 µl triethylamine (404 mg, 4.00 mmol, 
2.61 equiv.) was added and the solution was stirred for 5 min at room temperature. 
Freshly distilled 345 µl 2-hydroxyethylacrylate (HEA; 349 mg, 3.00 ml, 1.96 equiv.) 
was added and the reaction mixture was stirred at room temperature overnight. To the 
crude reaction mixture, 1.023 ml TEDETA (861.5 mg, 4.00 mmol, 2.61 equiv.) was 
added and the solution was stirred for 24 h at room temperature. 50 ml of water, 50 ml 
of saturated aqueous NaCl solution and 50 ml of 10% aqueous Na2CO3 were added, 
and the resulting solution was extracted with 3 x 100 ml dichloromethane. The 
combined organic phase was washed with 20 ml of 10% Na2CO3, dried over Na2SO4 
and concentrated in vacuum to yield a brown oil. The crude product was purified by 
flash chromatography (basic Al2O3, eluent: CH2Cl2 with 1.75 vol.% EtOH). The acetal 
was cleaved by dissolving the product in 10 ml acetonitril/water (2:1 v/v) and 
acidification with a few drops of HCl. The solution was stirred 1 h at room 
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temperature. Then, 50 ml of water and 10 ml of 3N HCl were added and 
impurities/side products were extracted with CH2Cl2 (1 x 50 ml, 1 x 10 ml). The pH of 
the aqueous phase was adjusted to pH 9-10 by addition of 10% Na2CO3. Then, the 
aqueous phase was extracted with 3 x 100 ml CH2Cl2. The combined organic phase 
was dried over Na2SO4 and concentrated in vacuum. For the product (compound 1) a 
yield of 85% was achieved. 
A.1.4 Preparation of BSA-LxCu  
15 mg of BSA (220 nmol, 1 equiv.) was weighted into a falcon tube and dissolved 
in 15 ml modification buffer (100 mM NaH2PO4, 150 mM NaCl, pH 6.5). 163 µl of a 
41.5 mM 3-N-maleimido-6-hydraziniumpyridine hydrochloride (MHPH) solution (1.6 
mg, 6.6 µmol, 30 equiv.) in dimethyl sulfoxide (DMSO) was added and the reaction 
mixture was incubated at 37°C while shaking for 2 h. The sample was concentrated to 
250 µl using 30k MWCO diafiltration devices at 4700 rpm. The supernatant was then 
diluted three times with 15 ml conjugation buffer (100 mM sodium phosphate, 150 mM 
NaCl, pH 6.0) and reconcentrated. 250 µl of the resulting BSA-MHPH solution (12.8 
mg, 187.7 µmol, 1.0 equiv.) was diluted with 12 ml conjugation buffer. 90.0 µl of a 
21.5 mM solution of compound 1 (see A.1.3) in DMSO (0.83 mg, 1.8 µmol, 10 equiv.) 
was added. The reaction mixture was shaken overnight at RT and concentrated with a 
30k MWCO diafiltration device to 250 µl at 4700 rpm. Buffer was exchanged to 
complexation buffer (100 mM sodium acetate, pH 5.2) with three spun cycles. To nine 
parts of BSA-Lx solution (9.8 mg, 143.7 nmol) one part of a 50 mM CuBr2 solution in 
complexation buffer was added. The successful complexation of Cu could be seen by a 
change in color from light blue to yellow if high concentrations of protein were used. 
To remove non-complexed copper, the solution was concentrated with a 30k MWCO 
diafiltration device to 250 µl at 4700 rpm, three times diluted and reconcentrated with 
15 ml reaction buffer (100 mM sodium acetate, 150 mM NaCl, 80 mM MgCl2, pH 5.2) 
or ddH2O. Finally, the BSA-LxCu solution was diluted with the corresponding solvent 
to a volume of 2.0 ml, yielding 5.5 mg (80.6 nmol) protein. The number of bis-aryl 
hydrazone linker groups formed was determined from the absorbance at 354 nm using 
an extinction coefficient of (ε(hydrazone)354 nm = 29000 M–1 cm–1).316 According to 
UV/Vis data 0.21 ± 0.1 of the available cysteins in BSA carry a ligand and NAA yields 
a complexation of approx. 50% (see A.1.5) resulting in 95 ng copper per mg BSA.  
A.1.5 Quantitative Neutron Activation Analysis 
Quantitative analysis with neutron activation analysis (NAA) of a 3.0 mg ml–1 (45 
nmol ml–1) BSA-LxCu sample revealed a copper concentration of 270 ng ml–1 copper 
which corresponds to 4.2 nmol ml–1. With a TEDETA-ligand to BSA molar 
substitution ratio (MSR) of 0.21 ± 0.01, a CuII/ligand complexation efficiency of 
approx. 50% was calculated. 
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A.1.6 MHPH Molar Substitution Ratio 
The 6-hydraziniumpyridine molar substitution ratio (MSR) for BSA was 
determined by adding a 20 µl aliquot of a BSA-MHPH sample in conjugation buffer to 
480 µl of a 0.5 mM 4-nitrobenzaldehyde solution in 100 mM sodium acetate buffer (pH 
5.2). The solution was incubating at 37°C for 1 h and the absorbance at 390 nm 
(ε(hydrazone)390 nm = 24000 M–1 cm–1) was determined.317 A blank value determined 
with 20 µl conjugation buffer was subtracted. The determination of MSR was carried 
out in triplicates and the mean values and standard deviations are reported. The MSR 
for BSA resulted in 0.22 ± 0.01 modified cysteins per BSA. 
A.1.7 ARGET ATRP of NiPAAm 
25.0 mg NiPAAm (220 µmol, 66.7 equiv.) and 0.7 mg 2-hydroxyethyl-2-
bromoisobutyrate (HEBIB; 3.3 µmol, 1.0 equiv.) were dissolved in 375 µl reaction 
buffer (100 mM sodium acetate, 150 mM NaCl, 80 mM MgCl2, pH 5.2). 30.0 µl of 
BSA-LxCu in reaction buffer (50 µg, 0.8 nmol, 2.2 10–4 equiv.) containing approx. 5 ng 
copper (0.08 nmol, 2.4 10–5 equiv.) was added. The polymerizations were started by 
adding 200 µl of deoxygenized 4.25 mM L-ascorbic acid solution (0.15 mg, 0.85 µmol, 
0.25 equiv.) in reaction buffer. The reactions were stirred for 20 h at room temperature 
and stopped by adding 605 µl non-deoxygenated reaction buffer and exposure to 
ambient air. 
A.1.8 ARGET ATRP of PEGA in Aqueous Solution 
0.1 ml PEGA (220.0 µmol, 66.7 equiv.) and HEBIB (0.7 mg, 3.3 µmol, 1.0 equiv.) 
were dissolved in 375 µl reaction buffer. 30 µl of BSA-LxCu in reaction buffer (50.0 
µg, 0.8 nmol, 2.2 10–4 equiv.) containing approx. 5 ng copper (0.08 nmol, 2.4 10–5 
equiv.) was added. The polymerizations were started by adding 200 µl of deoxygenized 
4.25 mM L-ascorbic acid solution (0.15 mg, 0.85 µmol, 0.25 equiv.) in reaction buffer. 
The reactions were stirred for 20 h at room temperature and stopped by adding 605 µl 
non-deoxygenated reaction buffer and exposure to ambient air. 
A.1.9 Precipitation Experiments 
BSA or Hb were prepared in concentrations of 0.5 mg ml–1, 1 mg ml–1  and 2 mg 
ml–1 in water. To these solution organic cosolvent (MeOH, EtOH and formamide) was 
added in vol.% of 5%, 10%, 15%, 20%, 30%, 40%, 50%, 60%, 70%, 80% and 90%. 
Subsequently, the protein absorbtion at 280 nm was measured with UV/Vis 
spectroscopy.  
 
 
                                           
317  SoluLink Company, Catalog and Reference Manual 2008. 
 120 
A.1.10 Dynabead Removal 
The procedure was performed according to the instruction manual.318 BSA was 
bound over an antibody-antigen recognition to magnetic spheres via rabbit IgG anti-
BSA antibody. The magnetic spheres were manipulated with a strong magnet to 
remove the BSA-catalyst complex from solution. Protein concentrations were 
determined from the UV/Vis absorption at 280 nm, using an extinction coefficient of 
43824 M–1 cm–1 for BSA.319 
                                           
318  “Dynabead Manual,” can be found under http://tools.lifetechnologies.com/content/sfs/manuals/ 
ImmunoprecipitationKitDynalProteinA_man.pdf, 2013. 
319  K. Hirayama, S. Akashi, M. Furuya, K. Fukuhara, Biochem. Biophys. Res. Commun. 1990, 173, 
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A.2 Horseradish Peroxidase as Catalyst for Atom Transfer 
Radical Polymerization  
A.2.1 Materials 
N-isopropylacrylamide (NiPAAm, 97%, Sigma-Aldrich) was purified by 
recrystallization from a hexane/toluene (2:1) mixture. Horseradish peroxidase (HRP; 
highly stabilized, essential salt-free, lyophilized powder with an activity of 200-300 
units per mg solid (using pyrogallol), P2088, Sigma-Aldrich), (+)-sodium L-ascorbate 
(Asc, ≥ 98%, Sigma-Aldrich), ethylene glycol (≥ 99%, Sigma-Aldrich), 
bromoisobutyryl bromide (98%, Sigma-Aldrich), pyridine (≥ 99.8%, Fluka) and 
dichloro methane (DCM, Baker) were used as received. NMR solvents were obtained 
from Cambridge Isotope Laboratories. The water soluble initiator 2-hydroxyethyl-2-
bromoisobutyrate (HEBIB) was synthesized according to a published protocol by the 
overnight reaction of ethylene glycol and bromoisobutyryl bromide in the presence of 
pyridine in DCM.320 
A.2.2 Methods 
The conversion of the reaction as well as the purity of the starting materials was 
determined by 1H NMR spectroscopy using a Bruker DPX-NMR (400 MHz) 
instrument. The solvents were D2O and CDCl3. All the measurements were performed 
at room temperature. Conversion was calculated from the baseline corrected spectra 
using the integrals of the signal at 5.59 ppm, which corresponds to one proton of the 
residual monomer, and the overlapping signals at 3.85 and 3.77 ppm, which correspond 
to one proton of the monomer and one of the polymer. The endgroup determination by 
NMR (1H COSY) and the 1H NMR spectrum was measured on a Bruker Ultrashield 
NMR (600 MHz) instrument with 7 mg of purified pNiPAAm dissolved in 0.5 ml of 
100% deuterated D2O.  
Neutron activation analysis (NAA) was performed by activation of 14 mg purified 
pNiPAAm at 2 kW for 30 min by thermal neutrons in the nuclear reactor of the 
Department of Physics, University of Basel. The quantitative analysis was performed 
using the main peak of 82Br at 776.517 keV with respect to an internal calibrated gold 
standard and validated against a bromine doped curcuma reference. The distinct 
gamma energy of the resulting nuclide was measured after 3 days with a Ge-detector.  
The number average molecular weight Mn and the polydispersity index (PDI) of 
the polymers were determined by gel permeation chromatography (GPC). The 
measurements were performed on an Agilent 1100 Series instrument equipped with 
Viscotek I-columns (I-GUARD-0478 (40 mm x 7.8 mm), I-MBHMW-3078 (300 mm x 
7.8 mm, exclusion limit > 10 106 g mol–1), and I-MBMMW-3078 (300 mm x 7.8 mm, 
exclusion limit > 2 105 g mol–1)) thermostated to 45°C and a refractive index detector 
maintained at 35°C. N,N-Dimethylformamide (DMF) containing 20 mM lithium 
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bromide was used as mobile phase with a flow rate of 1.0 ml min–1. Polystyrene 
standards were used for calibration.  
UV/Vis spectra were recorded on a Spectra Max M5e (Molecular Devices) in 1 cm 
quartz cuvettes. The step width was set to 1 nm. Circular dichroism (CD) spectroscopy 
was performed on a Chirascan CD spectrometer (Applied Photophysics) equipped with 
a thermostated cuvette holder (TC425, Quantum Northwest). The samples were 
measured at 22°C in 0.2 nm steps with a bandwidth of 1 nm and 1 s integration time 
using a 1 mm quartz cuvette. Spectra were averaged over five points. The protein 
concentration was adjusted to measure in a HT voltage range between 250 and 800 V 
in the far-UV region. Subsequently, the protein concentration was determined by 
UV/Vis spectroscopy using an extinction coefficient of 102 000 M−1 cm−1 at 403 nm.321 
Matrix-assisted laser desorption/ionization with time of flight detector mass 
spectrometry (MALDI-ToF MS) was carried out with a Voyager DE PRO (Perseptive 
Biosystems) in the linear mode using delayed extraction (750 ns), positive polarity, an 
accelerating voltage of 25000 V, a grid voltage of 93% and a guide wire voltage of 
0.15%. The mass spectra were averaged over a total of 1000 laser shots. Sinapic acid 
(Sigma-Aldrich) was used as matrix. 5 µl of aqueous sample solution was added to 10 
µl of a 21 mg ml–1 matrix solution in 50% acetonitrile and 0.1% trifluoroacetic acid. 2 
µl of the mixture were applied to a 100-well stainless steel plate and allowed to dry at 
room temperature.  
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed with self-casted 12% tris-glycine gels in a Biorad Miniprotean 3 cell setup 
at 200 V for 80 min. Novex Sharp Pre-stained Protein Standard (Invitrogen) was used 
as molecular weight marker. Acidic native gel electrophoresis was carried out using 
self-casted 10% acetate-glycine gels and tris-glycine as running buffer. The gel was run 
for 180 min at 80 V. All gels were Coomassie stained. 
A.2.3 Polymerizations 
Polymerizations were carried out in 100 mM sodium phosphate or 100 mM sodium 
carbonate buffers set to pH 5.2, 6.0, 6.5, 7.0, 7.5, 8.5, 9.5, and 10.5. Oxygen was 
removed from buffers by purging them with argon for 20 – 30 minutes. HEBIB (4.8 
ml, 7.0 mg, 33 mmol) and NiPAAm (255.0 mg, 2.253 mmol) were weighed into a two-
neck round bottom flask. HRP (5.0 mg, 0.11 mmol) and sodium ascorbate (9.0 mg, 45 
mmol) were weighted into two 2-ml glass vial and the vials were placed into two 10 ml 
two-neck round bottom flask. Air was removed from all the flasks in three evacuation 
and Argon flushing cycles. The vials fulfilled two purposes: They prevented the 
powders from being blown around by the argon and the one with the protein served as 
small-volume reaction vessel for the polymerization. The monomer and the initiator 
were dissolved in 3.0 ml oxygen-free buffer, the HRP in 0.2 ml and ascorbate in 1.2 ml 
of the same buffer. 0.3 ml of initiator/monomer solution was syringed to the HRP 
solution, and then the reaction was started by transferring 0.1 ml of the reducing agent 
solution into the HRP/NiPAAm/HEBIB solution in the vial by means of a syringe. The 
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ratio of reactants in the reaction mixture was 1:68:1.1:0.034 (HEBIB:NiPAAm:Asc: 
HRP) unless otherwise noted. The reaction was stirred at room temperature and 0.1 ml 
samples were removed for analytical purposes in periodic intervals. The analytical 
samples were exposed to air, and filtered over a small plug of neutral aluminium oxide. 
The plug was washed with additional 0.2 ml of water and the filtrates were combined. 
0.25 ml of filtrate was added to 0.25 ml of D2O and analyzed by 1H NMR to determine 
the conversion. Then the sample was lyophilized, redissolved in THF and filtered 
through a plug of neutral aluminium oxide in order to remove salts and protein. The 
THF was evaporated using a rotary evaporator to yield a white solid containing that 
was analyzed by GPC.  
For start- and end-group determination by NMR and NAA, a pNiPAAm sample 
was synthesized and purified to remove small molecules such as unreacted initiator, 
monomer, and salts. Polymerization was performed for 1.5 h with a ratio of 
1:20:0.66:0.009 (HEBIB:NiPAAm:Asc:HRP). After filtration through aluminum 
oxide, the crude product was extensively dialyzed against double distilled water 
(MWCO 1000 g mol–1). The product solution was lyophilized and the polymer (Mn = 
92500 g mol–1, PDI = 2.6 (GPC)) was analyzed using a 600 MHz NMR (1H, and 1H 
COSY) and NAA.  
HRP was purified at the end of typical polymerization reaction carried out at pH 
6.0 for 16 h in order to analyze its structural integrity. The polymerization mixture was 
centrifuged at 40°C at relative centrifugation force of 20000 g in a Sigma 3-18k 
centrifuge to remove PNIPAAm. The pellet was colorless, indicating that it did not 
contain HRP. The brown supernatant was subsequently buffer-exchanged three times 
with water in an Amicon Ultra-15 spin centrifugal filter unit (MWCO 3000 g mol–1), 
which removed small molecules like unreacted monomer and ascorbate. 
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A.3 Hemoglobin and Red Blood Cells  Catalyze Atom 
Transfer Radical Polymerization  
A.3.1 Materials 
Hemoglobin from bovine blood (Hb; lyophilized powder, H2500), hemin from 
bovine (≥ 90%), L-ascorbic acid (AscA; ≥ 98%), sodium L-ascorbate (≥ 98%) N,N-
dimethyl formamide (DMF; 99% (for synthesis) and Chromasolv plus (for gel 
permeation chromatography (GPC)), N-methyl-2-pyrrolidone (NMP; Chromasolv 
plus), lithium bromide (≥ 99%), copper bromide (≥ 98%,) 2-bromopropionitrile (BPN; 
97%), and the reagents for the Ellman’s test were purchased from Sigma-Aldrich, and 
used as received unless otherwise indicated. Ultraviolet/visible (UV/Vis) spectra of Hb 
solutions revealed that the commercial product was Hb in its iron(III) state, i.e., 
methemoglobin. N-isopropylacrylamide (NiPAAm; 97%, Sigma-Aldrich) was purified 
by recrystallization from a hexane/toluene (2:1) mixture. Poly(ethylene glycol) methyl 
ether acrylate (PEGA; Mn = 480 g mol−1, Sigma-Aldrich) and poly(ethylene glycol) 
methyl ether methacrylate (PEGMA; Mn = 500 g mol–1, Sigma-Aldrich) were passed 
over aluminum oxide prior to use in order to remove the inhibitor. N,N,N′,N′ 
Tetraethyldiethylenetriamine (TEDETA; 90%, Sigma-Aldrich) was distilled before 
use. N-(2-hydroxyethyl)maleimide (HEMI)322 and 2-hydroxyethyl-2-bromoisobutyrate 
(HEBIB)323 were synthesized according to published protocols. Polymerizations were 
carried out in double distilled water as the solvent unless otherwise stated. Oxygen was 
removed from water prior to polymerizations by purging it with argon for 30 min. 
NMR solvents were obtained from Cambridge Isotope Laboratories. Argon (99.998%, 
Carbagas) was used without further purification. Fresh human erythrocytes were 
obtained from the Corresponding Author by taking a 7.5 ml blood sample with a 
monovette EDTA KE blood collection system (Sarstedt), followed by centrifugation 
and removal of the blood plasma and of the buffy coat. 
A.3.2 Methods 
1H NMR spectroscopy was carried out with a Bruker DPX-NMR (400 MHz) 
instrument. All measurements were performed at room temperature. The purity of 
starting materials and the spectra of a purified pNiPAAm sample were determined 
using CDCl3 as solvent. The conversion of polymerizations was measured using a 
mixture of D2O and water as solvent. Conversion of NIPAAm was calculated from 
baseline-corrected spectra using the integrals of the signal at 5.59 ppm, which 
corresponds to one proton of the residual monomer, and the overlapping signals at 3.85 
and 3.77 ppm, which correspond to one proton of the monomer and one of the 
polymer. Conversion of PEGA was calculated accordingly from the integrals of the 
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peaks at 6.48, 6.21, 6.00 ppm (3H of monomer) and at 3.37 ppm (3H of monomer and 
polymer). Conversion of PEGMA was calculated accordingly from the integrals of the 
peak at 5.73 ppm (3H of monomer) and at 3.37 ppm (3H of monomer and polymer). 
The apparent number average molecular weight (Mn) based on polystyrene (PS) 
standards and the polydispersity index (PDI) of the polymers were determined by GPC. 
Measurements of pNiPAAm were performed on an Agilent 1100 Series instrument 
equipped with a refractive index detector. Two different column setups were used. The 
samples synthesized using native Hb and Cys-blocked Hb as catalyst were measured 
with three Viscotek I-columns (I-GUARD-0478 (40 mm x 7.8 mm), I-MBHMW-3078 
(300 mm x 7.8 mm, exclusion limit > 10 106 g mol–1), and I-MBMMW-3078 (300 mm 
x 7.8 mm, exclusion limit > 2 105 g mol–1)) thermostatted to 45°C, using DMF (with 20 
mM lithium bromide) as the mobile phase with a flow rate of 1.0 ml min–1. The 
samples obtained from polymerizations with erythrocytes were measured with a PLgel 
5 µm MIXED-C (300 x 7.5 mm, Varian) column plus a PLgel 3 µm (50 x 7.5 mm, 
Varian) guard column thermostatted to 70°C. In this case, the mobile phase was NMP 
(with 50 mM lithium bromide) with a flow rate of 1.0 ml min–1. PS standards were used 
for calibration of both setups. Control experiments with poly(methyl methacrylate) 
(PMMA) standards on the I-column setup showed the calibration curves to be similar: 
PMMA calibration results in apparent molecular weights 3-11% lower than PS 
calibration. Measurements of pPEGA were performed on a Viscotek GPCmax system 
using a refractive index detector, with Agilent PLgel columns (10 µm guard + 2 x 5 µm 
mixed C, or 10 µm guard + mixed C + 10 µm 100 Å + 5 µm 103 Å) thermostatted to 
30°C and THF as mobile phase at a flow rate of 1 ml min–1. Calibration was carried out 
with PS standards. For GPC analysis of PEGA and PEGMA polymerization kinetics, 
the polymer was not separated from the monomer during sample work (see above). As 
the peaks of residual monomer and polymer were not baseline-separated, a lower 
molecular weight limit was set to the polymer peak for Mn and PDI determination 
(PEGA polymerization with Cys-blocked Hb: log M = 3.08, PEGMA polymerization 
with Cys-blocked Hb: log M = 3.2, erythrocyte-catalyzed polymerization of PEGA: log 
M = 3.2). The limit was kept constant throughout the analysis of each kinetic run. NAA 
was performed by activation of 8 mg purified pNiPAAm at 2 kW for 30 min by 
thermal neutrons in the nuclear research reactor of the Department of Physics, 
University of Basel. The quantitative analysis was performed using the main peak of 
82Br at 776.517 keV with respect to an internal calibrated gold standard and validated 
against a bromine doped curcuma reference. The distinct gamma energy of the 
resulting nuclide was measured after 3 days with a Ge-detector. UV/Vis spectra were 
recorded on a Specord 210 Plus (Analytik Jena) in 1 cm quartz cuvettes. The spectra 
are reported as millimolar absorptivity (referring to one heme group and one globin 
subunit). To this end, heme concentration of samples were determined as 
cyanmethemoglobin:324 A dilution series of each sample was prepared using a solution 
that contained 200 mg l–1 K3Fe(CN)6, 50 mg l–1 KCN, and 1.0 g l–1 NaHCO3. After at 
least 20 min of incubation at room temperature, the absorbance at 540 nm of each 
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solution was measured. The sample’s heme concentration was calculated from this data 
by linear regression, using an extinction coefficient of 11.0 mM–1 cm–1.52 CD 
spectroscopy was performed on a Chirascan CD spectrometer (Applied Photophysics) 
equipped with a thermostatted cuvette holder (TC425, Quantum Northwest). The 
samples were measured at 22°C in 0.2 nm steps with a bandwidth of 1 nm and 1 s 
integration time using a 1 mm quartz cuvette. Spectra were averaged from two 
consecutive scans and smoothed over five data points. The protein concentration was 
adjusted so as to be able to measure within an HAT voltage range between 250 and 900 
V in the far-UV region. The protein concentration was determined by UV/Vis 
spectroscopy of cyanmethemoglobin complexes as described above. Ellipticities are 
reported on a molar heme basis. Sodium dodecyl sulfate (SDS) polyacrylamide gel 
electrophoresis was performed with self-casted 12% tris-glycine gels in a Biorad 
Miniprotean 3-cell setup at 200 V for 40 min. Novex Sharp Prestained Protein 
Standard or BenchMark Protein Ladder (Invitrogen) were used as molecular weight 
markers. Samples from polymerization reactions analyzed by SDS gel 
electrophoresiswere taken directly from the reaction mixture, and analyzed without 
prior filtration through aluminum oxide. 
A.3.3 Synthesis of Cys-Blocked Hb  
To eliminate the possibility of chain transfer reactions, the accessible cysteine 
groups of bovine Hb were modified with N-(2-hydroxyethyl)maleimide (HEMI). To 
this end, Hb (300 mg, 4.65 µmol) and HEMI (20.0 mg, 0.140 mmol) were incubated in 
300 ml of 100 mM sodium phosphate buffer (pH 6.5, 150 mM NaCl) for 2 h at 37°C. 
The protein was then desalted by spin diafiltration against 100 mM sodium phosphate 
buffer (pH 6.0, 150 mM NaCl) (2x) and against water (3x) using Amicon Ultra-15 spin 
centrifugal filter unit (molecular weight cutoff (MWCO) 10 000 g mol–1, Millipore). 
The degree of modification was analyzed by measuring the concentration of Hb’s 
accessible cysteines before and after modification with the Ellman’s test. 
A.3.4 NiPAAm Polymerization with Native Hb or Cys-Blocked Hb 
HEBIB (24 mg, 0.11 mmol) and NiPAAm (1016 mg, 8.978 mmol) were weighed 
into a two-neck round-bottom flask and dissolved in 15 ml water in an argon 
atmosphere. Solutions of native Hb and AscA were prepared by dissolving Hb (70.0 
mg, 1.09 µmol Hb tetramer) in 5 ml water and AscA (30.0 mg, 0.170 mmol) in 3 ml 
water in two-neck round-bottom flasks under an argon atmosphere. Cys-blocked Hb 
was obtained as stock solution from the modification step, and its concentration was 
measured by UV/Vis spectroscopy. The solution was diluted with water to obtain the 
same protein concentration as with native Hb. This solution was deprived of oxygen by 
purging with argon for 30 min. A polymerization was started by transferring 2 ml of 
AscA solution and 4.3 ml of either native Hb or Cys-blocked Hb solution to the 
initiator/monomer flask. The ratio of reactants in the reaction mixture was 1:79:1:0.008 
(HEBIB:NiPAAm:AscA:Hb; Hb refers to the full protein consisting of 4 heme groups 
and 4 globins) unless otherwise noted. The reaction was stirred at room temperature, 
and 1 ml samples were removed for analytical purposes at periodic intervals. The 
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analytical samples were exposed to air and filtered over a small plug of neutral 
aluminum oxide. The plug was washed with an additional 2 ml of nondeoxygenated 
water, and the filtrates were combined. The filtrate (0.4 ml) was added to 0.4 ml of 
D2O and analyzed by 1H NMR to determine the conversion. The remaining analytical 
sample was lyophilized to yield a solid that was redissolved in DMF (with 20 mM 
lithium bromide) and analyzed by GPC.  
pH-dependent reactions were carried out for 24 h in 100 mM KCl solution (set to 
pH = 1.5 with HCl), 100 mM sodium citrate buffer (pH = 3.2 after addition of 
ascorbate), 100 mM sodium acetate buffers (4.0, and 4.5 after addition of ascorbate) or 
100 mM sodium phosphate buffers (pH 5.0, 5.8, and 7.6 after addition of ascorbate), 
replacing AscA with sodium ascorbate as the reducing agent.  
Hb was purified at the end of a typical 24 h polymerization reaction in order to 
characterize the recovered protein with circular dichroism (CD) and UV/Vis 
spectroscopy. To this end, the polymerization mixture was centrifuged at 40°C at a 
relative centrifugation force of 15000 g in a Sigma 3-18k centrifuge to remove 
pNiPAAm. The supernatant was subsequently buffer-exchanged three times with water 
in an Amicon Ultra-15 spin centrifugal filter unit (MWCO 10000 g mol–1), which 
removed small molecules such as unreacted monomer and AscA. 
For bromine quantification by neutron activation analysis (NAA) and a chain 
extension experiment, a polymerization was stopped after 45 min (10% conversion). 
The polymer was purified as described above, followed by extensive dialysis against 
water (Spectra/Por 7 dialysis membrane, MWCO 1000; Spectrum Laboratories). Part 
of the sample solution was lyophilized and analyzed by NAA. The rest of the polymer 
was used as macroinitiator for conventional ATRP. To this end, NiPAAm (625 mg, 
5.52 mmol) was dissolved in 20 ml of the dialyzed polymer solution (3.53 mg ml–1 
pNiPAAm). The resulting mixture was purged with argon for 30 min. Solutions of 
CuBr (31.5 mg, 0.219 mmol) in 1 ml DMF and of TEDETA (22.6 µl, 88.0 µmol) in 
200 µl DMF were prepared. Both solutions were purged with argon. Then, 200 µl of 
the CuBr solution was transferred to the TEDETA solution. To start the 
polymerization, all of this catalyst solution was transferred to the flask that contained 
the macroinitiator/monomer solution. The reaction was stirred at room temperature for 
3 h under argon. It was stopped by exposing it to air and by adding 10 ml of 
nondeoxygenated water. The copper was removed by filtration over a basic aluminum 
oxide column. The nonreacted monomer was removed by extensive dialysis against 
water (Spectra/Por 7 dialysis membrane, MWCO 1000; Spectrum Laboratories). 
Finally, the solution was lyophilized to obtain a white solid.  
A control reaction with hemin instead of Hb was carried out overnight under argon 
atmosphere with deoxygenated reagent solutions. HEBIB (24 mg, 0.11 mmol) and 
NiPAAm (1044 mg, 9.226 mmol) were dissolved in 20 ml water. Hemin (4.0 mg, 6.1 
mmol) was dissolved in 4 ml DMSO. AscA (12.0 mg, 68 µmol) was dissolved in 2 ml 
water. The hemin solution (0.8 ml) and 1 ml of the AscA solution were transferred into 
the monomer/initiator solution. The reaction was stirred at room temperature overnight.  
To follow the polymerization in situ with UV/Vis spectroscopy, the reaction was 
downscaled to the volume of a standard cuvette. HEBIB (2.4 mg, 0.011 mmol) and 
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NiPAAm (100 mg, 0.884 mmol) were weighed into a sealable cuvette and dissolved in 
1.5 ml water. AscA (20.3 mg, 0.115 mmol) was dissolved in 2 ml water in a two-neck 
round-bottom flask. A solution of Cys-blocked Hb was diluted with water to a 
concentration of 12.4 mg ml–1 (0.193 µmol ml–1). All solutions were purged for 30 min 
with argon. The polymerization was started by transferring 0.5 ml of Hb solution and 
0.2 ml of AscA solution to the cuvette. The reaction was run at room temperature. The 
first spectrum was recorded directly after the addition of the AscA solution. Thereafter, 
spectra were recorded every 45 s, or every 4 min.  
A.3.5 PEGA and PEGMA Polymerization with Cys-Blocked Hb 
HEBIB (12 mg, 0.057 mmol) and monomer (PEGA: 2120 mg, 4.42 mmol; 
PEGMA: 2120 mg, 4.24 mmol) were weighed into a two-neck round-bottom flask and 
dissolved in 6 ml water in an argon atmosphere. Cys-blocked Hb stock solution was 
diluted with water to a concentration of 12.5 mg ml–1 and deprived of oxygen by 
purging with argon for 30 min. Polymerization was started by transferring 2 ml of 
AscA solution (30 mg ml–1 in the PEGA polymerization, 15 mg ml–1 in the PEGMA 
polymerization) and 2 ml of Cys-blocked Hb solution to the initiator/monomer flask. 
The ratios of reactants in the reaction mixture were 1:78:3:0.007 
(HEBIB:PEGA:AscA:Hb) and 1:75:1.5:0.008 (HEBIB:PEGMA:AscA:Hb). (Hb refers 
to the full protein consisting of 4 heme groups and 4 globins.) The reaction was stirred 
at room temperature, and 1 ml samples were removed for analytical purposes at 
periodic intervals and exposed to air. The analytical sample (0.5 ml) was diluted with 
0.5 ml of D2O and filtered over a small plug of neutral aluminum oxide. The filtrate 
was analyzed by 1H NMR to determine the conversion. The remaining analytical 
sample was mixed with 2 ml of tetrahydrofuran (THF). MgSO4 was added to remove 
the water, the sample was filtered through a Millex-LCR syringe filter (hydrophilic 
PTFE, 0.45 µm; Milipore), and the THF solution was analyzed by GPC. 
A.3.6 Polymerization with Erythrocytes 
Polymerizations with fresh human erythrocytes were carried out on the same day 
on which the blood sample was taken. NiPAAm polymerization: HEBIB (24 mg, 0.11 
mmol) and NiPAAm (1008 mg, 8.908 mmol) were weighed into a two-neck round-
bottom flask and dissolved in 15 ml water. The solution was purged for 30 min with 
argon. AscA (120 mg, 0.681 mmol) was dissolved in 3 ml deoxygenated water in a 
two-neck round-bottom flask under an argon atmosphere. Two milliliters of 
erythrocytes was purged with argon for 30 min and then diluted with 3 ml of 
deoxygenated water under an argon atmosphere. The polymerization was started by 
transferring 1.5 ml of AscA solution and 4 ml of erythrocyte suspension to the 
initiator/monomer flask. The reaction was stirred at room temperature for 24 h. 
Samples for 1H NMR and GPC analysis were prepared as described above. PEGA 
polymerization: HEBIB (12 mg, 0.057 mmol), and PEGA (2120 mg, 4.42 mmol) were 
weighed into a two-neck round-bottom flask and dissolved in 5 ml water. The solution 
was purged for 30 min with argon. AscA (60 mg, 0.34 mmol) was dissolved in 2 ml 
deoxygenated water in a two-neck round-bottom flask under an argon atmosphere. 
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Two ml of erythrocytes were purged with argon for 30 min. The polymerization was 
started by transferring 1 ml of AscA solution and 2 ml of erythrocyte suspension to the 
initiator/monomer flask. The reaction was stirred at room temperature. Samples for 1H 
NMR and GPC analysis were taken every hour and prepared for analysis as described 
above. 
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A.4 A Chaperonin as Protein Nanoreactor for Atom 
Transfer Radical Polymerization 
A.4.1 Materials 
Commercially available chemicals were purchased from Sigma-Aldrich and used 
without further purification unless otherwise noted. The linker 3-N-maleimido-6-
hydraziniumpyridine hydrochloride (MHPH) was obtained from SoluLink (San Diego, 
USA). NMR solvents were obtained from Cambridge Isotope Laboratories. Buffers 
were produced using double-distilled water. N-isopropyl acrylamide (NiPAAm) was 
recrystallized from a mixture of hexane and toluene (2:1 v/v). Poly(ethylene glycol) 
methylether acrylate (PEGA) with a number average molecular weight of 480 g mol–1 
was filtered over an neutral aluminium oxide column. 2-hydroxyethyl acrylate (HEA) 
and N,N,N',N'-tetraethyl-diethylenetriamine (TEDETA) were purified by vacuum 
distillation. 
Albumin from bovine serum (BSA) was purchased from Sigma-Aldrich 
(Switzerland) which was prepared using heat shock fractionation and may be referred 
to as Cohn Fraction V serum albumin. To encapsulate an ATRP catalyst into the 
thermosome (THS), a THS with three point mutations C363A (α-subunit), K316C (β-
subunit) and C364A (β-subunit) was used. The mutant was described previously.325 
The fermentation and purification of this THS was carried out as reported 
previously.323 In brief, the mutated α- and β-subunit genes were co-expressed in E. coli 
BL21 (DE3) Codon Plus-RIL. Fermentations were carried out in Terrific Broth 
medium at 30°C. Purification of THS was performed in three chromatography steps. 
An anion-exchange chromatography (column: HiPrep 16/10 Q FF, GE Healthcare) to 
capture the THS from the cell lysate was followed by size-exclusion chromatography 
(two columns in series: first a Superose 6 prep grade and second a HiPrep 16/60 
Sephacryl S-200 high resolution, GE Healthcare) to remove low molecular mass 
assemblies and single subunits. The sample was further purified by high-resolution 
anion-exchange chromatography (column: Mono Q 10/100 GL, GE Healthcare) to 
yield fully assembled THS with a α- to β-subunit ratio of 8:8.326 The corresponding 
fractions were identified by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and native PAGE. 
A.4.2 Methods  
Matrix-assisted laser desorption/ionization with time of flight detector mass 
spectrometry (MALDI-ToF MS) was carried out with a Voyager DE PRO (Perseptive 
Biosystems) in the linear mode using delayed extraction (750 ns), positive polarity, an 
accelerating voltage of 25000 V, a grid voltage of 93% and a guide wire voltage of 
0.15%. The mass spectra were averaged over a total of 1000 laser shots. pNiPAAm 
was separated from the protein cage by size exclusion spin centrifugation using 100k 
                                           
325  N. Bruns, K. Pustelny, L. M. Bergeron, T. A. Whitehead, D. S. Clark, Angew. Chem. Int. Ed. 
2009, 48, 5666–5669. 
326  M. G. Bigotti, A. R. Clarke, J. Mol. Biol. 2005, 348, 13–26. 
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MWCO diafiltration devices (Amicon Ultra, Millipore, MA, USA) at 13600 rpm 
leaving the THS in the supernatant while the polymer could be collected from the flow-
through. 5 µl of the flow-through was added to 10 µl of a 21 mg ml–1 sinapinic acid 
solution in 50% acetonitrile and 0.1% trifluoroacetic acid. 2 µl of the mixture were 
applied to a 100-well stainless steel plate and allowed to dry at room temperature. Data 
Explorer Software (Applied Biosystems) was used to calculate the number average 
molecular weight (Mn) and the polydispersity index (PDI) from the mass-spectra. 
The Mn and the PDI of the polymers were determined by gel permeation 
chromatography (GPC) unless otherwise noted. Samples for GPC (0.1 ml) were 
removed from the reaction mixture without separation of the protein and filtered over a 
small plug of basic aluminium oxide in order to remove salts and protein. The plug was 
washed with additional 0.2 ml of water and the filtrates were combined. Then the 
sample was lyophilized and redissolved in the appropriate GPC eluent to 
concentrations of 1 mg ml–1. The measurements of pNiPAAm were performed on an 
Agilent 1100 Series instrument equipped with Viscotek I-columns (I-GUARD-0478 
(40 mm x 7.8 mm), I-MBHMW-3078 (300 mm x 7.8 mm, exclusion limit > 10 106 g 
mol–1), and I-MBMMW-3078 (300 mm x 7.8 mm, exclusion limit > 2 105 g mol–1)) 
thermostated to 45°C and a refractive index detector maintained at 35°C. N,N-
dimethylformamide (DMF) containing 20 mM lithium bromide was used as mobile 
phase with a flow rate of 1.0 ml min–1. Poly(methyl methacrylate) standards (PSS, 
Mainz) were used for calibration. The measurements of Analysis of pPEGA was 
performed on an Agilent 1100 Series instrument equipped with Agilent PL aquagel-OH 
columns (PL aquagel-OH Guard 8 µm (50 mm x 7.5 mm), and PL aquagel-OH 
MIXED-M 8 µm (300 mm x 7.5 mm, exclusion limit > 6 105 g mol–1)) thermostated to 
30°C and a refractive index detector maintained at 35°C. 100 mM NaNO3 and 10 mM 
NaH2PO4 in aqueous solution at pH 7.0 containing 4:1 (v/v) MeOH was used as mobile 
phase with a flow rate of 1.0 ml min–1. Polyethylene oxide ReadyCal standards (PSS, 
Mainz) were used for calibration. Small angle X-ray scattering (SAXS) was performed 
on a Bruker AXS Nanostar with an Incoatec Cu - IµS Microfocus X-ray source (λ = 
0.154 nm), and a VANTEC 2000 2D detector. The measurements were done with 45 
kV and 650 µA and the integration time was 12 h. About 20 µl of sample with the 
concentration of 1.5 mg ml–1 was loaded into a glass capillary (d = 1 mm, thickness of 
the wall = 0.01 mm), the capillary was closed by melting the top of the capillary, the 
closed capillary was put into the Nanostar, vacuum was applied and the measurement 
was started. The data were azimuthally averaged with SAXS v.4.1.36 Bruker software 
and fitted with BrukerAXS Nanofit software (version 1.2.1.1). UV/Vis analyses were 
performed on a Lambda 35 spectrometer (Perkin Elmer) with 1 cm quartz cuvettes 
(Hellma, Germany) and on a NanoDrop (Thermo Scientific). Protein concentrations 
were determined from the absorption at 280 nm, using an extinction coefficient of 
210880 M–1 cm–1 for the hexadecameric THS complex327 and of 43824 M–1 cm–1 for 
                                           
327  N. Bruns, K. Pustelny, L. M. Bergeron, T. A. Whitehead, D. S. Clark, Angew. Chem. Int. Ed. 
2009, 48, 5666–5669. 
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BSA.328 1H NMR spectroscopy was carried out on a Bruker DPX-NMR (400 MHz) 
instrument. All experiments were performed at room temperature. Sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed with self-
casted 12% polyacrylamide gels and tris-HCl as running buffer in a Biorad 
Miniprotean 3 cell setup at 200 V for 70 min. Novex BenchMark Protein Ladder 
(Invitrogen) was used as molecular weight marker. Native gel electrophoresis was 
carried out using ready-casted 5% polyacrylamide gels (Biorad) and tris-glycine as 
running buffer. The gel was run for 180 min at 80 V. NativeMark Unstained Protein 
Standard (Invitrogen) was used as molecular weight marker. All gels were Coomassie 
stained with SimplyBlue SafeStain (Invitrogen). Gels were scanned on a Gel Doc EZ 
imager (Biorad). Graphical images of THS were produced with the UCSF Chimera 
package329 from the Resource for Biocomputing, Visualization and Informatics at the 
University of California, San Francisco. 
A.4.3 Preparation of THS-LxCu  
0.2 mg of THS (0.2 nmol, 1 equiv.) was diluted in 200 µl modification buffer (100 
mM NaH2PO4, 150 mM NaCl, pH 6.5). 1.5 µl of a 41.5 mM 3-N-maleimido-6-
hydraziniumpyridine hydrochloride (MHPH) solution (14.9 µg, 60.0 nmol, 270 equiv.) 
in dimethyl sulfoxide (DMSO) and 2 µl of a 100 mM phenylmethylsulfonylfluorid 
(PMSF) aqueous solution were added. The reaction mixture was incubated under 
shaking at 37°C for 2 h. Excess of reagents were removed and the buffer of the sample 
was changed using 100k MWCO diafiltration devices at 13600 rpm. The sample was 
first concentrated to 25 µl and the supernatant was then diluted three times with 0.5 ml 
conjugation buffer (100 mM sodium phosphate, 150 mM NaCl, pH 6.0) and 
reconcentrated. 50 µl of the resulting THS-MHPH solution (0.18 mg, 0.18 nmol, 1 
equiv.) was diluted in 350 µl conjugation buffer and 0.8 µl of a 21.5 mM solution of 
compound 1 (synthesis see A.1.3) in DMSO (6.5 µg, 14 nmol, 80 equiv.). 4 µl of the 
PMSF solution was added. The reaction mixture was shaken overnight at RT and 
concentrated with a 100k MWCO diafiltration device to 25 µl at 13600 rpm. Excess of 
reagents was removed and the buffer was exchanged to complexation buffer (100 mM 
sodium acetate, pH 5.2) with three spun cycles. To nine parts of THS-Lx solution (0.15 
mg, 0.16 nmol) one part of a 50 mM CuBr2 solution in complexation buffer was added. 
To remove non-complexed copper, the solution was concentrated to 25 µl with a 100k 
MWCO diafiltration device at 13600 rpm, three times diluted and reconcentrated with 
0.5 ml reaction buffer (100 mM sodium acetate, 150 mM NaCl, 80 mM MgCl2, pH 5.2) 
or ddH2O. Finally, the THS-LxCu solution was diluted with the corresponding solvent 
to a volume of 2.0 ml, yielding 0.1 mg (0.1 nmol) protein. The number of bis-aryl 
hydrazone linker groups that had formed was determined from the absorbance at 354 
nm using an extinction coefficient of (ε(hydrazone)354 nm = 29000 M–1 cm–1).330 UV/Vis 
                                           
328  K. Hirayama, S. Akashi, M. Furuya, K. Fukuhara, Biochem. Biophys. Res. Commun. 1990, 173, 
639–646. 
329  E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. 
Ferrin, J. Comput. Chem. 2004, 25, 1605–1612. 
330  SoluLink Company, Catalog and Reference Manual 2008. 
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data revealed that 3.9 ± 0.1 of the available 8 cysteins per THS carry a ligand. The CuII 
content of the THS-LxCu sample was estimated from the complexation efficiency of 
the ligand in BSA-LxCu (see A.1.5). If 3.9 ± 0.1 cysteins carry a ligand and 50% of the 
ligands in THS-LxCu complex CuII, a copper concentration of 135 ng per mg THS 
would be achieved.  
A.4.4 Preparation of BSA-4FB 
15 mg of BSA (220 nmol, 1 equiv.) was weighted into a falcon tube and dissolved 
in 15 ml modification buffer. 163 µl of a 41.5 mM MHPH solution (1.6 mg, 6.6 µmol, 
30.0 equiv.) in DMSO was added and the reaction mixture was incubated at 37°C 
while shaking for 2 h. The sample was concentrated to 250 µl using 30k MWCO 
diafiltration devices at 4700 rpm. The supernatant was then diluted three times with 15 
ml conjugation buffer and reconcentrated. 250 µl of the resulting BSA-MHPH solution 
(11.5 mg, 168.7 nmol, 1.0 equiv.) was diluted with 12 ml conjugation buffer. 90.0 µl of 
a 21.5 mM methyl 4-formylbenzoate (4FB) solution in DMSO (0.82 mg, 1.73 µmol, 
10.00 equiv.) was added. The reaction mixture was shaken overnight at RT and 
concentrated with a 30k MWCO diafiltration device to 250 µl at 4700 rpm. Buffer was 
exchanged to compexation buffer with three spun cycles. To nine parts of BSA-4FB 
solution (9.1 mg, 133.5 nmol) one part of a 50 mM CuBr2 solution in complexation 
buffer was added. To remove non-complexed copper, the solution was concentrated 
with a 30k MWCO diafiltration device to 250 µl at 4700 rpm, three times diluted and 
reconcentrated with 15 ml reaction buffer. Finally, the solution was diluted to a volume 
of 2.0 ml, yielding 5.8 mg (85.1 nmol) BSA-4FB 
A.4.5 MHPH Molar Substitution Ratio 
The 6-hydraziniumpyridine molar substitution ratio (MSR) for THS was 
determined by adding a 20 µl aliquot of a THS-MHPH or BSA-MHPH sample in 
conjugation buffer to 480 µl of a 0.5 mM 4-nitrobenzaldehyde solution in 100 mM 
sodium acetate buffer (pH 5.2). The solution was incubating at 37°C for 1 h and the 
absorbance at 390 nm (ε(hydrazone)390 nm = 24000 M–1 cm–1) was determined.331 A 
blank value determined with 20 µl conjugation buffer was subtracted. The 
determination of MSR was carried out in triplicates and the mean values and standard 
deviations are reported. The MSR for THS resulted in 7.7 ± 0.4 modified cysteins per 
THS, i.e. all eight thiol groups present in the THS could be modified. 
A.4.6 ARGET ATRP of NiPAAm 
25.0 mg NiPAAm (220 µmol, 66.7 equiv.) and 0.7 mg 2-hydroxyethyl-2-
bromoisobutyrate (HEBIB; 3.3 µmol, 1.0 equiv.) were dissolved in 375 µl reaction 
buffer (100 mM sodium acetate, 150 mM NaCl, 80 mM MgCl2, pH 5.2). 30.0 µl of 
THS-LxCu in reaction buffer (50.0 µg, 0.05 nmol, 1.5 10–5 equiv.) containing approx. 7 
ng copper (0.1 nmol, 3 10–5 equiv.) was added and the solution was deoxygenated by 
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bubbling with argon for 20 min. The polymerizations were started by adding 200 µl of 
deoxygenized 4.25 mM L-ascorbic acid solution (0.15 mg, 0.85 µmol, 0.25 equiv.) in 
reaction buffer. The reactions were stirred for 20 h at room temperature and stopped by 
adding 605 µl non-deoxygenated reaction buffer and exposure to aµbient air. The 
control reactions were performed accordingly but with 30.0 µl of native THS in 
reaction buffer (incubated with CuBr2 solution. Size exclusion spin centrifugation was 
used to remove the unbound copper; 50.0 µg, 0.05 nmol, 1.5 10–5 equiv.) or with 30.0 
µl of BSA-4FB in reaction buffer (50.0 µg, 0.8 nmol, 2.2 10–4 equiv.). 
A.4.7 ARGET ATRP of PEGA in Aqueous Solution 
0.1 ml PEGA (220.0 µmol, 66.7 equiv.) and HEBIB (0.7 mg, 3.3 µmol, 1.0 equiv.) 
were dissolved in 375 µl reaction buffer. 30 µl of THS-LxCu in reaction buffer (50 µg, 
0.05 nmol, 1.5 10–5 equiv.) containing approx. 7 ng copper (0.1 nmol, 3 10–5 equiv.) 
was added. Argon was bubbled trough the solution for 20 min. The polymerizations 
were started by adding 200 µl of deoxygenized 4.25 mM L-ascorbic acid solution (0.15 
mg, 0.85 µmol, 0.25 equiv.) in reaction buffer. The reactions were stirred for 20 h at 
room temperature and stopped by adding 605 µl non-deoxygenated reaction buffer and 
exposure to ambient air. The control reactions were performed accordingly but with 
30.0 µl of native THS in reaction buffer (incubated with CuBr2 solution. Size exclusion 
spin centrifugation was used to remove the unbound copper; 50.0 µg, 0.05 nmol, 1.5 
10–5 equiv.). 
A.4.8 ARGET ATRP of PEGA in the Presence of ATP 
0.1 ml PEGA (220 µmol, 66.7 equiv.), HEBIB (0.7 mg, 3.3 µmol, 1.0 equiv.) and 
170 µg adenosine 5’-diphosphate sodium salt (ATP; 395 nmol, 0.1 equiv.) were 
dissolved in 375 µl reaction buffer. 30 µl of THS-LxCu in reaction buffer (50 µg, 0.05 
nmol, 1.5 10–5 equiv.) containing approx. 7 ng copper (0.1 nmol, 3 10–5 equiv.) was 
added. Argon was bubbled trough the solution for 20 min. The polymerizations were 
started by adding 200 µl of deoxygenized 4.25 mM L-ascorbic acid solution (0.15 mg, 
0.85 µmol, 0.25 equiv.) in reaction buffer. The reactions were stirred for 20 h at room 
temperature and stopped by adding 605 µl non-deoxygenated reaction buffer and 
exposure to ambient air.  
A.4.9 ARGET ATRP of PEGA in a ddH2O/THF Mixture 
0.1 ml PEGA (220 µmol, 66.7 equiv.) and 0.7 mg HEBIB (3.3 µmol, 1.0 equiv.) 
were dissolved in 300 µl of a ddH2O/THF (7:3 v/v) mixture. 1500 µl of THS-LxCu in 
ddH2O (50 µg, 0.05 nmol, 1.5 10–5 equiv.) containing approx. 7 ng copper (0.1 nmol, 3 
10–5 equiv.) was added. Argon was bubbled through the solution for 20 min. For the 
reactions with BSA 150 µl of BSA-LxCu in ddH2O (50 µg, 0.8 nmol, 2.2 10–4 equiv.) 
containing approx. 5 ng copper (0.08 nmol, 2.4 10–5 equiv.) was added. The 
polymerizations were started by adding 100 µl of 3.15 mM sodium ascorbate solution 
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(0.75 mg, 3.75 µmol, 0.12 equiv.) in a ddH2O/THF (7:3 v/v) mixture. The reactions 
were stirred for 20 h and stopped by adding 550 µl non-deoxygenated ddH2O and 
exposure to ambient air. The control reactions were performed accordingly but with 30 
µl of native THS (incubated with CuBr2 solution. Size exclusion spin centrifugation 
was used to remove the unbound copper in ddH2O; 50.0 µg, 0.05 nmol, 1.5 10–5 equiv.) 
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A.5 Incorporation of ATRPases into Protein Nanoreactors  
A.5.1 Materials 
Commercially available chemicals were purchased from Sigma-Aldrich and used 
without further purification unless otherwise noted. The linkers maleimido trioxa-6-
formyl benzamide (MTFB) and succinimidyl 6-hydrazinonicotinate acetone hydrazine 
(HyNic) were obtained from SoluLink (San Diego, USA). Buffers were produced using 
double-distilled water. Poly(ethylene glycol) methylether acrylate (PEGA) with a 
number average molecular weight of 480 g mol–1 was filtered over a neutral aluminium 
oxide column. THS was expressed in E. coli as described above. 
A.5.2 Methods  
The Mn and the PDI of the polymers were determined by gel permeation 
chromatography (GPC) unless otherwise noted. Samples for GPC (0.1 ml) were 
removed from the reaction mixture without separation of the protein and filtered over a 
small plug of basic aluminium oxide in order to remove salts and protein. The plug was 
washed with additional 0.2 ml of water and the filtrates were combined. Then the 
sample was lyophilized and redissolved in the GPC eluent to concentrations of 1 mg 
ml–1. Measurements of pPEGA were performed on a Viscotek GPCmax system using a 
refractive index detector, with Agilent PLgel columns (10 µm guard + 2 x 5 µm mixed 
C, or 10 µm guard + mixed C + 10 µm 100 Å + 5 µm 103 Å) thermostatted to 30°C and 
THF as mobile phase at a flow rate of 1 ml min–1. Calibration was carried out with PS 
standards. Small angle X-ray scattering (SAXS) experiments were performed with a 
Bruker AXS Metaljet Nanostar. The X-ray are generated by focusing electrons onto a 
micro-size liquid metal jet of an allow consisting of 95% Ga and 5% In. This setup 
allows for a power load of > 100 kW mm2. The scattering patterns are detected by a 
Vantec 2000 2D detector. Exposure time were 3600 s. About 20 µl of sample with the 
concentration of 1.5 mg ml–1 was loaded into a glass capillary (d = 1 mm, thickness of 
the wall = 0.01 mm), the capillary was closed by melting the top of the capillary, the 
closed capillary was put into the Nanostar, vacuum was applied and the measurement 
was started. The data were azimuthally averaged with SAXS v.4.1.36 Bruker software 
and fitted with BrukerAXS Nanofit software (version 1.2.1.1). UV/Vis analyses were 
performed on a NanoDrop (Thermo Scientific). Protein concentrations were 
determined from the absorption at 280 nm, using an extinction coefficient of 210880 
M–1 cm–1 for the hexadecameric THS complex332 and of 102 000 M−1 cm−1 at 403 nm 
for HRP. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed with self-casted 12% polyacrylamide gels and tris-HCl as running buffer in 
a Biorad Miniprotean 3 cell setup at 200 V for 70 min. Novex BenchMark Protein 
Ladder (Invitrogen) was used as molecular weight marker. All gels were Coomassie 
stained with SimplyBlue SafeStain (Invitrogen). Gels were scanned on a Gel Doc EZ 
imager (Biorad). Graphical images of THS were produced with the UCSF Chimera 
                                           
332  N. Bruns, K. Pustelny, L. M. Bergeron, T. A. Whitehead, D. S. Clark, Angew. Chem. Int. Ed. 
2009, 48, 5666–5669. 
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package333 from the Resource for Biocomputing, Visualization and Informatics at the 
University of California, San Francisco. 
A.5.3 THS-MTFB Modification 
8.1 µl of 35.7 mM MTFB in DMSO was diluted in 41.9 µl modification buffer, 
which lead to 50 µl 5.78 mM MTFB. 100 µl of 10 µM THS was added to the 50 µl 5.78 
µM MTFB (150 µl 6.4 µM THS, 1.93 mM MTFB, > 25 fold excess of MTFB to cysteins 
in THS) and incubated under gentle shaking at 37°C for 2.5 h. The sample was 
centrifuged 4 times for 5 min at 13000 rpm and refilled every time with conjugation 
buffer at pH 6.0. The final sample was filled up to 200 µl with conjugation buffer and 
reversely centrifuged for 3 min at 3800 rpm to retrieve the sample. 
A.5.4 HRP-HyNic Modification 
HyNic stock solution: 20 µl 100 mM HyNic + 80 µl modification buffer = 100 µl 
20 mM HyNic. HRP stock solution: 1.76 mg HRP + 100 µl modification buffer = 100 
µl 400 µM HRP. 100 µl 400 µM HRP + 30 µl modification buffer + 20 µl 20 mM HyNic 
(150 µl 266.67 µM HRP, 2.67 mM HyNic, 10 fold excess of HyNic) were incubated for 
1.5 h at room temperature and shaked. The sample was centrifuged 4 times for 5 min at 
13400 rpm and refilled every time with conjugation buffer at pH 6.0. The final sample 
was filled up to 200 µl with conjugation buffer and reversely centrifuged for 3 min at 
3800 rpm to retrieve the sample. 
A.5.5 THS-HRP Conjugation 
200 µl THS-MTFB + 200 µl HRP-HyNic were incubated at room temperature 
under shaking for 14 h. The sample was then purified with HiPrep 16/60 Sephacryl 
S-200 column in modification buffer. The method used was MN HiPrep Sephacryl 
S200 THSHRP. A SDS-gel electrophoresis was performed and tubes were filtered 
with 0.22 µm filters and centrifuged (Amicon 5 ml 100 kDa, 5000 g, 3 min) to a 
final volume of 200 µl and an approx. amount of 1 mg THS-HRP. The successful 
conjugation was confirmed by SDS PAGE. The molecular substitution ratio (MSR) 
was calculated by determining the number of HRP molecules using the absorption 
at 403 nm. This value was deducted from the 280 nm signal, which is an overlay 
signal of THS and HRP.   
 
 
 
 
                                           
333  E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. 
Ferrin, J. Comput. Chem. 2004, 25, 1605–1612. 
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A.5.6 ARGET ATRP of PEGA in a ddH2O/THF Mixture 
0.1 ml PEGA (220 µmol, 66.7 equiv.) and 0.7 mg HEBIB (3.3 µmol, 1.0 equiv.) 
were dissolved in 300 µl of a ddH2O/THF (7:3 v/v) mixture. 1500 µl of THS-HRP in 
ddH2O (50 µg, 0.05 nmol, 1.5 10–5 equiv.) was added. Argon was bubbled through the 
solution for 20 min. The polymerizations were started by adding 100 µl of 3.15 mM 
sodium ascorbate solution (0.75 mg, 3.75 µmol, 0.12 equiv.) in a ddH2O/THF (7:3 v/v) 
mixture. The reactions were stirred for 20 h and stopped by adding 550 µl non-
deoxygenated ddH2O and exposure to ambient air.  
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A.6 The Archaeal Chaperonin Thermosome as ATP 
Triggerable Protein Nanoreactor 
A.6.1 Materials 
Commercially available chemicals were purchased from Sigma-Aldrich and used 
without further purification unless otherwise noted. Dithio-bis-(succinimidyl 
undecanoate) (DSU) was produced according to protocol.334 Expression of 
Thermosome in E. coli is described above. The conjugation of THS-HRP is reported in 
sections A.5.3 to A.5.5. 
A.6.2 Methods 
Kinetic experiments were performed on a SpectraMax M5e machine with following 
method: FL-Kinetic, excitation = 505 nm, emission = 535 nm, autocutoff. The 
measurement was done for 30 min with an intervall of 10 seconds and 6 readings. PMT 
was medium.  
A.6.3 Kinetic Experiments 
0.5 µl (2.25 mM) of dihydro Rhodamine 6G (dhRh6G) were added to 400 µl MES 
buffer (100 mM MES, 150 mM NaCl, 20 mM MgCl2). 200 µl of this solution was 
transferred into a FCS cuvette and 1 µl of the incubated (30 min, 37°C) ATP solutions 
listed in Table A.6.1 was added (3.5 µl for the ATP-AlFx solution). First, the cuvette 
was blanked, then 10 µl freshly prepared H2O2 (0.6%) was added and the FCS 
measurement was started. In order to assess how much H2O2 can also degrade dhRh6G 
in the absence of HRP, a no-HRP control was performed. The following SpectraMax 
method was used for all experiments: FL-Kinetic, excitation = 505 nm, emission = 535 
nm, autocutoff. The measurement was done for 30 min with an intervall of 10 seconds 
and 6 readings. PMT was medium. 
 
 
 
Table A.6.1 ATP solutions for kinetic experiments. 
A.6.4 Cantilever Array Coating 
Gold coated cantilevers (2 nm Ti and 20 nm Au, IBM Rüschlikon) were rinsed in 
EtOH, 5 min UV cleaning and again rinsed in EtOH. In a next step, reference 
                                           
334  P. Wagner, P. Kernen, M. Hegner, E. Ungewickell, G. Semenza, FEBS Lett. 1994, 356, 267–271. 
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cantilevers 1,3,5,7 with 11-mercapto-1-unedecanol and sample cantilevers 2,4,6,8 were 
functionalized with DSU. The functionalization was performed with a self-build 
apparatus for 45min at RT. Subsequently, the cantilevers were rinse 3x in EtOH and 6x 
in MES buffer (100 mM MES, 150 mM NaCl, 20 mM MgCl2). Finally, 25 µl THS in 20 
mM phosphate at pH 7.4 (520 nM) was added on the cantilevers and incubation for 30 
min. The functionalized cantilever array was then rinsed in MES buffer twice and 
assembled into the measuring chamber. 
A.6.5 Nanomechanical Sensing of Conformation Changes in THS 
Measurements were performed in static mode at 31°C with a constant flow of 1 µl 
min–1. After equilibration of the system with MES buffer the different ATP solutions 
according to Table A.6.1 were injected onto the cantilever array. The experiments were 
monitored with the NOSEtool software. The individual deflection curves of the sample 
and reference cantilevers were averaged and the difference is plotted. 
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